Gene,gene_allele,U2OS_cc_t_stat,U2OS_cc_t_pval,U2OS_abun_t_stat,U2OS_abun_t_pval,Metadata_Bio_Batch,AUROC_BioRep1_Morph,AUROC_BioRep1_AGP,AUROC_BioRep1_GFP,AUROC_BioRep1_Mito,AUROC_BioRep1_DNA,AUROC_BioRep2_Morph,AUROC_BioRep2_AGP,AUROC_BioRep2_GFP,AUROC_BioRep2_Mito,AUROC_BioRep2_DNA,AUROC_Mean_Morph,AUROC_Mean_AGP,AUROC_Mean_GFP,AUROC_Mean_Mito,AUROC_Mean_DNA,Altered_95th_perc_both_batches_Morph,Altered_95th_perc_both_batches_AGP,Altered_95th_perc_both_batches_GFP,Altered_95th_perc_both_batches_Mito,Altered_95th_perc_both_batches_DNA,Altered_99th_perc_Morph,Altered_99th_perc_AGP,Altered_99th_perc_GFP,Altered_99th_perc_Mito,Altered_99th_perc_DNA,image_assayed,symbol,ensembl_gene_id,orf_id,mut_id,ccsb_mutation_id,ccsb_allele_id,spdi,nt_change,aa_change,collection,entry_plate_orig,entry_well_orig,entry_plate_conso,entry_well_conso,entry_seq_pool,db_plate,db_well,n2h_plate,n2h_well,dualip_plate,dualip_well,mislocalization_plate,mislocalization_well,entry_sequenced,entry_sequence_confirmation_class,db_sequenced,db_sequence_confirmation_class,n2h_sequenced,n2h_sequence_confirmation_class,n2h_ref_sequence_confirmation_class,dualip_sequenced,dualip_sequence_confirmation_class,dualip_ref_sequence_confirmation_class,mislocalization_sequenced,mislocalization_sequence_confirmation_class,mislocalization_ref_sequence_confirmation_class,gene_variant,chr_num,nuc_loc,ref_allele,alt_allele,Chrom,entry_seq_final,db_seq_final,n2h_seq_final,dualip_seq_final,mislocalization_seq_final,varid,#AlleleID,Type,Name,GeneID,GeneSymbol,HGNC_ID,ClinicalSignificance,ClinSigSimple,LastEvaluated,RS# (dbSNP),nsv/esv (dbVar),RCVaccession,PhenotypeIDS,PhenotypeList,Origin,OriginSimple,Assembly,ChromosomeAccession,Chromosome,Start,Stop,Cytogenetic,ReviewStatus,NumberSubmitters,Guidelines,TestedInGTR,OtherIDs,SubmitterCategories,VariationID,PositionVCF,ReferenceAlleleVCF,AlternateAlleleVCF,SomaticClinicalImpact,SomaticClinicalImpactLastEvaluated,ReviewStatusClinicalImpact,Oncogenicity,OncogenicityLastEvaluated,ReviewStatusOncogenicity,SCVsForAggregateGermlineClassification,SCVsForAggregateSomaticClinicalImpact,SCVsForAggregateOncogenicityClassification,clinvar_nt_change,clinvar_aa_change,RefSeq_mRNA,StarStatus,clinvar_clnsig_clean,gnomad_af,clinvar_id,#chr,pos(1-based),ref,alt,aaref,aaalt,rs_dbSNP,hg19_chr,hg19_pos(1-based),hg18_chr,hg18_pos(1-based),aapos,genename,Ensembl_geneid,Ensembl_transcriptid,Ensembl_proteinid,Uniprot_acc,Uniprot_entry,HGVSc_snpEff,HGVSp_snpEff,HGVSc_VEP,HGVSp_VEP,APPRIS,GENCODE_basic,TSL,VEP_canonical,MANE,cds_strand,refcodon,codonpos,codon_degeneracy,Ancestral_allele,AltaiNeandertal,Denisova,VindijiaNeandertal,ChagyrskayaNeandertal,SIFT_score,SIFT_converted_rankscore,SIFT_pred,SIFT4G_score,SIFT4G_converted_rankscore,SIFT4G_pred,Polyphen2_HDIV_score,Polyphen2_HDIV_rankscore,Polyphen2_HDIV_pred,Polyphen2_HVAR_score,Polyphen2_HVAR_rankscore,Polyphen2_HVAR_pred,MutationTaster_score,MutationTaster_converted_rankscore,MutationTaster_pred,MutationTaster_model,MutationTaster_trees_benign,MutationTaster_trees_deleterious,MutationAssessor_score,MutationAssessor_rankscore,MutationAssessor_pred,PROVEAN_score,PROVEAN_converted_rankscore,PROVEAN_pred,VEST4_score,VEST4_rankscore,MetaSVM_score,MetaSVM_rankscore,MetaSVM_pred,MetaLR_score,MetaLR_rankscore,MetaLR_pred,Reliability_index,MetaRNN_score,MetaRNN_rankscore,MetaRNN_pred,M-CAP_score,M-CAP_rankscore,M-CAP_pred,REVEL_score,REVEL_rankscore,MutPred_score,MutPred_rankscore,MutPred_protID,MutPred_AAchange,MutPred_Top5features,MVP_score,MVP_rankscore,gMVP_score,gMVP_rankscore,MPC_score,MPC_rankscore,PrimateAI_score,PrimateAI_rankscore,PrimateAI_pred,DEOGEN2_score,DEOGEN2_rankscore,DEOGEN2_pred,BayesDel_addAF_score,BayesDel_addAF_rankscore,BayesDel_addAF_pred,BayesDel_noAF_score,BayesDel_noAF_rankscore,BayesDel_noAF_pred,ClinPred_score,ClinPred_rankscore,ClinPred_pred,LIST-S2_score,LIST-S2_rankscore,LIST-S2_pred,VARITY_R_score,VARITY_R_rankscore,VARITY_ER_score,VARITY_ER_rankscore,VARITY_R_LOO_score,VARITY_R_LOO_rankscore,VARITY_ER_LOO_score,VARITY_ER_LOO_rankscore,ESM1b_score,ESM1b_rankscore,ESM1b_pred,AlphaMissense_score,AlphaMissense_rankscore,AlphaMissense_pred,PHACTboost_score,PHACTboost_rankscore,MutFormer_score,MutFormer_rankscore,MutScore_score,MutScore_rankscore,Aloft_Fraction_transcripts_affected,Aloft_prob_Tolerant,Aloft_prob_Recessive,Aloft_prob_Dominant,Aloft_pred,Aloft_Confidence,CADD_raw,CADD_raw_rankscore,CADD_phred,DANN_score,DANN_rankscore,fathmm-XF_coding_score,fathmm-XF_coding_rankscore,fathmm-XF_coding_pred,Eigen-raw_coding,Eigen-raw_coding_rankscore,Eigen-phred_coding,Eigen-PC-raw_coding,Eigen-PC-raw_coding_rankscore,Eigen-PC-phred_coding,GERP++_NR,GERP++_RS,GERP++_RS_rankscore,GERP_91_mammals,GERP_91_mammals_rankscore,phyloP100way_vertebrate,phyloP100way_vertebrate_rankscore,phyloP470way_mammalian,phyloP470way_mammalian_rankscore,phyloP17way_primate,phyloP17way_primate_rankscore,phastCons100way_vertebrate,phastCons100way_vertebrate_rankscore,phastCons470way_mammalian,phastCons470way_mammalian_rankscore,phastCons17way_primate,phastCons17way_primate_rankscore,bStatistic,bStatistic_converted_rankscore,1000Gp3_AC,1000Gp3_AF,1000Gp3_AFR_AC,1000Gp3_AFR_AF,1000Gp3_EUR_AC,1000Gp3_EUR_AF,1000Gp3_AMR_AC,1000Gp3_AMR_AF,1000Gp3_EAS_AC,1000Gp3_EAS_AF,1000Gp3_SAS_AC,1000Gp3_SAS_AF,TOPMed_frz8_AC,TOPMed_frz8_AN,TOPMed_frz8_AF,gnomAD2.1.1_exomes_flag,gnomAD2.1.1_exomes_controls_AC,gnomAD2.1.1_exomes_controls_AN,gnomAD2.1.1_exomes_controls_AF,gnomAD2.1.1_exomes_controls_nhomalt,gnomAD2.1.1_exomes_non_neuro_AC,gnomAD2.1.1_exomes_non_neuro_AN,gnomAD2.1.1_exomes_non_neuro_AF,gnomAD2.1.1_exomes_non_neuro_nhomalt,gnomAD2.1.1_exomes_non_cancer_AC,gnomAD2.1.1_exomes_non_cancer_AN,gnomAD2.1.1_exomes_non_cancer_AF,gnomAD2.1.1_exomes_non_cancer_nhomalt,gnomAD2.1.1_exomes_controls_AFR_AC,gnomAD2.1.1_exomes_controls_AFR_AN,gnomAD2.1.1_exomes_controls_AFR_AF,gnomAD2.1.1_exomes_controls_AFR_nhomalt,gnomAD2.1.1_exomes_controls_AMR_AC,gnomAD2.1.1_exomes_controls_AMR_AN,gnomAD2.1.1_exomes_controls_AMR_AF,gnomAD2.1.1_exomes_controls_AMR_nhomalt,gnomAD2.1.1_exomes_controls_ASJ_AC,gnomAD2.1.1_exomes_controls_ASJ_AN,gnomAD2.1.1_exomes_controls_ASJ_AF,gnomAD2.1.1_exomes_controls_ASJ_nhomalt,gnomAD2.1.1_exomes_controls_EAS_AC,gnomAD2.1.1_exomes_controls_EAS_AN,gnomAD2.1.1_exomes_controls_EAS_AF,gnomAD2.1.1_exomes_controls_EAS_nhomalt,gnomAD2.1.1_exomes_controls_FIN_AC,gnomAD2.1.1_exomes_controls_FIN_AN,gnomAD2.1.1_exomes_controls_FIN_AF,gnomAD2.1.1_exomes_controls_FIN_nhomalt,gnomAD2.1.1_exomes_controls_NFE_AC,gnomAD2.1.1_exomes_controls_NFE_AN,gnomAD2.1.1_exomes_controls_NFE_AF,gnomAD2.1.1_exomes_controls_NFE_nhomalt,gnomAD2.1.1_exomes_controls_SAS_AC,gnomAD2.1.1_exomes_controls_SAS_AN,gnomAD2.1.1_exomes_controls_SAS_AF,gnomAD2.1.1_exomes_controls_SAS_nhomalt,gnomAD2.1.1_exomes_controls_POPMAX_AC,gnomAD2.1.1_exomes_controls_POPMAX_AN,gnomAD2.1.1_exomes_controls_POPMAX_AF,gnomAD2.1.1_exomes_controls_POPMAX_nhomalt,gnomAD2.1.1_exomes_non_neuro_AFR_AC,gnomAD2.1.1_exomes_non_neuro_AFR_AN,gnomAD2.1.1_exomes_non_neuro_AFR_AF,gnomAD2.1.1_exomes_non_neuro_AFR_nhomalt,gnomAD2.1.1_exomes_non_neuro_AMR_AC,gnomAD2.1.1_exomes_non_neuro_AMR_AN,gnomAD2.1.1_exomes_non_neuro_AMR_AF,gnomAD2.1.1_exomes_non_neuro_AMR_nhomalt,gnomAD2.1.1_exomes_non_neuro_ASJ_AC,gnomAD2.1.1_exomes_non_neuro_ASJ_AN,gnomAD2.1.1_exomes_non_neuro_ASJ_AF,gnomAD2.1.1_exomes_non_neuro_ASJ_nhomalt,gnomAD2.1.1_exomes_non_neuro_EAS_AC,gnomAD2.1.1_exomes_non_neuro_EAS_AN,gnomAD2.1.1_exomes_non_neuro_EAS_AF,gnomAD2.1.1_exomes_non_neuro_EAS_nhomalt,gnomAD2.1.1_exomes_non_neuro_FIN_AC,gnomAD2.1.1_exomes_non_neuro_FIN_AN,gnomAD2.1.1_exomes_non_neuro_FIN_AF,gnomAD2.1.1_exomes_non_neuro_FIN_nhomalt,gnomAD2.1.1_exomes_non_neuro_NFE_AC,gnomAD2.1.1_exomes_non_neuro_NFE_AN,gnomAD2.1.1_exomes_non_neuro_NFE_AF,gnomAD2.1.1_exomes_non_neuro_NFE_nhomalt,gnomAD2.1.1_exomes_non_neuro_SAS_AC,gnomAD2.1.1_exomes_non_neuro_SAS_AN,gnomAD2.1.1_exomes_non_neuro_SAS_AF,gnomAD2.1.1_exomes_non_neuro_SAS_nhomalt,gnomAD2.1.1_exomes_non_neuro_POPMAX_AC,gnomAD2.1.1_exomes_non_neuro_POPMAX_AN,gnomAD2.1.1_exomes_non_neuro_POPMAX_AF,gnomAD2.1.1_exomes_non_neuro_POPMAX_nhomalt,gnomAD2.1.1_exomes_non_cancer_AFR_AC,gnomAD2.1.1_exomes_non_cancer_AFR_AN,gnomAD2.1.1_exomes_non_cancer_AFR_AF,gnomAD2.1.1_exomes_non_cancer_AFR_nhomalt,gnomAD2.1.1_exomes_non_cancer_AMR_AC,gnomAD2.1.1_exomes_non_cancer_AMR_AN,gnomAD2.1.1_exomes_non_cancer_AMR_AF,gnomAD2.1.1_exomes_non_cancer_AMR_nhomalt,gnomAD2.1.1_exomes_non_cancer_ASJ_AC,gnomAD2.1.1_exomes_non_cancer_ASJ_AN,gnomAD2.1.1_exomes_non_cancer_ASJ_AF,gnomAD2.1.1_exomes_non_cancer_ASJ_nhomalt,gnomAD2.1.1_exomes_non_cancer_EAS_AC,gnomAD2.1.1_exomes_non_cancer_EAS_AN,gnomAD2.1.1_exomes_non_cancer_EAS_AF,gnomAD2.1.1_exomes_non_cancer_EAS_nhomalt,gnomAD2.1.1_exomes_non_cancer_FIN_AC,gnomAD2.1.1_exomes_non_cancer_FIN_AN,gnomAD2.1.1_exomes_non_cancer_FIN_AF,gnomAD2.1.1_exomes_non_cancer_FIN_nhomalt,gnomAD2.1.1_exomes_non_cancer_NFE_AC,gnomAD2.1.1_exomes_non_cancer_NFE_AN,gnomAD2.1.1_exomes_non_cancer_NFE_AF,gnomAD2.1.1_exomes_non_cancer_NFE_nhomalt,gnomAD2.1.1_exomes_non_cancer_SAS_AC,gnomAD2.1.1_exomes_non_cancer_SAS_AN,gnomAD2.1.1_exomes_non_cancer_SAS_AF,gnomAD2.1.1_exomes_non_cancer_SAS_nhomalt,gnomAD2.1.1_exomes_non_cancer_POPMAX_AC,gnomAD2.1.1_exomes_non_cancer_POPMAX_AN,gnomAD2.1.1_exomes_non_cancer_POPMAX_AF,gnomAD2.1.1_exomes_non_cancer_POPMAX_nhomalt,gnomAD4.1_joint_flag,gnomAD4.1_joint_AC,gnomAD4.1_joint_AN,gnomAD4.1_joint_AF,gnomAD4.1_joint_nhomalt,gnomAD4.1_joint_POPMAX_AC,gnomAD4.1_joint_POPMAX_AN,gnomAD4.1_joint_POPMAX_AF,gnomAD4.1_joint_POPMAX_nhomalt,gnomAD4.1_joint_AFR_AC,gnomAD4.1_joint_AFR_AN,gnomAD4.1_joint_AFR_AF,gnomAD4.1_joint_AFR_nhomalt,gnomAD4.1_joint_AMI_AC,gnomAD4.1_joint_AMI_AN,gnomAD4.1_joint_AMI_AF,gnomAD4.1_joint_AMI_nhomalt,gnomAD4.1_joint_AMR_AC,gnomAD4.1_joint_AMR_AN,gnomAD4.1_joint_AMR_AF,gnomAD4.1_joint_AMR_nhomalt,gnomAD4.1_joint_ASJ_AC,gnomAD4.1_joint_ASJ_AN,gnomAD4.1_joint_ASJ_AF,gnomAD4.1_joint_ASJ_nhomalt,gnomAD4.1_joint_EAS_AC,gnomAD4.1_joint_EAS_AN,gnomAD4.1_joint_EAS_AF,gnomAD4.1_joint_EAS_nhomalt,gnomAD4.1_joint_FIN_AC,gnomAD4.1_joint_FIN_AN,gnomAD4.1_joint_FIN_AF,gnomAD4.1_joint_FIN_nhomalt,gnomAD4.1_joint_MID_AC,gnomAD4.1_joint_MID_AN,gnomAD4.1_joint_MID_AF,gnomAD4.1_joint_MID_nhomalt,gnomAD4.1_joint_NFE_AC,gnomAD4.1_joint_NFE_AN,gnomAD4.1_joint_NFE_AF,gnomAD4.1_joint_NFE_nhomalt,gnomAD4.1_joint_SAS_AC,gnomAD4.1_joint_SAS_AN,gnomAD4.1_joint_SAS_AF,gnomAD4.1_joint_SAS_nhomalt,ALFA_European_AC,ALFA_European_AN,ALFA_European_AF,ALFA_African_Others_AC,ALFA_African_Others_AN,ALFA_African_Others_AF,ALFA_East_Asian_AC,ALFA_East_Asian_AN,ALFA_East_Asian_AF,ALFA_African_American_AC,ALFA_African_American_AN,ALFA_African_American_AF,ALFA_Latin_American_1_AC,ALFA_Latin_American_1_AN,ALFA_Latin_American_1_AF,ALFA_Latin_American_2_AC,ALFA_Latin_American_2_AN,ALFA_Latin_American_2_AF,ALFA_Other_Asian_AC,ALFA_Other_Asian_AN,ALFA_Other_Asian_AF,ALFA_South_Asian_AC,ALFA_South_Asian_AN,ALFA_South_Asian_AF,ALFA_Other_AC,ALFA_Other_AN,ALFA_Other_AF,ALFA_African_AC,ALFA_African_AN,ALFA_African_AF,ALFA_Asian_AC,ALFA_Asian_AN,ALFA_Asian_AF,ALFA_Total_AC,ALFA_Total_AN,ALFA_Total_AF,clinvar_clnsig,clinvar_trait,clinvar_review,clinvar_hgvs,clinvar_var_source,clinvar_MedGen_id,clinvar_OMIM_id,clinvar_Orphanet_id,Interpro_domain,aaref_3,aaalt_3,#AlleleID_dbnsfp,Type_dbnsfp,Name_dbnsfp,GeneID_dbnsfp,GeneSymbol_dbnsfp,HGNC_ID_dbnsfp,ClinicalSignificance_dbnsfp,ClinSigSimple_dbnsfp,LastEvaluated_dbnsfp,RS# (dbSNP)_dbnsfp,nsv/esv (dbVar)_dbnsfp,RCVaccession_dbnsfp,PhenotypeIDS_dbnsfp,PhenotypeList_dbnsfp,Origin_dbnsfp,OriginSimple_dbnsfp,Assembly_dbnsfp,ChromosomeAccession_dbnsfp,Chromosome_dbnsfp,Start_dbnsfp,Stop_dbnsfp,Cytogenetic_dbnsfp,ReviewStatus_dbnsfp,NumberSubmitters_dbnsfp,Guidelines_dbnsfp,TestedInGTR_dbnsfp,OtherIDs_dbnsfp,SubmitterCategories_dbnsfp,VariationID_dbnsfp,PositionVCF_dbnsfp,ReferenceAlleleVCF_dbnsfp,AlternateAlleleVCF_dbnsfp,SomaticClinicalImpact_dbnsfp,SomaticClinicalImpactLastEvaluated_dbnsfp,ReviewStatusClinicalImpact_dbnsfp,Oncogenicity_dbnsfp,OncogenicityLastEvaluated_dbnsfp,ReviewStatusOncogenicity_dbnsfp,SCVsForAggregateGermlineClassification_dbnsfp,SCVsForAggregateSomaticClinicalImpact_dbnsfp,SCVsForAggregateOncogenicityClassification_dbnsfp,clinvar_nt_change_dbnsfp,clinvar_aa_change_dbnsfp,RefSeq_mRNA_dbnsfp,StarStatus_dbnsfp,clinvar_clnsig_clean_dbnsfp,plddt,rsa,OMIM_IDs,inheritance_pattern,disease_modules,disease_module_count,OMIM_disease_names,protein_AA,protein_Accessible surface area (Å²)*,protein_Acetylation,protein_Active site (UniProt),protein_AlphaFold confidence (pLDDT),protein_Amino acid properties,protein_Amino acid residues,protein_Binding site (UniProt),protein_Chain (UniProt),protein_Coiled coil (UniProt),protein_Compositional bias (UniProt),protein_Cross-link (UniProt),protein_DNA binding (UniProt),protein_Disease-associated PTMs,protein_Disulfide bond (UniProt),protein_Domain (UniProt),protein_Druggability score (fpocket)*,protein_Glycosylation (UniProt),protein_Hydropathy,protein_Initiator methionine (UniProt),protein_Inter-chain Disulfide bond (PDB),protein_Inter-chain Hydrogen bond (PDB),protein_Inter-chain Non-bonded interaction (PDB),protein_Inter-chain Salt bridge (PDB),protein_Intra-chain Disulfide bond (AlphaFold2),protein_Intra-chain Disulfide bond (PDB),protein_Intra-chain Hydrogen bond (AlphaFold2),protein_Intra-chain Hydrogen bond (PDB),protein_Intra-chain Non-bonded interaction (AlphaFold2),protein_Intra-chain Non-bonded interaction (PDB),protein_Intra-chain Salt bridge (AlphaFold2),protein_Intra-chain Salt bridge (PDB),protein_Intramembrane (UniProt),protein_Lipidation (UniProt),protein_Methylation,protein_Modified residue (UniProt),protein_Molar mass (g/mol),protein_Motif (UniProt),protein_Mutagenesis (UniProt),protein_Non-adjacent residues (UniProt),protein_Non-standard residue (UniProt),protein_Non-terminal residue (UniProt),protein_O-GalNAc,protein_O-GlcNAc,protein_Peptide (UniProt),protein_Phi angle (degrees)*,protein_Phosphorylation,protein_Pocket number (fpocket)*,protein_Propeptide (UniProt),protein_Psi angle (degrees)*,protein_Region (UniProt),protein_Regulatory sites,protein_Repeat (UniProt),protein_SNP-associated PTMs,protein_SUMOylation,protein_Secondary structure (DSSP 3-state)*,protein_Secondary structure (DSSP 9-state)*,protein_Secondary structure (PDBe/SIFTS),protein_Sequence conflict (UniProt),protein_Sequence uncertainty (UniProt),protein_Signal (UniProt),protein_Site (UniProt),protein_Substrate genes,protein_Topological domain (UniProt),protein_Transit peptide (UniProt),protein_Transmembrane (UniProt),protein_Ubiquitination,protein_Zinc finger (UniProt),protein_00000005-a-1 avg,protein_00000005-a-1 outliers⁺⁺,protein_00000005-a-2 avg,protein_00000005-a-2 outliers⁺⁺,protein_00000005-a-3 avg,protein_00000005-a-3 outliers⁺⁺,protein_00000005-a-4 avg,protein_00000005-a-4 outliers⁺⁺,protein_00000061-a-1 avg,protein_00000061-a-1 outliers⁺⁺,protein_00000061-b-1 avg,protein_00000061-b-1 outliers⁺⁺,protein_00000061-c-1 avg,protein_00000061-c-1 outliers⁺⁺,protein_00000061-d-1 avg,protein_00000061-d-1 outliers⁺⁺,protein_00000061-e-1 avg,protein_00000061-e-1 outliers⁺⁺,protein_00000061-f-1 avg,protein_00000061-f-1 outliers⁺⁺,protein_00000061-g-1 avg,protein_00000061-g-1 outliers⁺⁺,protein_00000061-h-1 avg,protein_00000061-h-1 outliers⁺⁺,protein_00000061-i-1 avg,protein_00000061-i-1 outliers⁺⁺,protein_00001002-a-1 avg,protein_00001002-a-1 outliers⁺⁺,protein_00000911-a-1 avg,protein_00000911-a-1 outliers⁺⁺,protein_00000875-a-1 avg,protein_00000875-a-1 outliers⁺⁺,protein_00000107-a-1 avg,protein_00000107-a-1 outliers⁺⁺,protein_00000107-b-1 avg,protein_00000107-b-1 outliers⁺⁺,protein_00000114-a-1 avg,protein_00000114-a-1 outliers⁺⁺,protein_00001007-a-1 avg,protein_00001007-a-1 outliers⁺⁺,protein_00000674-a-1 avg,protein_00000674-a-1 outliers⁺⁺,protein_00000674-a-2 avg,protein_00000674-a-2 outliers⁺⁺,protein_00000674-a-3 avg,protein_00000674-a-3 outliers⁺⁺,protein_00000674-a-4 avg,protein_00000674-a-4 outliers⁺⁺,protein_00000998-a-1 avg,protein_00000998-a-1 outliers⁺⁺,protein_00000108-a-1 avg,protein_00000108-a-1 outliers⁺⁺,protein_00000108-a-2 avg,protein_00000108-a-2 outliers⁺⁺,protein_00000108-a-3 avg,protein_00000108-a-3 outliers⁺⁺,protein_00000066-a-1 avg,protein_00000066-a-1 outliers⁺⁺,protein_00000736-a-1 avg,protein_00000736-a-1 outliers⁺⁺,protein_00000990-a-1 avg,protein_00000990-a-1 outliers⁺⁺,protein_00000096-a-1 avg,protein_00000096-a-1 outliers⁺⁺,protein_00000096-b-1 avg,protein_00000096-b-1 outliers⁺⁺,protein_00000926-a-1 avg,protein_00000926-a-1 outliers⁺⁺,protein_00000927-a-1 avg,protein_00000927-a-1 outliers⁺⁺,protein_00000928-a-1 avg,protein_00000928-a-1 outliers⁺⁺,protein_00000059-a-1 avg,protein_00000059-a-1 outliers⁺⁺,protein_00000068-a-1 avg,protein_00000068-a-1 outliers⁺⁺,protein_00000068-b-1 avg,protein_00000068-b-1 outliers⁺⁺,protein_00000068-c-1 avg,protein_00000068-c-1 outliers⁺⁺,protein_00001211-0-2 avg,protein_00001211-0-2 outliers⁺⁺,protein_00001211-a-10 avg,protein_00001211-a-10 outliers⁺⁺,protein_00001211-a-11 avg,protein_00001211-a-11 outliers⁺⁺,protein_00001211-a-12 avg,protein_00001211-a-12 outliers⁺⁺,protein_00001211-a-13 avg,protein_00001211-a-13 outliers⁺⁺,protein_00001211-a-14 avg,protein_00001211-a-14 outliers⁺⁺,protein_00001211-a-15 avg,protein_00001211-a-15 outliers⁺⁺,protein_00001211-a-16 avg,protein_00001211-a-16 outliers⁺⁺,protein_00001211-a-9 avg,protein_00001211-a-9 outliers⁺⁺,protein_00000803-a-1 avg,protein_00000803-a-1 outliers⁺⁺,protein_00001205-a-1 avg,protein_00001205-a-1 outliers⁺⁺,protein_00000925-a-1 avg,protein_00000925-a-1 outliers⁺⁺,protein_00000057-a-1 avg,protein_00000057-a-1 outliers⁺⁺,protein_00000057-b-1 avg,protein_00000057-b-1 outliers⁺⁺,protein_00000057-c-1 avg,protein_00000057-c-1 outliers⁺⁺,protein_00000057-d-1 avg,protein_00000057-d-1 outliers⁺⁺,protein_00000703-a-1 avg,protein_00000703-a-1 outliers⁺⁺,protein_00000067-a-1 avg,protein_00000067-a-1 outliers⁺⁺,protein_00000706-a-1 avg,protein_00000706-a-1 outliers⁺⁺,protein_00001050-a-1 avg,protein_00001050-a-1 outliers⁺⁺,protein_00000787-a-1 avg,protein_00000787-a-1 outliers⁺⁺,protein_00000013-b-1 avg,protein_00000013-b-1 outliers⁺⁺,protein_00000051-c-1 avg,protein_00000051-c-1 outliers⁺⁺,protein_00001102-a-1 avg,protein_00001102-a-1 outliers⁺⁺,protein_00000060-a-1 avg,protein_00000060-a-1 outliers⁺⁺,protein_00000060-a-2 avg,protein_00000060-a-2 outliers⁺⁺,protein_00001090-a-1 avg,protein_00001090-a-1 outliers⁺⁺,protein_00000045-a-1 avg,protein_00000045-a-1 outliers⁺⁺,protein_00000045-b-1 avg,protein_00000045-b-1 outliers⁺⁺,protein_00000045-c-1 avg,protein_00000045-c-1 outliers⁺⁺,protein_00000045-d-1 avg,protein_00000045-d-1 outliers⁺⁺,protein_00000045-e-1 avg,protein_00000045-e-1 outliers⁺⁺,protein_00000045-f-1 avg,protein_00000045-f-1 outliers⁺⁺,protein_00000045-g-1 avg,protein_00000045-g-1 outliers⁺⁺,protein_00000045-h-1 avg,protein_00000045-h-1 outliers⁺⁺,protein_00000045-i-1 avg,protein_00000045-i-1 outliers⁺⁺,protein_00000045-j-1 avg,protein_00000045-j-1 outliers⁺⁺,protein_00000045-k-1 avg,protein_00000045-k-1 outliers⁺⁺,protein_00000045-l-1 avg,protein_00000045-l-1 outliers⁺⁺,protein_00000895-a-1 avg,protein_00000895-a-1 outliers⁺⁺,protein_00000809-a-1 avg,protein_00000809-a-1 outliers⁺⁺,protein_00000810-a-1 avg,protein_00000810-a-1 outliers⁺⁺,protein_00000939-a-1 avg,protein_00000939-a-1 outliers⁺⁺,protein_00000050-a-1 avg,protein_00000050-a-1 outliers⁺⁺,protein_00000858-a-1 avg,protein_00000858-a-1 outliers⁺⁺,protein_00000112-a-1 avg,protein_00000112-a-1 outliers⁺⁺,protein_00000747-a-1 avg,protein_00000747-a-1 outliers⁺⁺,protein_00000847-a-1 avg,protein_00000847-a-1 outliers⁺⁺,protein_00001062-a-1 avg,protein_00001062-a-1 outliers⁺⁺,protein_00000657-a-1 avg,protein_00000657-a-1 outliers⁺⁺,protein_00000657-a-2 avg,protein_00000657-a-2 outliers⁺⁺,protein_00000738-a-1 avg,protein_00000738-a-1 outliers⁺⁺,protein_00000091-a-1 avg,protein_00000091-a-1 outliers⁺⁺,protein_00000708-a-1 avg,protein_00000708-a-1 outliers⁺⁺,protein_00000978-a-1 avg,protein_00000978-a-1 outliers⁺⁺,protein_00000710-a-1 avg,protein_00000710-a-1 outliers⁺⁺,protein_00000659-a-1 avg,protein_00000659-a-1 outliers⁺⁺,protein_00000748-a-1 avg,protein_00000748-a-1 outliers⁺⁺,protein_00000685-a-1 avg,protein_00000685-a-1 outliers⁺⁺,protein_00001204-a-2 avg,protein_00001204-a-2 outliers⁺⁺,protein_00001204-a-3 avg,protein_00001204-a-3 outliers⁺⁺,protein_00001204-a-4 avg,protein_00001204-a-4 outliers⁺⁺,protein_00001204-a-6 avg,protein_00001204-a-6 outliers⁺⁺,protein_00001206-a-1 avg,protein_00001206-a-1 outliers⁺⁺,protein_00001206-a-2 avg,protein_00001206-a-2 outliers⁺⁺,protein_00001082-a-1 avg,protein_00001082-a-1 outliers⁺⁺,protein_00000899-a-1 avg,protein_00000899-a-1 outliers⁺⁺,protein_00000780-a-1 avg,protein_00000780-a-1 outliers⁺⁺,protein_00000095-a-1 avg,protein_00000095-a-1 outliers⁺⁺,protein_00000095-b-1 avg,protein_00000095-b-1 outliers⁺⁺,protein_00001051-a-1 avg,protein_00001051-a-1 outliers⁺⁺,protein_00001003-a-1 avg,protein_00001003-a-1 outliers⁺⁺,protein_00000664-a-1 avg,protein_00000664-a-1 outliers⁺⁺,protein_00000664-a-2 avg,protein_00000664-a-2 outliers⁺⁺,protein_00000664-a-3 avg,protein_00000664-a-3 outliers⁺⁺,protein_00000664-a-4 avg,protein_00000664-a-4 outliers⁺⁺,protein_00000664-a-6 avg,protein_00000664-a-6 outliers⁺⁺,protein_00000963-a-1 avg,protein_00000963-a-1 outliers⁺⁺,protein_00000739-a-1 avg,protein_00000739-a-1 outliers⁺⁺,protein_00001087-a-1 avg,protein_00001087-a-1 outliers⁺⁺,protein_00001053-a-1 avg,protein_00001053-a-1 outliers⁺⁺,protein_00001032-a-1 avg,protein_00001032-a-1 outliers⁺⁺,protein_00001033-a-1 avg,protein_00001033-a-1 outliers⁺⁺,protein_00001034-a-1 avg,protein_00001034-a-1 outliers⁺⁺,protein_00000959-a-1 avg,protein_00000959-a-1 outliers⁺⁺,protein_00001177-a-1 avg,protein_00001177-a-1 outliers⁺⁺,protein_00000001-d-2 avg,protein_00000001-d-2 outliers⁺⁺,protein_00000966-a-1 avg,protein_00000966-a-1 outliers⁺⁺,protein_00000013-a-1 avg,protein_00000013-a-1 outliers⁺⁺,protein_00000101-a-1 avg,protein_00000101-a-1 outliers⁺⁺,protein_00000102-0-1 avg,protein_00000102-0-1 outliers⁺⁺,protein_00000745-a-1 avg,protein_00000745-a-1 outliers⁺⁺,protein_00000746-a-1 avg,protein_00000746-a-1 outliers⁺⁺,protein_00001065-a-1 avg,protein_00001065-a-1 outliers⁺⁺,protein_00000686-a-1 avg,protein_00000686-a-1 outliers⁺⁺,protein_00001112-a-1 avg,protein_00001112-a-1 outliers⁺⁺,ID,Dataset,Gene_pp,HGNC_id,STRAND,hg19_pos,hg38_start,hg38_end,auth_transcript_id,transcript_pos,transcript_ref,transcript_alt,aa_pos,aa_ref,aa_alt,hgvs_c,hgvs_p,consequence,simplified_consequence,auth_reported_score,auth_reported_rep_score,auth_reported_func_class,splice_measure,gnomad_MAF,clinvar_sig,clinvar_star,clinvar_date_last_reviewed,nucleotide_or_aa,MaveDB URN (score set),Ensembl_transcript_ID,Ref_seq_transcript_ID,Model_system,Assay Type ontology term,Phenotype Measured ontology term,Molecular or Biological Process Investigated (GO term),IGVF_produced,Interval 1 name,Interval 1 range,Interval 1 MaveDB class,Interval 2 name,Interval 2 range,Interval 2 MaveDB class,Interval 3 name,Interval 3 range,Interval 3 MaveDB class,Interval 4 name,Interval 4 range,Interval 4 MaveDB class,Interval 5 name,Interval 5 range,Interval 5 MaveDB class,Interval 6 name,Interval 6 range,Interval 6 MaveDB class,Flag,REVEL,AM_score,AM_class,Segregation LR_PMID:31131967,Pathology LR_PMID:31131967,Co-occurrence LR_PMID:31131967,Family History LR_PMID:31131967,Case-Control LR_PMID:31131967,Combined LR (Odds for Causality)_PMID:31131967,Prior Probability of Pathogenicity_PMID:31131967,Comment regarding class assignment_PMID:31131967,IARC Class_PMID:31131967,Naive_prior_prob_PMID:31131967,Calcualted_post_prob_PMID:31131967,calculated_classification_PMID:31131967,SGR LR_PMID:34273903,Personal and Family History LR (Combined)_PMID:34273903,Breast Tumor Pathology LR_PMID:34273903,Population Allele Frequency LR_PMID:34273903,BS2 LR_PMID:34273903,Classification by multifactorial model_PMID:34273903,Calculated_combined_LR_PMID:34273903,Naive_prior_prob_PMID:34273903,Calculated_post_prob_PMID:34273903,calculated_classification_PMID:34273903,Reference Group*_presumed_PMID:34273903,Component_presumed_PMID:34273903,Rationale_presumed_PMID:34273903,ClinVar Variation Id_ClinGen_repo,Allele Registry Id_ClinGen_repo,Disease_ClinGen_repo,Mondo Id_ClinGen_repo,Mode of Inheritance_ClinGen_repo,Assertion_ClinGen_repo,Applied Evidence Codes (Met)_ClinGen_repo,Applied Evidence Codes (Not Met)_ClinGen_repo,Summary of interpretation_ClinGen_repo,PubMed Articles_ClinGen_repo,Expert Panel_ClinGen_repo,Guideline_ClinGen_repo,Approval Date_ClinGen_repo,Published Date_ClinGen_repo,Retracted_ClinGen_repo,Evidence Repo Link_ClinGen_repo,Uuid_ClinGen_repo,Updated_Classification_ClinGen_repo,Updated_Evidence Codes_ClinGen_repo,gene_variant_pp,aa_change_pp,Pillar_VarChAMP_Match
BRCA1,BRCA1_Thr587Arg,-0.4548873787721197,0.6629621326061451,7.926953340626399,0.00009664275201696506,2025_01_Batch_13-14,0.9122962314024993,0.914388731015901,0.8807865638647172,0.9193700972050594,0.8179770783922686,0.9243496868775378,0.8900549220076304,0.9045064548376147,0.9357637402398886,0.8313383016906821,0.9183229591400186,0.9022218265117656,0.892646509351166,0.927566918722474,0.8246576900414754,true,false,false,false,true,0.0,0.0,0.0,0.0,0.0,true,BRCA1,ENSG00000012048,14613,218425.0,CCSBVarC003304,ALE00003304,NC_000017.11:43067610:G:C,1760C>G,Thr587Arg,CEGS2,CegsMutGDEh1003,H05,GDEhDisVCh_40059,C01,1.0,,,,,,,,,1.0,1.0,0.0,,0.0,,,0.0,,,0.0,,,BRCA1_Thr587Arg,17.0,43067610.0,G,C,17,Y,N,N,N,N,17-43067610-G-C,70040.0,single nucleotide variant,NM_007294.4(BRCA1):c.5072C>G (p.Thr1691Arg),672.0,BRCA1,HGNC:1100,Likely pathogenic,1.0,"Oct 04, 2021",80357034.0,-,RCV000577017|RCV001077998|RCV002257395,"MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162","Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome",germline;not applicable,germline,GRCh38,NC_000017.11,17,43067610.0,43067610.0,17q21.31,"criteria provided, multiple submitters, no conflicts",4.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,ClinGen:CA003189,3.0,55373.0,43067610.0,G,C,-,-,-,-,-,-,SCV002537807|SCV002644099,-,-,5072C>G ,Thr1691Arg,NM_007294.4,2.0,1_Pathogenic,,55373.0,17,43067610.0,G,C,T,R,rs80357034,17,41219627.0,17,38473153.0,1691.0,BRCA1,ENSG00000012048,ENST00000618469,ENSP00000478114,P38398,BRCA1_HUMAN,.,.,c.5072C>G,p.Thr1691Arg,principal2,Y,1,.,.,-,ACA,2.0,0.0,G,G/G,G/G,G/G,G/G,.,0.91343,.,.,0.92967,.,0.585,0.90580,P,0.218,0.92348,B,.,.,.,.,.,.,3.175,0.88626,M,.,0.81626,.,.,0.90585,0.5201,0.90791,D,0.6944,0.89429,D,10,.,0.86953,.,0.786117,0.98314,D,.,0.94900,.,.,.,.,.,.,0.94962,.,0.79901,.,0.15475,0.765162229538,0.76658,T,0.292953,0.76109,T,0.409641,0.90394,D,0.350645,0.90276,D,0.983474791049957,0.74950,D,0.952305,0.85727,D,0.955418,0.96765,0.8308187,0.90111,0.950228,0.96231,0.7571084,0.85471,-6.573,0.63425,T,.,0.88256,.,0.991494696303718,0.89054,0.99986839,0.99835,0.994,0.99793,.,.,.,.,.,.,4.249871,0.64569,24.7,0.995002398050606,0.68015,0.838290,0.75493,D,0.775208299271413,0.84447,8.314456,0.736429675756228,0.85057,8.492664,5.24,5.24,0.72825,.,.,6.008,0.70468,11.808000,0.96854,0.569,0.28905,1.0,0.71675,1.0,0.68239,0.985,0.61072,545,0.72635,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Likely_pathogenic,"Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1","criteria_provided,_multiple_submitters,_no_conflicts",NC_000017.11:g.43067610G>C,ClinGen:CA003189,C0346153|C0027672|C2676676,114480|604370,227535|140162|145,BRCT domain|BRCT domain|BRCT domain,Thr,Arg,70040.0,single nucleotide variant,NM_007294.4(BRCA1):c.5072C>G (p.Thr1691Arg),672.0,BRCA1,HGNC:1100,Likely pathogenic,1.0,"Oct 04, 2021",80357034.0,-,RCV000577017|RCV001077998|RCV002257395,"MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162","Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome",germline;not applicable,germline,GRCh38,NC_000017.11,17,43067610.0,43067610.0,17q21.31,"criteria provided, multiple submitters, no conflicts",4.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,ClinGen:CA003189,3.0,55373.0,43067610.0,G,C,-,-,-,-,-,-,SCV002537807|SCV002644099,-,-,5072C>G ,Thr1691Arg,NM_007294.4,2.0,1_Pathogenic,96.65,0.1126760563380281,"['114480', '604370']",multiple,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST CANCER; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Findlay_2018_var1780,BRCA1_Findlay_2018,BRCA1,1100,-1.0,41219627.0,43067610.0,43067610.0,NM_007294.3,5072,C,G,1691.0,T,R,c.5072C>G,p.Thr1691Arg,Missense,missense_variant,-2.04963143395105,-1.74773225393897;-2.35153061396312,LOF,Yes,,Likely pathogenic,"criteria provided, multiple submitters, no conflicts","Oct 04, 2021",nucleotide,urn:mavedb:00000097-0-2,ENST00000357654.9,NM_007294.3,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,Functional ,"[-0.748, Inf)",Normal,Intermediate,"(-1.328, -0.748)",Not specified,Non-functional,"(-Inf,-1.328]",Abnormal,,,,,,,,,,,0.838,0.9075,likely_pathogenic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Thr1691Arg,Thr1691Arg,false
BRCA1,BRCA1_Met1Ile,6.765004300970164,0.0002614050448425321,-8.007642466557492,0.0000905951237529456,2025_01_Batch_13-14,0.965432133065669,0.9708351231137582,0.9923100505613676,0.9890790736252655,0.9369278802773922,0.942537676845391,0.9128446786942379,0.9834795160559991,0.9841944238913661,0.876088559150052,0.95398490495553,0.941839900903998,0.9878947833086833,0.9866367487583159,0.9065082197137221,true,true,true,true,true,0.0,0.0,1.0,0.0,1.0,true,BRCA1,ENSG00000012048,14613,218379.0,CCSBVarC003295,ALE00003295,NC_000017.11:43124094:C:A,3G>T,Met1Ile,CEGS2,CegsMutGDEh1009,D10,GDEhDisVCh_40059,B03,1.0,,,,,,,,,1.0,4.0,0.0,,0.0,,,0.0,,,0.0,,,BRCA1_Met1Ile,17.0,43124094.0,C,A,17,N,N,N,N,N,17-43124094-C-A,69739.0,single nucleotide variant,NM_007294.4(BRCA1):c.3G>T (p.Met1Ile),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Jun 18, 2019",80357475.0,-,RCV000048405|RCV000111552|RCV000131890|RCV000763402|RCV001357041,"MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MedGen:C3661900","Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Familial cancer of breast;Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4|not provided",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43124094.0,43124094.0,17q21.31,reviewed by expert panel,10.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,ClinGen:CA002562,2.0,55072.0,43124094.0,C,A,-,-,-,-,-,-,SCV001161632,-,-,3G>T ,Met1Ile,NM_007294.4,3.0,1_Pathogenic,6.84988e-7,55072.0,17,43124094.0,C,A,M,I,rs80357475,17,41276111.0,17,38529637.0,1.0,BRCA1,ENSG00000012048,ENST00000470026,ENSP00000419274,P38398,BRCA1_HUMAN,c.3G>T,p.Met1?,c.3G>T,p.Met1?,principal2,Y,1,.,.,-,ATG,3.0,0.0,C,C/C,C/C,C/C,C/C,0.0,0.91343,D,0.009,0.92967,D,0.924,0.51298,P,0.878,0.62305,P,.,0.99291,.,.,.,.,.,.,.,-0.56,0.54406,N,.,0.93850,0.5223,0.90822,D,0.7099,0.90000,D,9,0.9873682,0.99089,D,0.932498,0.99511,D,0.696,0.88959,0.996,0.99957,E9PFC7,M1I,Gain of catalytic residue at M1 (P = 0.0314)| Loss of disorder (P = 0.1193)| Loss of loop (P = 0.1242)| Gain of helix (P = 0.2684)| Loss of phosphorylation at S4 (P = 0.3332),0.887736870969,0.88576,.,0.24402,.,.,.,.,.,0.280176,0.65093,T,0.398321,0.89744,D,0.334384,0.89616,D,0.996361911296844,0.89105,D,.,0.64967,.,0.90739095,0.91937,0.707353,0.82542,0.9052275,0.91737,0.64797,0.79185,-12.231,0.90483,D,.,.,.,0.999999926062728,0.99831,0.99954283,0.99470,.,.,.,.,.,.,.,.,4.144486,0.62186,24.4,0.9963500389217754,0.76291,0.062568,0.11864,N,0.34664899273018,0.58348,4.029269,0.312639291828477,0.56049,3.791295,3.83,3.83,0.43219,.,.,3.426,0.52638,3.191000,0.36784,-0.284,0.0639,1.0,0.71675,1.0,0.68239,0.255,0.23438,469,0.78193,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,1,1612162,6.202850e-07,0,1,1178330,8.486590e-07,0,0,74994,0.000000e+00,0,0,912,0.000000e+00,0,0,60018,0.000000e+00,0,0,29594,0.000000e+00,0,0,44826,0.000000e+00,0,0,64006,0.000000e+00,0,0,6024,0.000000e+00,0,1,1178330,8.486590e-07,0,0,91032,0.000000e+00,0,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Pathogenic,"Hereditary_cancer-predisposing_syndrome|not_provided|Familial_cancer_of_breast|Fanconi_anemia,_complementation_group_S|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Pancreatic_cancer,_susceptibility_to,_4|Hereditary_breast_ovarian_cancer_syndrome",reviewed_by_expert_panel,NC_000017.11:g.43124094C>A,ClinGen:CA002562,C0027672|C3661900|C0346153|C4554406|C2676676|C3280442|C0677776,114480|617883|604370|614320,140162|227535|145|1333|145,.,Met,Ile,69739.0,single nucleotide variant,NM_007294.4(BRCA1):c.3G>T (p.Met1Ile),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Jun 18, 2019",80357475.0,-,RCV000048405|RCV000111552|RCV000131890|RCV000763402|RCV001357041,"MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MedGen:C3661900","Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Familial cancer of breast;Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4|not provided",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43124094.0,43124094.0,17q21.31,reviewed by expert panel,10.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,ClinGen:CA002562,2.0,55072.0,43124094.0,C,A,-,-,-,-,-,-,SCV001161632,-,-,3G>T ,Met1Ile,NM_007294.4,3.0,1_Pathogenic,41.59,1.0,"['604370', '114480', '617883', '604370', '614320']",multiple,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST CANCER; FANCONI ANEMIA, COMPLEMENTATION GROUP S; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Findlay_2018_var74,BRCA1_Findlay_2018,BRCA1,1100,-1.0,41276111.0,43124094.0,43124094.0,NM_007294.3,3,G,T,1.0,M,I,c.3G>T,p.Met1Ile,Missense,missense_variant,-1.89730149043368,-2.08725907807767;-1.70734390278969,LOF,Yes,6.202850582013471e-7,Pathogenic,reviewed by expert panel,"Jun 18, 2019",nucleotide,urn:mavedb:00000097-0-2,ENST00000357654.9,NM_007294.3,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,Functional ,"[-0.748, Inf)",Normal,Intermediate,"(-1.328, -0.748)",Not specified,Non-functional,"(-Inf,-1.328]",Abnormal,,,,,,,,,,,0.696,,,1.9734,3.73,,,,7.360782,0.96,Multifac new calc,Pathogenic,0.1,0.44990404492890385,VUS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Met1Ile,Met1Ile,true
BRCA1,BRCA1_Pro533Leu,-0.7528200911783965,0.47610774311243165,5.735636261825845,0.0007088088193576657,2025_01_Batch_13-14,0.8966973181666507,0.9046777827911453,0.8366561191366582,0.8836138891142781,0.846603016213943,0.9912462879532155,0.9120658558726263,0.9363661078945147,0.9848881106736286,0.8643488539991834,0.9439718030599331,0.9083718193318858,0.8865111135155864,0.9342509998939533,0.8554759351065632,true,false,false,false,true,0.0,0.0,0.0,0.0,0.0,true,BRCA1,,14613,,CCSBVarC013043,,NC_000017.11:43071004:G:A,1598C>T,Pro533Leu,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Pro533Leu,17.0,43071004.0,G,A,17,,,,,,17-43071004-G-A,69981.0,single nucleotide variant,NM_007294.4(BRCA1):c.4910C>T (p.Pro1637Leu),672.0,BRCA1,HGNC:1100,Benign,0.0,"Aug 10, 2015",80357048.0,-,RCV000048691|RCV000077589|RCV000162989|RCV000586145|RCV001084321|RCV001358461|RCV004554683,"MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142|","not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast|BRCA1-related disorder",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43071004.0,43071004.0,17q21.31,reviewed by expert panel,15.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00090,ClinGen:CA003076,UniProtKB:P38398#VAR_007794",2.0,55314.0,43071004.0,G,A,-,-,-,-,-,-,SCV000244372,-,-,4910C>T ,Pro1637Leu,NM_007294.4,3.0,2_Benign,,55314.0,17,43071004.0,G,A,P,L,rs80357048,17,41223021,17,38476547,1637.0,BRCA1,ENSG00000012048,ENST00000713676,ENSP00000518978,P38398,BRCA1_HUMAN,.,.,c.4910C>T,p.Pro1637Leu,principal2,Y,.,.,.,-,CCA,2.0,0.0,G,G/G,G/G,G/G,G/G,.,0.58783,.,.,0.79703,.,0.364,0.66535,B,0.057,0.65195,B,.,0.53339,.,.,.,.,1.935,0.51654,L,.,0.81462,.,.,0.43554,0.4923,0.90403,D,0.7232,0.90488,D,10,.,0.62760,.,0.458461,0.94460,D,.,0.82485,.,.,.,.,.,.,0.90380,.,0.27141,.,0.09620,0.296533286572,0.09880,T,0.271505,0.64184,T,0.206619,0.74322,D,0.189468,0.82413,D,0.231254577636719,0.21745,T,.,0.48325,.,0.038577784,0.05118,0.050610814,0.07993,0.046824034,0.07827,0.055308446,0.09687,-3.524,0.18016,T,.,0.23603,.,0.544346036701319,0.62126,0.99945563,0.99403,0.431,0.66835,.,.,.,.,.,.,2.130503,0.27171,17.35,0.98451927561516039,0.41758,0.144722,0.26561,N,0.0679651651785688,0.44715,2.761733,-0.0712680779194096,0.36281,2.130881,4.82,4.82,0.61594,2.66,0.48641,0.768,0.26344,6.732000,0.56527,-0.105,0.15707,0.75,0.29224,1.0,0.68239,0.031,0.13278,543,0.72771,.,.,.,.,.,.,.,.,.,.,.,.,4,264690,1.51120175E-5,.,1,109402,9.140600e-06,0,7,208052,3.364540e-05,0,5,236818,2.111330e-05,0,0,7164,0.000000e+00,0,0,17110,0.000000e+00,0,0,2320,0.000000e+00,0,0,9046,0.000000e+00,0,0,13390,0.000000e+00,0,1,42768,2.338200e-05,0,0,15690,0.000000e+00,0,1,42768,2.338200e-05,0,0,16218,0.000000e+00,0,0,30522,0.000000e+00,0,0,6212,0.000000e+00,0,0,13416,0.000000e+00,0,0,16730,0.000000e+00,0,7,89482,7.822800e-05,0,0,30608,0.000000e+00,0,7,89482,7.822800e-05,0,0,14902,0.000000e+00,0,0,34258,0.000000e+00,0,0,9572,0.000000e+00,0,0,17692,0.000000e+00,0,0,21626,0.000000e+00,0,5,102628,4.871960e-05,0,0,30526,0.000000e+00,0,5,102628,4.871960e-05,0,.,60,1614068,3.717320e-05,0,57,1180046,4.830320e-05,0,0,74916,0.000000e+00,0,0,912,0.000000e+00,0,0,60004,0.000000e+00,0,0,29608,0.000000e+00,0,0,44898,0.000000e+00,0,0,64024,0.000000e+00,0,0,6084,0.000000e+00,0,57,1180046,4.830320e-05,0,0,91086,0.000000e+00,0,1,19780,5.0556117290192114E-5,0,298,0,0,86,0,0,7864,0,0,146,0,0,610,0,0,26,0,0,98,0,0,1982,0,0,8162,0,0,112,0,1,30890,3.237293622531564E-5,Benign,"Hereditary_cancer-predisposing_syndrome|Malignant_tumor_of_breast|BRCA1-related_disorder|not_provided|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|not_specified",reviewed_by_expert_panel,NC_000017.11:g.43071004G>A,BRCA1-HCI:BRCA1_00090|ClinGen:CA003076|UniProtKB:P38398#VAR_007794,C0027672|C0006142|C3661900|C0677776|C2676676|CN169374,604370,140162|145|145,.,Pro,Leu,69981.0,single nucleotide variant,NM_007294.4(BRCA1):c.4910C>T (p.Pro1637Leu),672.0,BRCA1,HGNC:1100,Benign,0.0,"Aug 10, 2015",80357048.0,-,RCV000048691|RCV000077589|RCV000162989|RCV000586145|RCV001084321|RCV001358461|RCV004554683,"MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142|","not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast|BRCA1-related disorder",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43071004.0,43071004.0,17q21.31,reviewed by expert panel,15.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00090,ClinGen:CA003076,UniProtKB:P38398#VAR_007794",2.0,55314.0,43071004.0,G,A,-,-,-,-,-,-,SCV000244372,-,-,4910C>T ,Pro1637Leu,NM_007294.4,3.0,2_Benign,27.9,0.8455882352941176,['604370'],,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Findlay_2018_var1257,BRCA1_Findlay_2018,BRCA1,1100,-1.0,41223021.0,43071004.0,43071004.0,NM_007294.3,4910,C,T,1637.0,P,L,c.4910C>T,p.Pro1637Leu,Missense,missense_variant,-0.417492856234616,-1.01659904827619;0.181613335806954,FUNC,Yes,0.0000371731550343,Benign,reviewed by expert panel,"Aug 10, 2015",nucleotide,urn:mavedb:00000097-0-2,ENST00000357654.9,NM_007294.3,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,Functional ,"[-0.748, Inf)",Normal,Intermediate,"(-1.328, -0.748)",Not specified,Non-functional,"(-Inf,-1.328]",Abnormal,,,,,,,,,,,0.571,0.1163,likely_benign,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Pro1637Leu,Pro1637Leu,false
BRCA1,BRCA1_Thr37Lys,-0.25728289233865603,0.80435939653231,4.817455604826412,0.0019270976461462776,2025_01_Batch_13-14,0.8174092776879838,0.9099221991247153,0.8751460309326402,0.8792001815247644,0.6670508282803029,0.9365262887156782,0.87455061964549,0.9119290812243445,0.9543367207758721,0.9395910456374548,0.876967783201831,0.8922364093851026,0.8935375560784924,0.9167684511503182,0.8033209369588789,false,false,false,false,false,0.0,0.0,0.0,0.0,0.0,true,BRCA1,,14613,,CCSBVarC011837,,NC_000017.11:43115750:G:T,110C>A,Thr37Lys,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Thr37Lys,17.0,43115750.0,G,T,17,,,,,,17-43115750-G-T,68798.0,single nucleotide variant,NM_007294.4(BRCA1):c.110C>A (p.Thr37Lys),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Aug 10, 2015",80356880.0,-,RCV000111781|RCV000763401|RCV001378528|RCV002433536,"MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162","Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast;Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43115750.0,43115750.0,17q21.31,reviewed by expert panel,7.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00112,ClinGen:CA000742",2.0,54131.0,43115750.0,G,T,-,-,-,-,-,-,SCV000244295,-,-,110C>A ,Thr37Lys,NM_007294.4,3.0,1_Pathogenic,,54131.0,17,43115750.0,G,T,T,K,rs80356880,17,41267767,17,38521293,37.0,BRCA1,ENSG00000012048,ENST00000357654,ENSP00000350283,P38398,BRCA1_HUMAN,c.110C>A,p.Thr37Lys,c.110C>A,p.Thr37Lys,principal2,Y,1,YES,Select,-,ACA,2.0,0.0,G,G/G,G/G,G/G,G/G,0.0,0.91343,D,0.0,0.92967,D,0.979,0.90580,D,0.777,0.92348,P,0.99,0.99291,A,simple_aae,1.0,99.0,2.54,0.73893,M,-0.91,0.87019,N,0.909,0.91390,1.0434,0.97975,D,0.9155,0.97195,D,10,0.9803947,0.97988,D,0.597518,0.96439,D,0.823,0.94336,0.94,0.99178,E9PFC7,T37K,Gain of methylation at T37 (P = 0.0325)| Gain of disorder (P = 0.0355)| Gain of ubiquitination at T37 (P = 0.0369)| Loss of catalytic residue at T37 (P = 0.1105)| Loss of sheet (P = 0.1158),0.980248173759,0.97984,.,0.87940,.,0.46547,0.74592012167,0.73798,T,0.4401,0.88719,T,0.478281,0.93590,D,0.449241,0.93510,D,0.992633044719696,0.83032,D,.,0.77715,.,0.9560325,0.96828,0.8919265,0.94327,0.96704304,0.97946,0.84243727,0.90882,-15.301,0.98159,D,0.9729,0.92484,P,0.992970792932514,0.89793,0.99969053,0.99611,0.962,0.98414,.,.,.,.,.,.,4.997611,0.82936,27.9,0.99301403670490562,0.58711,0.726971,0.67428,D,0.984277674482382,0.95215,13.43596,0.917667809072401,0.96277,14.52852,5.97,5.97,0.96929,.,.,4.401,0.59561,11.711000,0.94660,0.676,0.76753,1.0,0.71675,1.0,0.68239,0.998,0.85369,464,0.78507,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Pathogenic,"Hereditary_breast_ovarian_cancer_syndrome|Familial_cancer_of_breast|Fanconi_anemia,_complementation_group_S|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Pancreatic_cancer,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome",reviewed_by_expert_panel,NC_000017.11:g.43115750G>T,BRCA1-HCI:BRCA1_00112|ClinGen:CA000742,C0677776|C0346153|C4554406|C2676676|C3280442|C0027672,114480|617883|604370|614320,145|227535|145|1333|140162,"Zinc finger, C3HC4 RING-type|Zinc finger, RING-type|Zinc finger, RING-type",Thr,Lys,68798.0,single nucleotide variant,NM_007294.4(BRCA1):c.110C>A (p.Thr37Lys),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Aug 10, 2015",80356880.0,-,RCV000111781|RCV000763401|RCV001378528|RCV002433536,"MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162","Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast;Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43115750.0,43115750.0,17q21.31,reviewed by expert panel,7.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00112,ClinGen:CA000742",2.0,54131.0,43115750.0,G,T,-,-,-,-,-,-,SCV000244295,-,-,110C>A ,Thr37Lys,NM_007294.4,3.0,1_Pathogenic,88.99,0.028169014084507,"['604370', '114480', '617883', '604370', '614320']",,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST CANCER; FANCONI ANEMIA, COMPLEMENTATION GROUP S; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Findlay_2018_var462,BRCA1_Findlay_2018,BRCA1,1100,-1.0,41267767.0,43115750.0,43115750.0,NM_007294.3,110,C,A,37.0,T,K,c.110C>A,p.Thr37Lys,Missense,missense_variant,-2.49352324025865,-3.10651634626882;-1.88053013424848,LOF,Yes,,Pathogenic,reviewed by expert panel,"Aug 10, 2015",nucleotide,urn:mavedb:00000097-0-2,ENST00000357654.9,NM_007294.3,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,Functional ,"[-0.748, Inf)",Normal,Intermediate,"(-1.328, -0.748)",Not specified,Non-functional,"(-Inf,-1.328]",Abnormal,,,,,,,,,,,0.823,0.9729,likely_pathogenic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Thr37Lys,Thr37Lys,true
BRCA1,BRCA1_Cys64Tyr,-0.2411116846042154,0.8163785956912686,-2.2694527201623846,0.057523894319769224,2025_01_Batch_13-14,0.8767777326467615,0.9730828220329724,0.8770861220785622,0.7593569849355692,0.6491123281602564,0.984165069167112,0.9493837665828397,0.9688679226686315,0.9870125638742568,0.960958284831255,0.9304714009069368,0.961233294307906,0.9229770223735969,0.873184774404913,0.8050353064957557,false,true,false,false,false,0.0,0.0,0.0,0.0,0.0,true,BRCA1,,14613,,CCSBVarC011839,,NC_000017.11:43106477:C:T,191G>A,Cys64Tyr,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Cys64Tyr,17.0,43106477.0,C,T,17,,,,,,17-43106477-C-T,69067.0,single nucleotide variant,NM_007294.4(BRCA1):c.191G>A (p.Cys64Tyr),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Jun 11, 2024",55851803.0,-,RCV000047641|RCV000077501|RCV000131896|RCV000236464|RCV003334380|RCV004566890,"MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MONDO:MONDO:0700268,MedGen:CN377757","Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Pancreatic cancer, susceptibility to, 4|BRCA1-related cancer predisposition",germline;not applicable;paternal;unknown,germline,GRCh38,NC_000017.11,17,43106477.0,43106477.0,17q21.31,reviewed by expert panel,27.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"UniProtKB:P38398#VAR_007759,ClinGen:CA001262",2.0,54400.0,43106477.0,C,T,-,-,-,-,-,-,SCV004101417,-,-,191G>A ,Cys64Tyr,NM_007294.4,3.0,1_Pathogenic,,54400.0,17,43106477.0,C,T,C,Y,rs55851803,17,41258494,17,38512020,64.0,BRCA1,ENSG00000012048,ENST00000494123,ENSP00000419103,P38398,BRCA1_HUMAN,c.191G>A,p.Cys64Tyr,c.191G>A,p.Cys64Tyr,principal2,Y,1,.,.,-,TGT,2.0,0.0,C,C/C,C/C,C/C,C/C,0.001,0.91343,D,0.0,0.92967,D,0.999,0.77914,D,0.972,0.84488,D,.,0.99291,.,.,.,.,4.34,0.98393,H,-2.59,0.99046,D,.,0.97441,0.9543,0.96449,D,0.9922,0.99809,D,10,0.9909615,0.99609,D,0.946477,0.99626,D,0.954,0.99189,0.991,0.99904,E9PFC7,C64Y,Loss of stability (P = 0.0601)| Loss of disorder (P = 0.0647)| Loss of methylation at K65 (P = 0.0701)| Gain of phosphorylation at T69 (P = 0.1857)| Loss of catalytic residue at L63 (P = 0.238),0.999548998322,0.99953,.,0.88610,.,0.52543,0.801703929901,0.82191,T,0.476203,0.92995,T,0.553373,0.95819,D,0.557106,0.95755,D,0.998311161994934,0.93754,D,.,0.87587,.,0.98057026,0.99138,0.92475754,0.96684,0.9736041,0.98562,0.9065188,0.95378,-12.677,0.94701,D,0.9941,0.96039,LP,0.999711406740052,0.97610,0.99977249,0.99701,0.97,0.98836,.,.,.,.,.,.,5.19196,0.87099,29.1,0.99179197590808121,0.54687,0.851286,0.76729,D,0.880338828138272,0.90713,10.55451,0.762986794469818,0.87052,9.115097,4.64,4.64,0.57348,.,.,4.108,0.57643,7.641000,0.63257,0.531,0.24877,1.0,0.71675,1.0,0.68239,0.997,0.79771,459,0.78836,.,.,.,.,.,.,.,.,.,.,.,.,1,264690,3.7780044E-6,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,2,1601934,1.248490e-06,0,1,1170064,8.546540e-07,0,0,74760,0.000000e+00,0,0,912,0.000000e+00,0,0,59914,0.000000e+00,0,0,29512,0.000000e+00,0,0,44730,0.000000e+00,0,0,63954,0.000000e+00,0,0,5808,0.000000e+00,0,1,1170064,8.546540e-07,0,0,90238,0.000000e+00,0,0,9690,0,0,114,0,0,86,0,0,3210,0,0,146,0,0,610,0,0,26,0,0,98,0,0,548,0,0,3324,0,0,112,0,0,14528,0,Pathogenic,"not_provided|Hereditary_breast_ovarian_cancer_syndrome|Pancreatic_cancer,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|BRCA1-related_cancer_predisposition",reviewed_by_expert_panel,NC_000017.11:g.43106477C>T,ClinGen:CA001262|UniProtKB:P38398#VAR_007759,C3661900|C0677776|C3280442|C0027672|C2676676|CN377757,614320|604370,145|1333|140162|145,"Zinc finger, C3HC4 RING-type|Zinc finger, RING-type|Zinc finger, RING-type",Cys,Tyr,69067.0,single nucleotide variant,NM_007294.4(BRCA1):c.191G>A (p.Cys64Tyr),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Jun 11, 2024",55851803.0,-,RCV000047641|RCV000077501|RCV000131896|RCV000236464|RCV003334380|RCV004566890,"MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MONDO:MONDO:0700268,MedGen:CN377757","Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Pancreatic cancer, susceptibility to, 4|BRCA1-related cancer predisposition",germline;not applicable;paternal;unknown,germline,GRCh38,NC_000017.11,17,43106477.0,43106477.0,17q21.31,reviewed by expert panel,27.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"UniProtKB:P38398#VAR_007759,ClinGen:CA001262",2.0,54400.0,43106477.0,C,T,-,-,-,-,-,-,SCV004101417,-,-,191G>A ,Cys64Tyr,NM_007294.4,3.0,1_Pathogenic,88.77,0.3333333333333333,"['604370', '614320']",,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Findlay_2018_var802,BRCA1_Findlay_2018,BRCA1,1100,-1.0,41258494.0,43106477.0,43106477.0,NM_007294.3,191,G,A,64.0,C,Y,c.191G>A,p.Cys64Tyr,Missense,missense_variant,-2.05029821109945,-1.98360687536855;-2.11698954683035,LOF,Yes,1.2484908866e-6,Pathogenic,reviewed by expert panel,"Jun 11, 2024",nucleotide,urn:mavedb:00000097-0-2,ENST00000357654.9,NM_007294.3,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,Functional ,"[-0.748, Inf)",Normal,Intermediate,"(-1.328, -0.748)",Not specified,Non-functional,"(-Inf,-1.328]",Abnormal,,,,,,,,,,,0.954,0.9929,likely_pathogenic,5300394.0029,189.09064594,,,,1002254925.7158209,0.81,Multifac new calc,Pathogenic,0.1,0.9999999910202487,Pathogenic,,,,,,,,,,,,,,54400.0,CA001262,BRCA1-related cancer predisposition,MONDO:0700268,Autosomal dominant inheritance,Pathogenic,"PM2_Supporting,PP4_Strong,PS3,PP3",,"The c.191G>A variant in BRCA1 is a missense variant predicted to cause substitution of Cysteine by Tyrosine at amino acid 64 (p.Cys64Tyr). This variant is absent from gnomAD v2.1 (exomes only, non-cancer subset, read depth ≥25) and gnomAD v3.1 (non-cancer subset, read depth ≥25) (PM2_Supporting met). This BRCA1 missense variant is within a key functional domain and the computational predictor BayesDel (noAF) gives a score of 0.557, above the recommended threshold of 0.28 for prediction of impact on BRCA1 function via protein change. SpliceAI predictor score of 0.00 suggests that the variant has no impact on splicing (score threshold <0.10) (PP3 met). Reported by one calibrated study to exhibit protein function similar to pathogenic control variants (PMID: 30209399) (PS3 met). Multifactorial likelihood ratio analysis using clinically calibrated data produced a combined LR for this variant of 17239845573264 (based on Cosegregation LR=5300394; Pathology LR=189; Family History LR=17201), above the threshold for Very strong evidence towards pathogenicity (>350) (PP4_Very strong met; PMID: 31131967, 31853058). In summary, this variant meets the criteria to be classified as a Pathogenic variant for BRCA1-related cancer predisposition based on the ACMG/AMP criteria applied as specified by the ENIGMA BRCA1/2 VCEP (PM2_Supporting, PP3, PS3, PP4_Very strong).   ",30209399,ENIGMA BRCA1 and BRCA2 VCEP,https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50087,6/12/24,6/11/24,False,https://erepo.genome.network/evrepo/ui/classification/aed4706a-e502-48b4-8417-bb5c3aa01461,aed4706a-e502-48b4-8417-bb5c3aa01461,VUS,"PM2_Supporting,PS3",BRCA1_Cys64Tyr,Cys64Tyr,true
BRCA1,BRCA1_Phe558Ser,1.6111167737238428,0.15118946477997378,4.615270970171342,0.0024397297238219016,2025_01_Batch_13-14,0.9498482441279533,0.9308024365566823,0.9137788511755762,0.9572502165200717,0.8165718573701302,0.9856023871263442,0.9300413434020081,0.9248850903557055,0.9816134932174742,0.9586068154103601,0.9677253156271488,0.9304218899793452,0.9193319707656409,0.9694318548687729,0.8875893363902452,true,false,false,true,true,1.0,0.0,0.0,0.0,0.0,true,BRCA1,,14613,,CCSBVarC013021,,NC_000017.11:43070929:A:G,1673T>C,Phe558Ser,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Phe558Ser,17.0,43070929.0,A,G,17,,,,,,17-43070929-A-G,70006.0,single nucleotide variant,NM_007294.4(BRCA1):c.4985T>C (p.Phe1662Ser),672.0,BRCA1,HGNC:1100,Benign,0.0,"Aug 10, 2015",28897695.0,-,RCV000112441|RCV000130003|RCV000443012|RCV001421999|RCV001703954,"MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900","Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|not provided",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43070929.0,43070929.0,17q21.31,reviewed by expert panel,10.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00091,ClinGen:CA003117",2.0,55339.0,43070929.0,A,G,-,-,-,-,-,-,SCV000244375,-,-,4985T>C ,Phe1662Ser,NM_007294.4,3.0,2_Benign,,55339.0,17,43070929.0,A,G,F,S,rs28897695,17,41222946,17,38476472,1662.0,BRCA1,ENSG00000012048,ENST00000357654,ENSP00000350283,P38398,BRCA1_HUMAN,c.4985T>C,p.Phe1662Ser,c.4985T>C,p.Phe1662Ser,principal2,Y,1,YES,Select,-,TTT,2.0,0.0,A,A/A,A/A,A/A,A/A,0.324,0.13470,T,0.483,0.15624,T,0.327,0.33186,B,0.072,0.28044,B,0.26,0.51279,N,simple_aae,74.0,26.0,0,0.06502,N,-0.41,0.54888,N,0.17,0.20657,-0.8141,0.54115,T,0.2316,0.59602,T,10,0.08930129,0.15320,T,0.095936,0.76440,D,0.521,0.79537,.,.,.,.,.,0.346544149963,0.33848,.,0.38144,.,0.17918,0.32687741518,0.14450,T,0.127873,0.45213,T,-0.0538666,0.43515,T,-0.0894503,0.63948,T,0.0101923026540198,0.00137,T,.,0.29269,.,0.15882574,0.35418,0.05462813,0.09445,0.15678944,0.35072,0.06600715,0.13457,-2.062,0.15503,T,0.1159,0.48135,B,0.242492734673284,0.51903,0.99607220,0.97952,0.115,0.31465,.,.,.,.,.,.,1.575156,0.20196,14.62,0.63349936367485471,0.07307,0.176669,0.30175,N,-1.19592149865023,0.05004,0.2298717,-1.20530321707257,0.05732,0.2786036,4.82,-1.61,0.07934,-3.96,0.06349,0.047,0.13983,1.542000,0.27319,-0.681,0.0423,0.006,0.17427,0.0,0.08389,0.808,0.38116,544,0.72706,.,.,.,.,.,.,.,.,.,.,.,.,4,264690,1.51120175E-5,.,1,109362,9.143940e-06,0,2,206954,9.663980e-06,0,3,235478,1.274000e-05,0,0,7164,0.000000e+00,0,0,17112,0.000000e+00,0,0,2320,0.000000e+00,0,1,9044,1.105710e-04,0,0,13350,0.000000e+00,0,0,42768,0.000000e+00,0,0,15690,0.000000e+00,0,1,9044,1.105710e-04,0,0,16214,0.000000e+00,0,0,30522,0.000000e+00,0,0,6208,0.000000e+00,0,2,13414,1.490980e-04,0,0,16690,0.000000e+00,0,0,88440,0.000000e+00,0,0,30608,0.000000e+00,0,2,13414,1.490980e-04,0,0,14902,0.000000e+00,0,1,34258,2.919030e-05,0,0,9566,0.000000e+00,0,2,17690,1.130580e-04,0,0,21588,0.000000e+00,0,0,101348,0.000000e+00,0,0,30526,0.000000e+00,0,2,17690,1.130580e-04,0,.,21,1614022,1.301100e-05,0,17,44902,3.786020e-04,0,1,74928,1.334610e-05,0,0,912,0.000000e+00,0,1,60004,1.666560e-05,0,0,29608,0.000000e+00,0,17,44902,3.786020e-04,0,0,63964,0.000000e+00,0,0,6084,0.000000e+00,0,2,1180042,1.694850e-06,0,0,91090,0.000000e+00,0,0,85192,0,0,238,0,0,468,0,0,5996,0,0,648,0,0,2154,0,0,126,0,0,168,0,0,2604,0,0,6234,0,0,594,0,0,97594,0,Benign,"Hereditary_cancer-predisposing_syndrome|not_specified|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1",reviewed_by_expert_panel,NC_000017.11:g.43070929A>G,BRCA1-HCI:BRCA1_00091|ClinGen:CA003117,C0027672|CN169374|C0677776|C3661900|C2676676,604370,140162|145|145,BRCT domain|BRCT domain|BRCT domain,Phe,Ser,70006.0,single nucleotide variant,NM_007294.4(BRCA1):c.4985T>C (p.Phe1662Ser),672.0,BRCA1,HGNC:1100,Benign,0.0,"Aug 10, 2015",28897695.0,-,RCV000112441|RCV000130003|RCV000443012|RCV001421999|RCV001703954,"MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900","Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|not provided",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43070929.0,43070929.0,17q21.31,reviewed by expert panel,10.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00091,ClinGen:CA003117",2.0,55339.0,43070929.0,A,G,-,-,-,-,-,-,SCV000244375,-,-,4985T>C ,Phe1662Ser,NM_007294.4,3.0,2_Benign,96.18,0.0964467005076142,['604370'],,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Findlay_2018_var1473,BRCA1_Findlay_2018,BRCA1,1100,-1.0,41222946.0,43070929.0,43070929.0,NM_007294.3,4985,T,C,1662.0,F,S,c.4985T>C,p.Phe1662Ser,Missense,missense_variant,-0.254857537628401,0.150672227040838;-0.660387302297641,FUNC,Yes,0.0000130109750672,Benign,reviewed by expert panel,"Aug 10, 2015",nucleotide,urn:mavedb:00000097-0-2,ENST00000357654.9,NM_007294.3,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,Functional ,"[-0.748, Inf)",Normal,Intermediate,"(-1.328, -0.748)",Not specified,Non-functional,"(-Inf,-1.328]",Abnormal,,,,,,,,,,,0.521,0.1159,likely_benign,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Phe1662Ser,Phe1662Ser,false
BRCA1,BRCA1_Gly602Ala,3.458879566726189,0.010563565807662701,0.5419560155120805,0.604663137301014,2025_01_Batch_13-14,0.8899492981161312,0.9204675782920699,0.9160276724904372,0.9268155515133806,0.784515980472033,0.9905934057415612,0.9357264373572229,0.9509726911567646,0.9853495651625582,0.9186595541595897,0.9402713519288461,0.9280970078246464,0.9335001818236008,0.9560825583379694,0.8515877673158113,true,false,false,false,false,0.0,0.0,0.0,0.0,0.0,true,BRCA1,,14613,,CCSBVarC013096,,NC_000017.11:43063909:C:G,1805G>C,Gly602Ala,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Gly602Ala,17.0,43063909.0,C,G,17,,,,,,17-43063909-C-G,70073.0,single nucleotide variant,NM_007294.4(BRCA1):c.5117G>C (p.Gly1706Ala),672.0,BRCA1,HGNC:1100,Benign,0.0,"Aug 10, 2015",80356860.0,-,RCV000048801|RCV000077598|RCV000162991|RCV001086320|RCV001353853|RCV000586262,"MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:C3661900","not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast|not provided",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43063909.0,43063909.0,17q21.31,reviewed by expert panel,24.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00109,ClinGen:CA003250,UniProtKB:P38398#VAR_070502",2.0,55406.0,43063909.0,C,G,-,-,-,-,-,-,SCV000244384,-,-,5117G>C ,Gly1706Ala,NM_007294.4,3.0,2_Benign,,55406.0,17,43063909.0,C,G,G,A,rs80356860,17,41215926,17,38469452,1706.0,BRCA1,ENSG00000012048,ENST00000713676,ENSP00000518978,P38398,BRCA1_HUMAN,.,.,c.5117G>C,p.Gly1706Ala,principal2,Y,.,.,.,-,GGA,2.0,0.0,C,C/C,C/C,C/C,C/C,.,0.91343,.,.,0.92967,.,0.858,0.90580,P,0.415,0.97365,B,.,0.97016,.,.,.,.,1.88,0.49806,L,.,0.77997,.,.,0.83220,-0.0839,0.80378,T,0.4691,0.79463,T,10,.,0.52478,.,0.376865,0.92864,D,.,0.79354,.,.,.,.,.,.,0.85197,.,0.86205,.,0.41014,0.788811266422,0.80226,T,0.144841,0.58712,T,0.220015,0.75596,D,0.234626,0.84783,D,0.174270822478175,0.18632,T,.,0.95417,.,0.7676474,0.81684,0.45108074,0.67803,0.816965,0.84823,0.6340818,0.78412,-8.619,0.65921,D,.,0.77716,.,0.953210802210829,0.80831,0.99961549,0.99542,0.738,0.85485,.,.,.,.,.,.,4.015836,0.59356,24.1,0.99832727521296616,0.91463,0.783255,0.71325,D,0.704029495450117,0.79789,7.175777,0.72533764037511,0.84214,8.254455,5.83,5.83,0.93049,.,.,4.855,0.62708,7.634000,0.62929,0.53,0.24764,1.0,0.71675,1.0,0.68239,0.995,0.73271,549,0.72286,1,1.9968051118210862E-4,0,0.0,1,9.940357852882703E-4,0,0.0,0,0.0,0,0.0,25,264690,9.445011E-5,.,4,109376,3.657110e-05,0,11,208038,5.287500e-05,0,10,236838,4.222300e-05,0,0,7158,0.000000e+00,0,0,17106,0.000000e+00,0,0,2320,0.000000e+00,0,0,9044,0.000000e+00,0,1,13394,7.466030e-05,0,1,42758,2.338740e-05,0,0,15682,0.000000e+00,0,1,42758,2.338740e-05,0,0,16206,0.000000e+00,0,1,30514,3.277180e-05,0,0,6212,0.000000e+00,0,0,13414,0.000000e+00,0,1,16734,5.975860e-05,0,5,89502,5.586470e-05,0,0,30596,0.000000e+00,0,5,89502,5.586470e-05,0,0,14892,0.000000e+00,0,0,34250,0.000000e+00,0,0,9566,0.000000e+00,0,0,17690,0.000000e+00,0,1,21628,4.623640e-05,0,5,102688,4.869120e-05,0,0,30514,0.000000e+00,0,5,102688,4.869120e-05,0,.,75,1614060,4.646670e-05,0,4,6062,6.598480e-04,0,0,75038,0.000000e+00,0,0,912,0.000000e+00,0,4,59998,6.666890e-05,0,0,29604,0.000000e+00,0,0,44864,0.000000e+00,0,8,64028,1.249450e-04,0,4,6062,6.598480e-04,0,48,1179976,4.067880e-05,0,0,91072,0.000000e+00,0,2,31050,6.44122383252818E-5,0,114,0,0,86,0,0,2804,0,0,500,0,0,628,0,0,26,0,0,98,0,1,4596,2.175805047867711E-4,0,2918,0,0,112,0,3,39902,7.518420129316827E-5,Benign,"Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Malignant_tumor_of_breast",reviewed_by_expert_panel,NC_000017.11:g.43063909C>G,BRCA1-HCI:BRCA1_00109|ClinGen:CA003250|UniProtKB:P38398#VAR_070502,C0027672|CN169374|C3661900|C0677776|C2676676|C0006142,604370,140162|145|145,BRCT domain|BRCT domain|BRCT domain,Gly,Ala,70073.0,single nucleotide variant,NM_007294.4(BRCA1):c.5117G>C (p.Gly1706Ala),672.0,BRCA1,HGNC:1100,Benign,0.0,"Aug 10, 2015",80356860.0,-,RCV000048801|RCV000077598|RCV000162991|RCV001086320|RCV001353853|RCV000586262,"MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:C3661900","not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast|not provided",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43063909.0,43063909.0,17q21.31,reviewed by expert panel,24.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00109,ClinGen:CA003250,UniProtKB:P38398#VAR_070502",2.0,55406.0,43063909.0,C,G,-,-,-,-,-,-,SCV000244384,-,-,5117G>C ,Gly1706Ala,NM_007294.4,3.0,2_Benign,95.97,0.0,['604370'],,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Adamovich_2022_HDR_var4960,BRCA1_Adamovich_2022_HDR,BRCA1,1100,-1.0,,43063909.0,43063909.0,,5117,G,C,1706.0,G,A,c.5117G>C,p.Gly1706Ala,missense_variant,missense_variant,0.07118251875,-0.229987392;0.333306695;-0.120197644;0.301608415,,No,0.0000464666741013,Benign,reviewed by expert panel,"Aug 10, 2015",aa,urn:mavedb:00001222-b-1,ENST00000357654.9,NM_007294.4,immortalized human cells,,fluorescence intensity (BAO_0000363),"DNA repair (GO:0006281), double-strand break repair via homologous recombination (GO:0000724)",No,Functional,"(-0.233, Inf)",Normal,LOF,"(-Inf, -0.562)",Abnormal,Intermediate,"[-0.562,-0.233]",Not specified,,,,,,,,,,,0.518,0.4904,ambiguous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Gly1706Ala,Gly1706Ala,false
BRCA1,BRCA1_Cys61Gly,0.9686368160707995,0.36499496144588084,4.370983692104869,0.003270140985358988,2025_01_Batch_13-14,0.9816626134163466,0.9382680897369753,0.9381794369642189,0.9675114203479335,0.8882441185541432,0.94979174340731,0.83386982555295,0.8932073113961976,0.9429165361361207,0.9062998562885225,0.9657271784118283,0.8860689576449626,0.9156933741802082,0.955213978242027,0.8972719874213329,true,false,false,true,true,0.0,0.0,0.0,0.0,1.0,true,BRCA1,,14613,,CCSBVarC011874,,NC_000017.11:43106487:A:C,181T>G,Cys61Gly,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Cys61Gly,17.0,43106487.0,A,C,17,,,,,,17-43106487-A-C,32700.0,single nucleotide variant,NM_007294.4(BRCA1):c.181T>G (p.Cys61Gly),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Aug 10, 2015",28897672.0,-,RCV000019229|RCV000415051|RCV000159935|RCV000239114|RCV000047597|RCV000131902|RCV000412714|RCV001270967|RCV000785199|RCV005003390|RCV004802937,"MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|Human Phenotype Ontology:HP:0003002,MONDO:MONDO:0004989,MedGen:C0678222|MedGen:C3661900|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0010623,Human Phenotype Ontology:HP:0100013,MONDO:MONDO:0021100,MeSH:D001943,MedGen:C1458155|MedGen:CN221562|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MONDO:MONDO:0700268,MedGen:CN377757","Breast-ovarian cancer, familial, susceptibility to, 1|Breast carcinoma|not provided|Familial cancer of breast|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast neoplasm|Breast and/or ovarian cancer|Ovarian neoplasm|Breast-ovarian cancer, familial, susceptibility to, 1;Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4|BRCA1-related cancer predisposition",germline;not applicable;somatic;unknown,germline/somatic,GRCh38,NC_000017.11,17,43106487.0,43106487.0,17q21.31,reviewed by expert panel,59.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"OMIM:113705.0002,BRCA1-HCI:BRCA1_00099,ClinGen:CA001182,UniProtKB:P38398#VAR_007757",3.0,17661.0,43106487.0,A,C,-,-,-,-,-,-,SCV000244308,-,-,181T>G ,Cys61Gly,NM_007294.4,3.0,1_Pathogenic,,17661.0,17,43106487.0,A,C,C,G,rs28897672,17,41258504,17,38512030,61.0,BRCA1,ENSG00000012048,ENST00000494123,ENSP00000419103,P38398,BRCA1_HUMAN,c.181T>G,p.Cys61Gly,c.181T>G,p.Cys61Gly,principal2,Y,1,.,.,-,TGT,1.0,0.0,A,A/A,A/A,A/A,A/A,0.0,0.91343,D,0.0,0.92967,D,0.116,0.77914,B,0.026,0.82066,B,.,0.99291,.,.,.,.,4.355,0.98454,H,-2.81,0.99397,D,.,0.99781,0.9506,0.96392,D,0.9929,0.99832,D,10,0.99176705,0.99706,D,0.963103,0.99761,D,0.948,0.98989,0.995,0.99946,E9PFC7,C61G,Gain of disorder (P = 0.0488)| Loss of stability (P = 0.105)| Gain of phosphorylation at S59 (P = 0.1362)| Loss of methylation at K56 (P = 0.1519)| Gain of glycosylation at P62 (P = 0.1609),0.998499671764,0.99845,.,0.90513,.,0.44456,0.648884236813,0.59765,T,0.479885,0.92979,T,0.433365,0.91638,D,0.565018,0.95972,D,0.983885645866394,0.75212,D,.,0.85963,.,0.9937476,0.99925,0.9444327,0.98025,0.98292416,0.99313,0.9264142,0.96801,-14.65,0.98194,D,0.9865,0.94756,LP,0.998778029465221,0.95035,0.99978560,0.99726,0.984,0.99450,.,.,.,.,.,.,4.174515,0.62863,24.5,0.98518170788822967,0.42557,0.869181,0.78883,D,0.838128507262834,0.88357,9.572342,0.742507123425794,0.85517,8.62807,5.17,5.17,0.70808,5.61,0.95042,5.098,0.64462,11.169000,0.87924,0.667,0.69024,1.0,0.71675,1.0,0.68239,0.995,0.73271,459,0.78836,.,.,.,.,.,.,.,.,.,.,.,.,4,264690,1.51120175E-5,.,4,109170,3.664010e-05,0,7,207470,3.373980e-05,0,6,236276,2.539400e-05,0,0,7152,0.000000e+00,0,0,17022,0.000000e+00,0,0,2310,0.000000e+00,0,0,9042,0.000000e+00,0,1,13390,7.468260e-05,0,3,42724,7.021810e-05,0,0,15618,0.000000e+00,0,3,42724,7.021810e-05,0,0,16132,0.000000e+00,0,0,30412,0.000000e+00,0,0,6194,0.000000e+00,0,0,13404,0.000000e+00,0,1,16718,5.981580e-05,0,6,89312,6.718020e-05,0,0,30448,0.000000e+00,0,6,89312,6.718020e-05,0,0,14822,0.000000e+00,0,0,34140,0.000000e+00,0,0,9556,0.000000e+00,0,0,17674,0.000000e+00,0,1,21614,4.626630e-05,0,5,102510,4.877570e-05,0,0,30366,0.000000e+00,0,5,102510,4.877570e-05,0,.,30,1604818,1.869370e-05,0,28,1172588,2.387880e-05,0,0,74730,0.000000e+00,0,0,912,0.000000e+00,0,0,59940,0.000000e+00,0,0,29524,0.000000e+00,0,0,44766,0.000000e+00,0,1,63978,1.563040e-05,0,0,5856,0.000000e+00,0,28,1172588,2.387880e-05,0,0,90418,0.000000e+00,0,0,10344,0,0,144,0,0,88,0,0,4314,0,0,154,0,0,616,0,0,28,0,0,98,0,0,860,0,0,4458,0,0,116,0,0,16646,0,Pathogenic,"Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|not_provided|Pancreatic_cancer,_susceptibility_to,_4|Fanconi_anemia,_complementation_group_S|Hereditary_breast_ovarian_cancer_syndrome|Breast_carcinoma|Breast_neoplasm|Ovarian_neoplasm",reviewed_by_expert_panel,NC_000017.11:g.43106487A>C,BRCA1-HCI:BRCA1_00099|ClinGen:CA001182|OMIM:113705.0002|UniProtKB:P38398#VAR_007757,C2676676|C0346153|C0027672|CN221562|C3661900|C3280442|C4554406|C0677776|C0678222|C1458155|C0919267,604370|114480|614320|617883,145|227535|140162|1333|145,"Zinc finger, C3HC4 RING-type|Zinc finger, RING-type|Zinc finger, RING-type",Cys,Gly,32700.0,single nucleotide variant,NM_007294.4(BRCA1):c.181T>G (p.Cys61Gly),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Aug 10, 2015",28897672.0,-,RCV000019229|RCV000415051|RCV000159935|RCV000239114|RCV000047597|RCV000131902|RCV000412714|RCV001270967|RCV000785199|RCV005003390|RCV004802937,"MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|Human Phenotype Ontology:HP:0003002,MONDO:MONDO:0004989,MedGen:C0678222|MedGen:C3661900|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0010623,Human Phenotype Ontology:HP:0100013,MONDO:MONDO:0021100,MeSH:D001943,MedGen:C1458155|MedGen:CN221562|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MONDO:MONDO:0700268,MedGen:CN377757","Breast-ovarian cancer, familial, susceptibility to, 1|Breast carcinoma|not provided|Familial cancer of breast|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast neoplasm|Breast and/or ovarian cancer|Ovarian neoplasm|Breast-ovarian cancer, familial, susceptibility to, 1;Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4|BRCA1-related cancer predisposition",germline;not applicable;somatic;unknown,germline/somatic,GRCh38,NC_000017.11,17,43106487.0,43106487.0,17q21.31,reviewed by expert panel,59.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"OMIM:113705.0002,BRCA1-HCI:BRCA1_00099,ClinGen:CA001182,UniProtKB:P38398#VAR_007757",3.0,17661.0,43106487.0,A,C,-,-,-,-,-,-,SCV000244308,-,-,181T>G ,Cys61Gly,NM_007294.4,3.0,1_Pathogenic,86.97,0.0148148148148148,"['604370', '114480', '604370', '617883', '614320']",,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST CANCER; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; FANCONI ANEMIA, COMPLEMENTATION GROUP S; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Findlay_2018_var774,BRCA1_Findlay_2018,BRCA1,1100,-1.0,41258504.0,43106487.0,43106487.0,NM_007294.3,181,T,G,61.0,C,G,c.181T>G,p.Cys61Gly,Missense,missense_variant,-1.73834813947418,-1.68327576756543;-1.79342051138294,LOF,Yes,0.00001869370857,Pathogenic,reviewed by expert panel,"Aug 10, 2015",nucleotide,urn:mavedb:00000097-0-2,ENST00000357654.9,NM_007294.3,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,Functional ,"[-0.748, Inf)",Normal,Intermediate,"(-1.328, -0.748)",Not specified,Non-functional,"(-Inf,-1.328]",Abnormal,,,,,,,,,,,0.948,0.9904,likely_pathogenic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Cys61Gly,Cys61Gly,true
BRCA1,BRCA1_Arg71Gly,-1.183279693007538,0.275321882540562,5.634491429600972,0.000787086326597669,2025_01_Batch_13-14,0.9304760710892357,0.940321856870626,0.8585648206893093,0.9119236688191354,0.8374062887316356,0.9855224726609189,0.9404281751104907,0.9263130774563206,0.9809606129506918,0.9391781050206498,0.9579992718750773,0.9403750159905584,0.892438949072815,0.9464421408849136,0.8882921968761427,true,true,false,false,true,0.0,0.0,0.0,0.0,0.0,true,BRCA1,,14613,,CCSBVarC011856,,NC_000017.11:43106457:T:C,211A>G,Arg71Gly,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Arg71Gly,17.0,43106457.0,T,C,17,,,,,,17-43106457-T-C,32732.0,single nucleotide variant,NM_007294.4(BRCA1):c.211A>G (p.Arg71Gly),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Jun 18, 2019",80357382.0,-,RCV000047713|RCV000131899|RCV000195359|RCV000019263|RCV000469732|RCV000763009|RCV000508177|RCV004758595|RCV004802945,"MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MedGen:CN169374||MONDO:MONDO:0700268,MedGen:CN377757","not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4;Breast-ovarian cancer, familial, susceptibility to, 1;Familial cancer of breast|not specified|BRCA1-related disorder|BRCA1-related cancer predisposition",germline;not applicable;somatic;unknown,germline/somatic,GRCh38,NC_000017.11,17,43106457.0,43106457.0,17q21.31,reviewed by expert panel,33.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA001398,OMIM:113705.0034",3.0,17693.0,43106457.0,T,C,-,-,-,-,-,-,SCV001161539,-,-,211A>G ,Arg71Gly,NM_007294.4,3.0,1_Pathogenic,,17693.0,17,43106457.0,T,C,R,G,rs80357382,17,41258474,17,38512000,71.0,BRCA1,ENSG00000012048,ENST00000713676,ENSP00000518978,P38398,BRCA1_HUMAN,.,.,c.211A>G,p.Arg71Gly,principal2,Y,.,.,.,-,AGG,1.0,2.0,T,T/T,T/T,T/T,T/T,.,0.91343,.,.,0.83643,.,0.956,0.59057,P,0.444,0.68273,B,.,0.99291,.,.,.,.,2.455,0.71058,M,.,0.92366,.,.,0.86054,0.8364,0.94843,D,0.8394,0.94619,D,10,.,0.92374,.,0.80066,0.98437,D,.,0.95939,0.809,0.92541,E9PFC7,R71G,Gain of ubiquitination at K70 (P = 0.0519)| Loss of solvent accessibility (P = 0.0807)| Loss of phosphorylation at T69 (P = 0.1027)| Gain of relative solvent accessibility (P = 0.1684)| Loss of disorder (P = 0.1823),.,0.93459,.,0.57140,.,0.24793,0.550648927689,0.45883,T,0.325403,0.69435,T,0.464929,0.93082,D,0.430062,0.92996,D,0.867488086223602,0.51486,D,.,0.86835,.,0.7237265,0.79126,0.32902288,0.58556,0.63329226,0.74199,0.31909144,0.57647,-13.862,0.93673,D,.,0.89378,.,0.999229197308064,0.96001,0.99944407,0.99387,0.931,0.96596,.,.,.,.,.,.,5.274462,0.88579,29.6,0.99887384451911465,0.96206,0.840976,0.75732,D,0.586117233560111,0.72160,5.78522,0.5471513750929,0.71040,5.618586,4.64,4.64,0.57348,5.61,0.95042,4.16,0.58035,7.857000,0.71293,0.588,0.31377,1.0,0.71675,1.0,0.68239,0.994,0.71086,459,0.78836,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0,108704,0.000000e+00,0,1,206546,4.841540e-06,0,1,235294,4.250000e-06,0,0,7112,0.000000e+00,0,0,16894,0.000000e+00,0,0,2294,0.000000e+00,0,0,9040,0.000000e+00,0,0,13388,0.000000e+00,0,0,42620,0.000000e+00,0,0,15456,0.000000e+00,0,.,.,.,.,0,16078,0.000000e+00,0,0,30222,0.000000e+00,0,0,6166,0.000000e+00,0,0,13382,0.000000e+00,0,0,16704,0.000000e+00,0,1,89038,1.123120e-05,0,0,30132,0.000000e+00,0,1,89038,1.123120e-05,0,0,14770,0.000000e+00,0,0,33946,0.000000e+00,0,0,9522,0.000000e+00,0,0,17632,0.000000e+00,0,0,21592,0.000000e+00,0,1,102222,9.782630e-06,0,0,30050,0.000000e+00,0,1,102222,9.782630e-06,0,.,2,1580162,1.265690e-06,0,2,1150962,1.737680e-06,0,0,74308,0.000000e+00,0,0,912,0.000000e+00,0,0,59768,0.000000e+00,0,0,29370,0.000000e+00,0,0,44596,0.000000e+00,0,0,63918,0.000000e+00,0,0,5674,0.000000e+00,0,2,1150962,1.737680e-06,0,0,89324,0.000000e+00,0,0,6962,0,0,84,0,0,84,0,0,2636,0,0,146,0,0,610,0,0,24,0,0,94,0,0,518,0,0,2720,0,0,108,0,0,11158,0,Pathogenic,"Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome|not_specified|Familial_cancer_of_breast|Pancreatic_cancer,_susceptibility_to,_4|Fanconi_anemia,_complementation_group_S|not_provided|Hereditary_breast_ovarian_cancer_syndrome",reviewed_by_expert_panel,NC_000017.11:g.43106457T>C,ClinGen:CA001398|OMIM:113705.0034,C2676676|C0027672|CN169374|C0346153|C3280442|C4554406|C3661900|C0677776,604370|114480|614320|617883,145|140162|227535|1333|145,.,Arg,Gly,32732.0,single nucleotide variant,NM_007294.4(BRCA1):c.211A>G (p.Arg71Gly),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Jun 18, 2019",80357382.0,-,RCV000047713|RCV000131899|RCV000195359|RCV000019263|RCV000469732|RCV000763009|RCV000508177|RCV004758595|RCV004802945,"MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MedGen:CN169374||MONDO:MONDO:0700268,MedGen:CN377757","not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4;Breast-ovarian cancer, familial, susceptibility to, 1;Familial cancer of breast|not specified|BRCA1-related disorder|BRCA1-related cancer predisposition",germline;not applicable;somatic;unknown,germline/somatic,GRCh38,NC_000017.11,17,43106457.0,43106457.0,17q21.31,reviewed by expert panel,33.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA001398,OMIM:113705.0034",3.0,17693.0,43106457.0,T,C,-,-,-,-,-,-,SCV001161539,-,-,211A>G ,Arg71Gly,NM_007294.4,3.0,1_Pathogenic,82.37,0.9758064516129032,"['604370', '114480', '617883', '614320', '604370', '114480']",,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST CANCER; FANCONI ANEMIA, COMPLEMENTATION GROUP S; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST CANCER",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Findlay_2018_var863,BRCA1_Findlay_2018,BRCA1,1100,-1.0,41258474.0,43106457.0,43106457.0,NM_007294.3,211,A,G,71.0,R,G,c.211A>G,p.Arg71Gly,Missense,missense_variant,-1.49271759046098,-1.29740461218784;-1.68803056873412,LOF,Yes,1.2656930112e-6,Pathogenic,reviewed by expert panel,"Jun 18, 2019",nucleotide,urn:mavedb:00000097-0-2,ENST00000357654.9,NM_007294.3,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,Functional ,"[-0.748, Inf)",Normal,Intermediate,"(-1.328, -0.748)",Not specified,Non-functional,"(-Inf,-1.328]",Abnormal,,,,,,,,,,,0.866,0.9012,likely_pathogenic,383.26557922,,,,,383.2655792212203,0.81,Multifac new calc,Pathogenic,0.1,0.9770563605966447,Likely Pathogenic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Arg71Gly,Arg71Gly,true
BRCA1,BRCA1_Cys39Arg,0.8472010433103342,0.4248979667525149,4.1294175576416,0.004407203445207837,2025_01_Batch_13-14,0.9113364851976637,0.9137217340058423,0.9073086621204074,0.9371120204690024,0.7799000081227152,0.9652418848774538,0.9170687102373754,0.9237966176939698,0.9615767892708877,0.9409877921854897,0.9382891850375588,0.9153952221216088,0.9155526399071886,0.9493444048699451,0.8604439001541024,true,false,false,false,false,0.0,0.0,0.0,0.0,0.0,true,BRCA1,,14613,,CCSBVarC011862,,NC_000017.11:43115745:A:G,115T>C,Cys39Arg,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Cys39Arg,17.0,43115745.0,A,G,17,,,,,,17-43115745-A-G,68819.0,single nucleotide variant,NM_007294.4(BRCA1):c.115T>C (p.Cys39Arg),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Aug 10, 2015",80357164.0,-,RCV000077483|RCV000496824|RCV000570028|RCV000985365|RCV001270963,"MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MedGen:CN221562","Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Breast and/or ovarian cancer",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43115745.0,43115745.0,17q21.31,reviewed by expert panel,18.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00113,ClinGen:CA000766",2.0,54152.0,43115745.0,A,G,-,-,-,-,-,-,SCV000244296,-,-,115T>C ,Cys39Arg,NM_007294.4,3.0,1_Pathogenic,,54152.0,17,43115745.0,A,G,C,R,rs80357164,17,41267762,17,38521288,39.0,BRCA1,ENSG00000012048,ENST00000713676,ENSP00000518978,P38398,BRCA1_HUMAN,.,.,c.115T>C,p.Cys39Arg,principal2,Y,.,.,.,-,TGT,1.0,0.0,A,A/A,A/A,A/A,A/A,.,0.91343,.,.,0.92967,.,0.987,0.90580,D,0.879,0.92348,P,.,0.99291,.,.,.,.,4.355,0.98454,H,.,0.99400,.,.,0.97441,0.9518,0.96410,D,0.9931,0.99838,D,10,.,0.99503,.,0.908305,0.99312,D,.,0.98488,0.996,0.99957,E9PFC7,C39R,Gain of catalytic residue at C39 (P = 0.0465)| Gain of phosphorylation at T37 (P = 0.077)| Gain of helix (P = 0.132)| Gain of MoRF binding (P = 0.136)| Gain of glycosylation at T37 (P = 0.1377),.,0.99932,.,0.93989,.,0.50598,0.773955702782,0.77978,T,0.409909,0.93004,T,0.564887,0.96297,D,0.573645,0.96237,D,0.998840510845184,0.95303,D,.,0.97903,.,0.98947704,0.99732,0.93276787,0.97245,0.97528833,0.98709,0.93651694,0.97501,-13.367,0.98539,D,.,0.97565,.,0.999949474096148,0.99079,0.99980813,0.99752,0.992,0.99727,.,.,.,.,.,.,4.933548,0.81398,27.5,0.99705377574859155,0.80955,0.797421,0.72325,D,0.971278320987367,0.94761,13.04323,0.87581144299615,0.94398,12.75438,5.97,5.97,0.96929,3.64,0.66725,4.109,0.57651,11.102000,0.86162,0.756,0.943,1.0,0.71675,1.0,0.68239,0.998,0.85369,464,0.78507,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,1,1613730,6.196820e-07,0,1,1179810,8.475940e-07,0,0,75044,0.000000e+00,0,0,910,0.000000e+00,0,0,59942,0.000000e+00,0,0,29584,0.000000e+00,0,0,44862,0.000000e+00,0,0,64014,0.000000e+00,0,0,6060,0.000000e+00,0,1,1179810,8.475940e-07,0,0,91016,0.000000e+00,0,0,6962,0,0,84,0,0,84,0,0,2636,0,0,146,0,0,610,0,0,24,0,0,94,0,0,518,0,0,2720,0,0,108,0,0,11158,0,Pathogenic,"Hereditary_breast_ovarian_cancer_syndrome|Breast_and/or_ovarian_cancer|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome",reviewed_by_expert_panel,NC_000017.11:g.43115745A>G,BRCA1-HCI:BRCA1_00113|ClinGen:CA000766,C0677776|CN221562|C3661900|C2676676|C0027672,604370,145|145|140162,"Zinc finger, C3HC4 RING-type|Zinc finger, RING-type, conserved site|Zinc finger, RING-type|Zinc finger, RING-type",Cys,Arg,68819.0,single nucleotide variant,NM_007294.4(BRCA1):c.115T>C (p.Cys39Arg),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Aug 10, 2015",80357164.0,-,RCV000077483|RCV000496824|RCV000570028|RCV000985365|RCV001270963,"MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MedGen:CN221562","Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Breast and/or ovarian cancer",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43115745.0,43115745.0,17q21.31,reviewed by expert panel,18.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00113,ClinGen:CA000766",2.0,54152.0,43115745.0,A,G,-,-,-,-,-,-,SCV000244296,-,-,115T>C ,Cys39Arg,NM_007294.4,3.0,1_Pathogenic,88.54,0.1555555555555555,['604370'],,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Findlay_2018_var478,BRCA1_Findlay_2018,BRCA1,1100,-1.0,41267762.0,43115745.0,43115745.0,NM_007294.3,115,T,C,39.0,C,R,c.115T>C,p.Cys39Arg,Missense,missense_variant,-2.40360904850681,-2.98549622000011;-1.82172187701351,LOF,Yes,6.196823508269661e-7,Pathogenic,reviewed by expert panel,"Aug 10, 2015",nucleotide,urn:mavedb:00000097-0-2,ENST00000357654.9,NM_007294.3,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,Functional ,"[-0.748, Inf)",Normal,Intermediate,"(-1.328, -0.748)",Not specified,Non-functional,"(-Inf,-1.328]",Abnormal,,,,,,,,,,,0.934,0.9978,likely_pathogenic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Cys39Arg,Cys39Arg,true
BRCA1,BRCA1_Val632Ala,2.1490587662768768,0.06870905490576534,3.81823247434967,0.006557305473716378,2025_01_Batch_13-14,0.8813107186301908,0.8772968783547237,0.8683821066344395,0.905743118181431,0.7797971771542498,0.9800312051341327,0.9247600758234454,0.9297751709075213,0.9743619796830157,0.9522056147366262,0.9306709618821618,0.9010284770890846,0.8990786387709804,0.9400525489322233,0.866001395945438,true,false,false,false,false,0.0,0.0,0.0,0.0,0.0,true,BRCA1,,14613,,CCSBVarC011853,,NC_000017.11:43057122:A:G,1895T>C,Val632Ala,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Val632Ala,17.0,43057122.0,A,G,17,,,,,,17-43057122-A-G,46204.0,single nucleotide variant,NM_007294.4(BRCA1):c.5207T>C (p.Val1736Ala),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Jun 25, 2019",45553935.0,-,RCV000195366|RCV000031229|RCV000048857|RCV000131291|RCV000585878,"MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883","Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Fanconi anemia, complementation group S",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43057122.0,43057122.0,17q21.31,reviewed by expert panel,24.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA003357,UniProtKB:P38398#VAR_070506,OMIM:113705.0038",3.0,37648.0,43057122.0,A,G,-,-,-,-,-,-,SCV001161713,-,-,5207T>C ,Val1736Ala,NM_007294.4,3.0,1_Pathogenic,,37648.0,17,43057122.0,A,G,V,A,rs45553935,17,41209139,17,38462665,1736.0,BRCA1,ENSG00000012048,ENST00000713676,ENSP00000518978,P38398,BRCA1_HUMAN,.,.,c.5207T>C,p.Val1736Ala,principal2,Y,.,.,.,-,GTC,2.0,0.0,A,A/A,A/A,A/A,A/A,.,0.91343,.,.,0.92967,.,0.802,0.90580,P,0.38,0.92348,B,.,0.99291,.,.,.,.,3.265,0.89891,M,.,0.66695,.,.,0.89680,0.8523,0.95041,D,0.8418,0.94704,D,10,.,0.91075,.,0.753957,0.98037,D,.,0.94487,.,.,.,.,.,.,0.89179,.,0.79043,.,0.13518,0.580183625221,0.50045,T,0.137814,0.46804,T,0.456703,0.92720,D,0.418246,0.92630,D,0.982382714748383,0.74278,D,.,0.83839,.,0.64500636,0.74826,0.18117532,0.40826,0.56882757,0.70704,0.19759434,0.43395,-8.463,0.64259,D,.,0.87654,.,0.989452318288449,0.88181,0.99978083,0.99714,0.81,0.89500,.,.,.,.,.,.,4.681403,0.74972,26.2,0.99880114867489878,0.95656,0.684452,0.64551,D,0.735250864207851,0.81845,7.641852,0.688539164513861,0.81406,7.543151,5.07,5.07,0.68064,.,.,5.554,0.67074,10.840000,0.83929,0.748,0.86774,1.0,0.71675,1.0,0.68239,1.0,0.97202,518,0.74567,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,13,1613984,8.054600e-06,0,12,1179920,1.017020e-05,0,0,75034,0.000000e+00,0,0,912,0.000000e+00,0,0,59990,0.000000e+00,0,0,29600,0.000000e+00,0,0,44870,0.000000e+00,0,0,64010,0.000000e+00,0,0,6056,0.000000e+00,0,12,1179920,1.017020e-05,0,0,91084,0.000000e+00,0,1,24506,4.080633314290378E-5,0,84,0,0,84,0,0,2656,0,0,500,0,0,628,0,0,24,0,0,94,0,0,4632,0,0,2740,0,0,108,0,1,33208,3.0113225728740063E-5,Pathogenic,"not_provided|Fanconi_anemia,_complementation_group_S|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_breast_ovarian_cancer_syndrome",reviewed_by_expert_panel,NC_000017.11:g.43057122A>G,ClinGen:CA003357|OMIM:113705.0038|UniProtKB:P38398#VAR_070506,C3661900|C4554406|C0027672|C2676676|C0677776,617883|604370,140162|145|145,BRCT domain,Val,Ala,46204.0,single nucleotide variant,NM_007294.4(BRCA1):c.5207T>C (p.Val1736Ala),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Jun 25, 2019",45553935.0,-,RCV000195366|RCV000031229|RCV000048857|RCV000131291|RCV000585878,"MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883","Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Fanconi anemia, complementation group S",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43057122.0,43057122.0,17q21.31,reviewed by expert panel,24.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA003357,UniProtKB:P38398#VAR_070506,OMIM:113705.0038",3.0,37648.0,43057122.0,A,G,-,-,-,-,-,-,SCV001161713,-,-,5207T>C ,Val1736Ala,NM_007294.4,3.0,1_Pathogenic,97.64,0.0,"['604370', '617883']",,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; FANCONI ANEMIA, COMPLEMENTATION GROUP S",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Adamovich_2022_HDR_var5176,BRCA1_Adamovich_2022_HDR,BRCA1,1100,-1.0,,43057122.0,43057122.0,,5207,T,C,1736.0,V,A,c.5207T>C,p.Val1736Ala,missense_variant,missense_variant,-0.3849073175,-0.931080134;0.251635;-0.708107784;-0.152076352,,No,8.0546027717e-6,Pathogenic,reviewed by expert panel,"Jun 25, 2019",aa,urn:mavedb:00001222-b-1,ENST00000357654.9,NM_007294.4,immortalized human cells,,fluorescence intensity (BAO_0000363),"DNA repair (GO:0006281), double-strand break repair via homologous recombination (GO:0000724)",No,Functional,"(-0.233, Inf)",Normal,LOF,"(-Inf, -0.562)",Abnormal,Intermediate,"[-0.562,-0.233]",Not specified,,,,,,,,,,,0.827,0.8955,likely_pathogenic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Val1736Ala,Val1736Ala,false
BRCA1,BRCA1_Gly666Val,0.8111849338867764,0.4439619283781052,3.5112350638164833,0.009843009152846182,2025_01_Batch_13-14,0.8413339729777471,0.905374571810571,0.8714205125345021,0.9150813611590665,0.6980768194668904,0.9221979106285213,0.8248239232178372,0.8489993684039382,0.9412095699512582,0.7681921894318554,0.8817659418031343,0.8650992475142041,0.8602099404692202,0.9281454655551623,0.7331345044493729,false,false,false,false,false,0.0,0.0,0.0,0.0,0.0,true,BRCA1,,14613,,CCSBVarC011818,,NC_000017.11:43051086:C:A,1997G>T,Gly666Val,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Gly666Val,17.0,43051086.0,C,A,17,,,,,,17-43051086-C-A,404710.0,single nucleotide variant,NM_007294.4(BRCA1):c.5309G>T (p.Gly1770Val),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Jul 18, 2018",863224765.0,-,RCV000502156|RCV000477771|RCV001023895|RCV001572739|RCV001865421,"MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145","Malignant tumor of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43051086.0,43051086.0,17q21.31,reviewed by expert panel,13.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,ClinGen:CA10590929,2.0,417832.0,43051086.0,C,A,-,-,-,-,-,-,SCV001161716,-,-,5309G>T ,Gly1770Val,NM_007294.4,3.0,1_Pathogenic,,417832.0,17,43051086.0,C,A,G,V,rs863224765,17,41203103,17,38456629,1770.0,BRCA1,ENSG00000012048,ENST00000494123,ENSP00000419103,P38398,BRCA1_HUMAN,.,.,c.5309G>T,p.Gly1770Val,principal2,Y,1,.,.,-,GGG,2.0,0.0,C,C/C,C/C,C/C,C/C,.,0.78662,.,.,0.83643,.,0.583,0.77914,P,0.055,0.73565,B,.,0.99291,.,.,.,.,2.215,0.62356,M,.,0.90790,.,.,0.94206,0.6824,0.92930,D,0.7985,0.93160,D,10,.,0.91415,.,0.786529,0.98318,D,.,0.94788,.,.,.,.,.,.,0.93785,.,0.83211,.,0.40658,0.485455960035,0.36760,T,0.327304,0.69606,T,0.420504,0.90984,D,0.366249,0.90872,D,0.977009236812592,0.71446,D,.,0.91429,.,0.58132803,0.71391,0.22660044,0.47467,0.58380777,0.71528,0.32384387,0.58085,-9.173,0.85385,D,.,0.77473,.,0.994521859597463,0.90703,0.99981505,0.99752,0.916,0.95687,.,.,.,.,.,.,3.272588,0.44882,22.0,0.99741871120433134,0.83570,0.471283,0.51522,N,0.484917239323781,0.66032,4.920639,0.444495820101055,0.64170,4.689884,5.06,4.09,0.46976,4.36,0.82260,2.72,0.47021,4.864000,0.45576,0.599,0.40292,0.981,0.35482,1.0,0.68239,0.98,0.58201,449,0.79449,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,2,1613796,1.239310e-06,0,1,91068,1.098080e-05,0,0,74882,0.000000e+00,0,0,912,0.000000e+00,0,0,59982,0.000000e+00,0,0,29600,0.000000e+00,0,0,44870,0.000000e+00,0,0,63966,0.000000e+00,0,0,6056,0.000000e+00,0,0,1179952,0.000000e+00,0,1,91068,1.098080e-05,0,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Pathogenic,"Malignant_tumor_of_breast|Hereditary_cancer-predisposing_syndrome|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1",reviewed_by_expert_panel,NC_000017.11:g.43051086C>A,ClinGen:CA10590929,C0006142|C0027672|C0677776|C3661900|C2676676,604370,140162|145|145,.,Gly,Val,404710.0,single nucleotide variant,NM_007294.4(BRCA1):c.5309G>T (p.Gly1770Val),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Jul 18, 2018",863224765.0,-,RCV000502156|RCV000477771|RCV001023895|RCV001572739|RCV001865421,"MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145","Malignant tumor of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43051086.0,43051086.0,17q21.31,reviewed by expert panel,13.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,ClinGen:CA10590929,2.0,417832.0,43051086.0,C,A,-,-,-,-,-,-,SCV001161716,-,-,5309G>T ,Gly1770Val,NM_007294.4,3.0,1_Pathogenic,84.89,0.3333333333333333,['604370'],,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Findlay_2018_var2854,BRCA1_Findlay_2018,BRCA1,1100,-1.0,41203103.0,43051086.0,43051086.0,NM_007294.3,5309,G,T,1770.0,G,V,c.5309G>T,p.Gly1770Val,Missense,missense_variant,-2.59802661440298,-3.37985468566842;-1.81619854313753,LOF,Yes,1.2393140149e-6,Pathogenic,reviewed by expert panel,"Jul 18, 2018",nucleotide,urn:mavedb:00000097-0-2,ENST00000357654.9,NM_007294.3,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,Functional ,"[-0.748, Inf)",Normal,Intermediate,"(-1.328, -0.748)",Not specified,Non-functional,"(-Inf,-1.328]",Abnormal,,,,,,,,,,,0.835,0.7912,likely_pathogenic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Gly1770Val,Gly1770Val,false
BRCA1,BRCA1_Thr581Ile,2.1265294642858166,0.07103329880869202,-0.158636793647094,0.8784347489809712,2025_01_Batch_13-14,0.9316618456321135,0.9092375600621425,0.93286056207861,0.9617341429430188,0.8089472055930808,0.9794941865604404,0.9271412523148135,0.9097639680467864,0.9723372998209778,0.9052711664396076,0.955578016096277,0.918189406188478,0.9213122650626981,0.9670357213819983,0.8571091860163442,true,false,false,true,false,1.0,0.0,0.0,0.0,0.0,true,BRCA1,ENSG00000012048,14613,218422.0,CCSBVarC003303,ALE00003303,NC_000017.11:43067628:G:A,1742C>T,Thr581Ile,CEGS2,CegsMutGDEh1018,D09,GDEhDisVCh_40059,C06,1.0,,,,,,,,,1.0,1.0,0.0,,0.0,,,0.0,,,0.0,,,BRCA1_Thr581Ile,17.0,43067628.0,G,A,17,Y,N,N,N,N,17-43067628-G-A,70032.0,single nucleotide variant,NM_007294.4(BRCA1):c.5054C>T (p.Thr1685Ile),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Aug 10, 2015",80357043.0,-,RCV000112476|RCV001853017|RCV002336188|RCV004998172,"MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900","Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43067628.0,43067628.0,17q21.31,reviewed by expert panel,9.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00050,ClinGen:CA003175,UniProtKB:P38398#VAR_063903",2.0,55365.0,43067628.0,G,A,-,-,-,-,-,-,SCV000244380,-,-,5054C>T ,Thr1685Ile,NM_007294.4,3.0,1_Pathogenic,1.36983e-6,55365.0,17,43067628.0,G,A,T,I,rs80357043,17,41219645.0,17,38473171.0,1685.0,BRCA1,ENSG00000012048,ENST00000618469,ENSP00000478114,P38398,BRCA1_HUMAN,.,.,c.5054C>T,p.Thr1685Ile,principal2,Y,1,.,.,-,ACT,2.0,0.0,G,G/G,G/G,G/G,G/G,.,0.91343,.,.,0.92967,.,0.89,0.90580,P,0.329,0.92348,B,.,0.99291,.,.,.,.,3.31,0.90471,M,.,0.82367,.,.,0.95034,0.7600,0.93898,D,0.7898,0.92853,D,10,.,0.85827,.,0.72506,0.97777,D,.,0.96457,.,.,.,.,.,.,0.96144,.,0.90972,.,0.19319,0.753464519978,0.74914,T,0.409904,0.82120,T,0.438305,0.91883,D,0.391819,0.91782,D,0.983474791049957,0.74950,D,0.958004,0.85541,D,0.88979423,0.90355,0.6439081,0.78957,0.9066492,0.91869,0.62467957,0.77890,-14.562,0.94802,D,.,0.91617,.,0.991231594940223,0.88934,0.99987290,0.99835,0.987,0.99559,.,.,.,.,.,.,4.1672,0.62705,24.5,0.9990436228200248,0.97578,0.771366,0.70495,D,0.813238141695724,0.86857,9.04512,0.757877512501455,0.86669,8.988454,5.24,5.24,0.72825,.,.,6.008,0.70468,11.804000,0.96740,0.569,0.28905,1.0,0.71675,1.0,0.68239,0.976,0.56441,545,0.72635,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,3,1612146,1.860870e-06,0,1,44884,2.227970e-05,0,0,74826,0.000000e+00,0,0,912,0.000000e+00,0,0,59984,0.000000e+00,0,0,29592,0.000000e+00,0,1,44884,2.227970e-05,0,0,64008,0.000000e+00,0,0,6078,0.000000e+00,0,2,1178384,1.697240e-06,0,0,91058,0.000000e+00,0,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Pathogenic,"Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome",reviewed_by_expert_panel,NC_000017.11:g.43067628G>A,BRCA1-HCI:BRCA1_00050|ClinGen:CA003175|UniProtKB:P38398#VAR_063903,C0677776|C2676676|C0027672,604370,145|145|140162,BRCT domain|BRCT domain|BRCT domain,Thr,Ile,70032.0,single nucleotide variant,NM_007294.4(BRCA1):c.5054C>T (p.Thr1685Ile),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Aug 10, 2015",80357043.0,-,RCV000112476|RCV001853017|RCV002336188|RCV004998172,"MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900","Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43067628.0,43067628.0,17q21.31,reviewed by expert panel,9.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00050,ClinGen:CA003175,UniProtKB:P38398#VAR_063903",2.0,55365.0,43067628.0,G,A,-,-,-,-,-,-,SCV000244380,-,-,5054C>T ,Thr1685Ile,NM_007294.4,3.0,1_Pathogenic,94.85,0.352112676056338,['604370'],multiple,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Adamovich_2022_Cisplatin_var6277,BRCA1_Adamovich_2022_Cisplatin,BRCA1,1100,-1.0,,43067628.0,43067628.0,,5054,C,T,1685.0,T,I,c.5054C>T,p.Thr1685Ile,missense_variant,missense_variant,-1.03350250925,-1.321210618;-1.433452633;-0.670731515;-0.708615272,,No,1.8608736429e-6,Pathogenic,reviewed by expert panel,"Aug 10, 2015",aa,urn:mavedb:00001222-a-1,ENST00000357654.9,NM_007294.4,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),cellular response to cisplatin (GO:0072719),No,Functional,"(-0.503, Inf)",Normal,LOF,"(-Inf, -0.729)",Abnormal,Intermediate,"[-0.729,-0.503]",Not specified,,,,,,,,,,,0.88,0.9339,likely_pathogenic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Thr1685Ile,Thr1685Ile,false
BRCA1,BRCA1_Glu631Lys,1.0983392108185215,0.30839265196900983,1.9419342156297021,0.09326896956291159,2025_01_Batch_13-14,0.8653114532543542,0.8609513783183007,0.6786680870186188,0.7122638775895174,0.8390927652271518,0.9766476325556213,0.9213786545766204,0.9381547758252562,0.9808460116119835,0.9233140844072092,0.9209795429049877,0.8911650164474605,0.8084114314219375,0.8465549446007504,0.8812034248171805,false,false,false,false,true,0.0,0.0,0.0,0.0,0.0,true,BRCA1,ENSG00000012048,14613,218448.0,CCSBVarC003307,ALE00003307,NC_000017.11:43057126:C:T,1891G>A,Glu631Lys,CEGS2,CegsMutGDEh1026,D09,GDEhDisVCh_40059,A09,1.0,,,,,,,,,1.0,1.0,0.0,,0.0,,,0.0,,,0.0,,,BRCA1_Glu631Lys,17.0,43057126.0,C,T,17,Y,N,N,N,N,17-43057126-C-T,70122.0,single nucleotide variant,NM_007294.4(BRCA1):c.5203G>A (p.Glu1735Lys),672.0,BRCA1,HGNC:1100,not provided,0.0,-,397509238.0,-,RCV000577367|RCV001072517,"MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145","Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1",germline;not applicable,germline,GRCh38,NC_000017.11,17,43057126.0,43057126.0,17q21.31,no classification provided,2.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA003353,UniProtKB:P38398#VAR_070505",3.0,55455.0,43057126.0,C,T,-,-,-,-,-,-,SCV000679293|SCV001237915,-,-,5203G>A ,Glu1735Lys,NM_007294.4,,5_Others,,55455.0,17,43057126.0,C,T,E,K,rs397509238,17,41209143.0,17,38462669.0,1735.0,BRCA1,ENSG00000012048,ENST00000470026,ENSP00000419274,P38398,BRCA1_HUMAN,.,.,c.5203G>A,p.Glu1735Lys,principal2,Y,1,.,.,-,GAA,1.0,0.0,C,C/C,C/C,C/C,C/C,.,0.91343,.,.,0.92967,.,0.904,0.90580,P,0.17,0.88579,B,.,.,.,.,.,.,3.64,0.94011,H,.,0.66115,.,.,0.97441,1.0854,0.99062,D,0.9540,0.98504,D,10,.,0.91685,.,0.776902,0.98236,D,.,0.94374,.,.,.,.,.,.,0.94343,.,0.86555,.,0.10057,0.611799120903,0.54504,T,0.384042,0.81335,T,0.454957,0.92647,D,0.415738,0.92557,D,0.99232280254364,0.82639,D,.,0.97033,.,0.87069577,0.88763,0.49804372,0.70717,0.8283224,0.85601,0.4636008,0.68604,-14.271,0.93916,D,.,0.86411,.,0.997865992856704,0.93647,0.99988377,0.99849,0.931,0.96596,.,.,.,.,.,.,4.661471,0.74461,26.2,0.9990348176399078,0.97503,0.684509,0.64555,D,0.813291850711605,0.86860,9.046169,0.751252984158328,0.86175,8.829661,5.07,5.07,0.68064,3.31,0.60027,4.681,0.61438,7.412000,0.58717,0.593,0.32293,1.0,0.71675,1.0,0.68239,1.0,0.97202,518,0.74567,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,not_provided,"Familial_cancer_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_1",no_classification_provided,NC_000017.11:g.43057126C>T,ClinGen:CA003353|UniProtKB:P38398#VAR_070505,C0346153|C2676676,114480|604370,227535|145,BRCT domain,Glu,Lys,70122.0,single nucleotide variant,NM_007294.4(BRCA1):c.5203G>A (p.Glu1735Lys),672.0,BRCA1,HGNC:1100,not provided,0.0,-,397509238.0,-,RCV000577367|RCV001072517,"MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145","Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1",germline;not applicable,germline,GRCh38,NC_000017.11,17,43057126.0,43057126.0,17q21.31,no classification provided,2.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA003353,UniProtKB:P38398#VAR_070505",3.0,55455.0,43057126.0,C,T,-,-,-,-,-,-,SCV000679293|SCV001237915,-,-,5203G>A ,Glu1735Lys,NM_007294.4,,5_Others,97.25,0.0618556701030927,"['114480', '604370']",multiple,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST CANCER; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Findlay_2018_var2456,BRCA1_Findlay_2018,BRCA1,1100,-1.0,41209143.0,43057126.0,43057126.0,NM_007294.3,5203,G,A,1735.0,E,K,c.5203G>A,p.Glu1735Lys,Missense,missense_variant,-3.24294554301487,-3.25698355110448;-3.22890753492526,LOF,Yes,,not provided,no classification provided,-,nucleotide,urn:mavedb:00000097-0-2,ENST00000357654.9,NM_007294.3,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,Functional ,"[-0.748, Inf)",Normal,Intermediate,"(-1.328, -0.748)",Not specified,Non-functional,"(-Inf,-1.328]",Abnormal,,,,,,,,,,,0.824,0.8728,likely_pathogenic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Glu1735Lys,Glu1735Lys,false
BRCA1,BRCA1_Cys64Ser,-0.5198160846601582,0.619220375890755,-3.278051964362376,0.013523323462305666,2025_01_Batch_13-14,0.509193303597748,0.665192591066776,0.7746920340779846,0.7189477005715086,0.4156154156519475,0.7305620324311284,0.5904017028232041,0.7157838760695898,0.7219623155263104,0.700675173216614,0.6198776680144382,0.6277971469449901,0.7452379550737872,0.7204550080489095,0.5581452944342807,false,false,false,false,false,0.0,0.0,0.0,0.0,0.0,true,BRCA1,,14613,,CCSBVarC011841,,NC_000017.11:43106477:C:G,191G>C,Cys64Ser,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Cys64Ser,17.0,43106477.0,C,G,17,,,,,,17-43106477-C-G,468251.0,single nucleotide variant,NM_007294.4(BRCA1):c.191G>C (p.Cys64Ser),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Nov 09, 2022",55851803.0,-,RCV000559047|RCV001076723,"MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145","Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1",germline;not applicable,germline,GRCh38,NC_000017.11,17,43106477.0,43106477.0,17q21.31,"criteria provided, single submitter",2.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,ClinGen:CA10601786,2.0,462571.0,43106477.0,C,G,-,-,-,-,-,-,SCV000635819,-,-,191G>C ,Cys64Ser,NM_007294.4,1.0,1_Pathogenic,,462571.0,17,43106477.0,C,G,C,S,rs55851803,17,41258494,17,38512020,64.0,BRCA1,ENSG00000012048,ENST00000357654,ENSP00000350283,P38398,BRCA1_HUMAN,c.191G>C,p.Cys64Ser,c.191G>C,p.Cys64Ser,principal2,Y,1,YES,Select,-,TGT,2.0,0.0,C,C/C,C/C,C/C,C/C,0.0,0.91343,D,0.0,0.92967,D,0.99,0.68795,D,0.903,0.78943,P,1.0,0.99291,A,simple_aae,0.0,100.0,3.99,0.96635,H,-1.45,0.98450,N,0.982,0.99346,0.9381,0.96208,D,0.9931,0.99838,D,10,0.9888865,0.99322,D,0.959083,0.99729,D,0.922,0.98039,0.968,0.99690,E9PFC7,C64S,Gain of disorder (P = 0.0079)| Loss of stability (P = 0.0171)| Gain of phosphorylation at C64 (P = 0.0837)| Gain of glycosylation at P62 (P = 0.1363)| Loss of methylation at K65 (P = 0.1443),0.999450167335,0.99943,.,0.86148,.,0.40765,0.717033147812,0.69562,T,0.46945,0.92995,T,0.553376,0.95819,D,0.55711,0.95755,D,0.997346639633179,0.91262,D,.,0.80441,.,0.9870781,0.99591,0.88999635,0.94188,0.97642994,0.98806,0.88973695,0.94170,-12.832,0.92342,D,0.9961,0.97310,P,0.999399190328388,0.96461,0.99976617,0.99701,0.964,0.98523,.,.,.,.,.,.,5.090651,0.85032,28.5,0.99110843159672235,0.52805,0.851286,0.76729,D,0.91310061370465,0.92344,11.39386,0.783598264701654,0.88566,9.654935,4.64,4.64,0.57348,.,.,4.108,0.57643,7.641000,0.63257,0.531,0.24877,1.0,0.71675,1.0,0.68239,0.997,0.79771,459,0.78836,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Pathogenic,"Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_breast_ovarian_cancer_syndrome","criteria_provided,_single_submitter",NC_000017.11:g.43106477C>G,ClinGen:CA10601786,C2676676|C0677776,604370,145|145,"Zinc finger, C3HC4 RING-type|Zinc finger, RING-type|Zinc finger, RING-type",Cys,Ser,468251.0,single nucleotide variant,NM_007294.4(BRCA1):c.191G>C (p.Cys64Ser),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Nov 09, 2022",55851803.0,-,RCV000559047|RCV001076723,"MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145","Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1",germline;not applicable,germline,GRCh38,NC_000017.11,17,43106477.0,43106477.0,17q21.31,"criteria provided, single submitter",2.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,ClinGen:CA10601786,2.0,462571.0,43106477.0,C,G,-,-,-,-,-,-,SCV000635819,-,-,191G>C ,Cys64Ser,NM_007294.4,1.0,1_Pathogenic,88.77,0.3333333333333333,['604370'],,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Findlay_2018_var803,BRCA1_Findlay_2018,BRCA1,1100,-1.0,41258494.0,43106477.0,43106477.0,NM_007294.3,191,G,C,64.0,C,S,c.191G>C,p.Cys64Ser,Missense,missense_variant,-3.02220614509521,-3.14041663713947;-2.90399565305095,LOF,Yes,,Pathogenic,"criteria provided, single submitter","Nov 09, 2022",nucleotide,urn:mavedb:00000097-0-2,ENST00000357654.9,NM_007294.3,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,Functional ,"[-0.748, Inf)",Normal,Intermediate,"(-1.328, -0.748)",Not specified,Non-functional,"(-Inf,-1.328]",Abnormal,,,,,,,,,,,0.922,0.9961,likely_pathogenic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Cys64Ser,Cys64Ser,true
BRCA1,BRCA1_Ser611Arg,0.9435653387772786,1.0,3.4350690406883606,0.02202146477987949,2025_01_Batch_13-14,0.9553935623214184,0.9507932560196941,0.9084188437682514,0.949490270032494,0.883887929907112,0.9809933121913667,0.9396248586533601,0.9215061440810749,0.9789850450005839,0.889371169243643,0.9681934372563925,0.945209057336527,0.9149624939246632,0.964237657516539,0.8866295495753775,true,true,false,true,true,1.0,0.0,0.0,0.0,1.0,true,BRCA1,,14613,,CCSBVarC011835,,NC_000017.11:43063881:G:C,1833C>G,Ser611Arg,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Ser611Arg,17.0,43063881.0,G,C,17,,,,,,17-43063881-G-C,70085.0,single nucleotide variant,NM_007294.4(BRCA1):c.5145C>G (p.Ser1715Arg),672.0,BRCA1,HGNC:1100,Pathogenic/Likely pathogenic,1.0,"Oct 16, 2024",80357094.0,-,RCV000112509|RCV002336193|RCV005089439,"MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145","Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43063881.0,43063881.0,17q21.31,"criteria provided, multiple submitters, no conflicts",6.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA003268,UniProtKB:P38398#VAR_063906",2.0,55418.0,43063881.0,G,C,-,-,-,-,-,-,SCV000326168|SCV002645244|SCV005058237|SCV005812863,-,-,5145C>G ,Ser1715Arg,NM_007294.4,2.0,1_Pathogenic,,55418.0,17,43063881.0,G,C,S,R,rs80357094,17,41215898,17,38469424,1715.0,BRCA1,ENSG00000012048,ENST00000470026,ENSP00000419274,P38398,BRCA1_HUMAN,.,.,c.5145C>G,p.Ser1715Arg,principal2,Y,1,.,.,-,AGC,3.0,2.0,G,G/G,G/G,G/G,G/G,.,0.91343,.,.,0.92967,.,0.064,0.90580,B,0.031,0.92348,B,.,0.99291,.,.,.,.,3.09,0.87301,M,.,0.74220,.,.,0.93850,0.3749,0.88675,D,0.6610,0.88183,D,10,.,0.79960,.,0.483874,0.94878,D,.,0.88582,.,.,.,.,.,.,0.91515,.,0.92636,.,0.45682,0.678713917732,0.64025,T,0.249441,0.61729,T,0.397653,0.89708,D,0.333424,0.89578,D,0.98091846704483,0.73434,D,.,0.85294,.,0.9707088,0.98298,0.7604528,0.85672,0.97296304,0.98504,0.7653877,0.85971,-15.775,0.97410,D,.,0.96584,.,0.998593400129946,0.94714,0.99986792,0.99835,0.992,0.99727,.,.,.,.,.,.,3.655532,0.51985,23.2,0.99838730133180587,0.91978,0.429032,0.49057,N,0.670045961903725,0.77549,6.719747,0.654600882003088,0.78837,6.981316,6.04,4.89,0.63341,4.33,0.81833,2.013,0.40665,4.969000,0.46465,0.596,0.33565,1.0,0.71675,1.0,0.68239,0.998,0.85369,549,0.72286,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Pathogenic/Likely_pathogenic,"Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1","criteria_provided,_multiple_submitters,_no_conflicts",NC_000017.11:g.43063881G>C,ClinGen:CA003268|UniProtKB:P38398#VAR_063906,C0027672|C2676676,604370,140162|145,BRCT domain|BRCT domain|BRCT domain,Ser,Arg,70085.0,single nucleotide variant,NM_007294.4(BRCA1):c.5145C>G (p.Ser1715Arg),672.0,BRCA1,HGNC:1100,Pathogenic/Likely pathogenic,1.0,"Oct 16, 2024",80357094.0,-,RCV000112509|RCV002336193|RCV005089439,"MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145","Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43063881.0,43063881.0,17q21.31,"criteria provided, multiple submitters, no conflicts",6.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA003268,UniProtKB:P38398#VAR_063906",2.0,55418.0,43063881.0,G,C,-,-,-,-,-,-,SCV000326168|SCV002645244|SCV005058237|SCV005812863,-,-,5145C>G ,Ser1715Arg,NM_007294.4,2.0,1_Pathogenic,97.51,0.0,['604370'],,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Findlay_2018_var2052,BRCA1_Findlay_2018,BRCA1,1100,-1.0,41215898.0,43063881.0,43063881.0,NM_007294.3,5145,C,G,1715.0,S,R,c.5145C>G,p.Ser1715Arg,Missense,missense_variant,-1.8710630832529,-1.86394968753962;-1.87817647896617,LOF,Yes,,Pathogenic/Likely pathogenic,"criteria provided, multiple submitters, no conflicts","Mar 06, 2024",nucleotide,urn:mavedb:00000097-0-2,ENST00000357654.9,NM_007294.3,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,Functional ,"[-0.748, Inf)",Normal,Intermediate,"(-1.328, -0.748)",Not specified,Non-functional,"(-Inf,-1.328]",Abnormal,,,,,,,,,,,0.688,0.9947,likely_pathogenic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Ser1715Arg,Ser1715Arg,false
BRCA1,BRCA1_Met548Ile,0.2873204807817469,0.7821863607221871,4.279146156570467,0.003659222814302877,2025_01_Batch_13-14,0.9785719900798429,0.9429073217627154,0.924181783445701,0.9557560006145543,0.8910223522970666,0.9890623605680183,0.9493701734682697,0.9512223971201553,0.9882025107135686,0.9632357125212221,0.9838171753239306,0.9461387476154925,0.9377020902829282,0.9719792556640614,0.9271290324091443,true,true,false,true,true,1.0,0.0,0.0,0.0,1.0,true,BRCA1,,14613,,CCSBVarC013069,,NC_000017.11:43070958:C:T,1644G>A,Met548Ile,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Met548Ile,17.0,43070958.0,C,T,17,,,,,,17-43070958-C-T,50269.0,single nucleotide variant,NM_007294.4(BRCA1):c.4956G>A (p.Met1652Ile),672.0,BRCA1,HGNC:1100,Benign,0.0,"Aug 10, 2015",1799967.0,-,RCV000034756|RCV000128916|RCV000048709|RCV000112434|RCV000120261|RCV000476093|RCV001270155|RCV004803120,"MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0700268,MedGen:CN377757","not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Familial cancer of breast|Malignant tumor of breast|BRCA1-related cancer predisposition",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43070958.0,43070958.0,17q21.31,reviewed by expert panel,46.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00107,ClinGen:CA003103,UniProtKB:P38398#VAR_007795",2.0,41830.0,43070958.0,C,T,-,-,-,-,-,-,SCV000244374,-,-,4956G>A ,Met1652Ile,NM_007294.4,3.0,2_Benign,,41830.0,17,43070958.0,C,T,M,I,rs1799967,17,41222975,17,38476501,1652.0,BRCA1,ENSG00000012048,ENST00000470026,ENSP00000419274,P38398,BRCA1_HUMAN,.,.,c.4956G>A,p.Met1652Ile,principal2,Y,1,.,.,-,ATG,3.0,0.0,C,C/C,C/C,C/C,C/C,.,0.33898,.,.,0.36968,.,0.0,0.28566,B,0.004,0.29523,B,.,0.16373,.,.,.,.,0.175,0.08964,N,.,0.38141,.,.,0.33676,-0.8538,0.51511,T,0.1432,0.46308,T,10,.,0.00157,.,.,.,.,.,0.73230,.,.,.,.,.,.,.,.,0.30010,.,0.10046,0.360434174538,0.19429,T,0.099528,0.40156,T,-0.195766,0.21097,T,-0.0261181,0.68398,D,0.0072100418028408,0.00082,T,.,0.64025,.,0.19599688,0.41094,0.13775083,0.32824,0.25679418,0.48390,0.11591255,0.27917,-4.756,0.35788,T,.,0.64691,.,0.164986458329954,0.48018,0.95295440,0.93539,0.216,0.48172,.,.,.,.,.,.,2.32095,0.29778,18.21,0.96644426836776054,0.30766,0.454853,0.50568,N,-0.274289964374125,0.29865,1.678113,-0.0674097859341404,0.36444,2.142461,4.82,3.78,0.42561,3.78,0.69545,1.313,0.33295,2.710000,0.34310,0.599,0.40292,1.0,0.71675,1.0,0.68239,0.99,0.65338,544,0.72706,56,0.011182108626198083,0,0.0,16,0.015904572564612324,3,0.004322766570605188,0,0.0,37,0.03783231083844581,2323,264690,0.008776304,.,2157,109398,1.971700e-02,48,3761,207690,1.810870e-02,80,4287,236388,1.813540e-02,88,10,7164,1.395870e-03,0,64,17110,3.740500e-03,0,67,2320,2.887930e-02,0,1,9046,1.105460e-04,0,723,13386,5.401170e-02,25,632,42768,1.477740e-02,3,626,15690,3.989800e-02,20,626,15690,3.989800e-02,20,30,16216,1.850020e-03,0,114,30522,3.735010e-03,0,157,6210,2.528180e-02,1,2,13416,1.490760e-04,0,890,16726,5.321060e-02,31,1317,89130,1.477620e-02,11,1163,30608,3.799660e-02,37,1163,30608,3.799660e-02,37,27,14902,1.811840e-03,0,144,34258,4.203400e-03,0,225,9568,2.351590e-02,2,2,17692,1.130450e-04,0,1113,21624,5.147060e-02,37,1517,102208,1.484230e-02,12,1159,30526,3.796760e-02,37,1159,30526,3.796760e-02,37,.,23606,1614160,1.462430e-02,338,3175,64006,4.960470e-02,99,143,75032,1.905850e-03,0,7,910,7.692310e-03,0,271,60024,4.514860e-03,0,679,29608,2.293300e-02,8,5,44892,1.113780e-04,0,3175,64006,4.960470e-02,99,143,6062,2.358960e-02,3,15052,1180032,1.275560e-02,119,3269,91088,3.588840e-02,99,3242,204736,0.015835026570803375,1,394,0.0025380710659898475,0,4556,0,31,10580,0.0029300567107750472,8,818,0.009779951100244499,9,1028,0.008754863813229572,0,1850,0,6,280,0.02142857142857143,228,18068,0.012618994908124861,32,10974,0.00291598323309641,0,6406,0,3525,242310,0.014547480500185712,Benign,"not_provided|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|not_specified|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Familial_cancer_of_breast|Malignant_tumor_of_breast",reviewed_by_expert_panel,NC_000017.11:g.43070958C>T,BRCA1-HCI:BRCA1_00107|ClinGen:CA003103|UniProtKB:P38398#VAR_007795,C3661900|C0677776|C0027672|CN169374|C2676676|C0346153|C0006142,604370|114480,145|140162|145|227535,BRCT domain|BRCT domain|BRCT domain,Met,Ile,50269.0,single nucleotide variant,NM_007294.4(BRCA1):c.4956G>A (p.Met1652Ile),672.0,BRCA1,HGNC:1100,Benign,0.0,"Aug 10, 2015",1799967.0,-,RCV000034756|RCV000128916|RCV000048709|RCV000112434|RCV000120261|RCV000476093|RCV001270155|RCV004803120,"MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0700268,MedGen:CN377757","not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Familial cancer of breast|Malignant tumor of breast|BRCA1-related cancer predisposition",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43070958.0,43070958.0,17q21.31,reviewed by expert panel,46.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00107,ClinGen:CA003103,UniProtKB:P38398#VAR_007795",2.0,41830.0,43070958.0,C,T,-,-,-,-,-,-,SCV000244374,-,-,4956G>A ,Met1652Ile,NM_007294.4,3.0,2_Benign,96.01,0.0,"['604370', '114480']",,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST CANCER",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Findlay_2018_var1393,BRCA1_Findlay_2018,BRCA1,1100,-1.0,41222975.0,43070958.0,43070958.0,NM_007294.3,4956,G,A,1652.0,M,I,c.4956G>A,p.Met1652Ile,Missense,missense_variant,0.143488826026886,-0.073549181598319;0.360526833652091,FUNC,Yes,0.0146243247261733,Benign,reviewed by expert panel,"Aug 10, 2015",nucleotide,urn:mavedb:00000097-0-2,ENST00000357654.9,NM_007294.3,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,Functional ,"[-0.748, Inf)",Normal,Intermediate,"(-1.328, -0.748)",Not specified,Non-functional,"(-Inf,-1.328]",Abnormal,,,,,,,,,,,0.426,0.388,ambiguous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Met1652Ile,Met1652Ile,false
BRCA1,BRCA1_Lys502Glu,0.8105603126478718,0.44429777323077857,4.989655621459293,0.0015836344442593491,2025_01_Batch_13-14,0.8872472228434506,0.8853565853297606,0.883380119926835,0.940891248085023,0.7309200947844363,0.8760282906814945,0.834676051235093,0.8217419276734688,0.8994130753199278,0.762667311487012,0.8816377567624725,0.8600163182824268,0.8525610238001519,0.9201521617024754,0.7467937031357241,true,false,false,false,false,0.0,0.0,0.0,0.0,0.0,true,BRCA1,ENSG00000012048,14613,218418.0,CCSBVarC003301,ALE00003301,NC_000017.11:43071098:T:C,1504A>G,Lys502Glu,CEGS2,CegsMutGDEh1026,D01,GDEhDisVCh_40059,H08,1.0,,,,,,,,,1.0,1.0,0.0,,0.0,,,0.0,,,0.0,,,BRCA1_Lys502Glu,17.0,43071098.0,T,C,17,Y,N,N,N,N,17-43071098-T-C,46168.0,single nucleotide variant,NM_007294.4(BRCA1):c.4816A>G (p.Lys1606Glu),672.0,BRCA1,HGNC:1100,Benign,0.0,"Jun 18, 2019",80356943.0,-,RCV000048668|RCV000436368|RCV000735492|RCV000130005|RCV004554630|RCV000031193|RCV001281714,"MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374|MedGen:CN221562|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162||MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900","Hereditary breast ovarian cancer syndrome|not specified|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|BRCA1-related disorder|Breast-ovarian cancer, familial, susceptibility to, 1|not provided",germline;unknown,germline,GRCh38,NC_000017.11,17,43071098.0,43071098.0,17q21.31,reviewed by expert panel,16.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA003037,UniProtKB:P38398#VAR_007790",2.0,37612.0,43071098.0,T,C,-,-,-,-,-,-,SCV001161595,-,-,4816A>G ,Lys1606Glu,NM_007294.4,3.0,2_Benign,0.0000321515,37612.0,17,43071098.0,T,C,K,E,rs80356943,17,41223115.0,17,38476641.0,1606.0,BRCA1,ENSG00000012048,ENST00000618469,ENSP00000478114,P38398,BRCA1_HUMAN,.,.,c.4816A>G,p.Lys1606Glu,principal2,Y,1,.,.,-,AAA,1.0,0.0,T,T/T,T/T,T/T,T/T,.,0.72322,.,.,0.49207,.,0.0,0.02950,B,0.0,0.01384,B,.,0.99291,.,.,.,.,0,0.06502,N,.,0.10767,.,.,0.28302,-0.5432,0.66897,T,0.4017,0.75178,T,10,.,0.37017,.,0.227152,0.88048,D,.,0.75894,.,.,.,.,.,.,0.58443,.,0.16602,.,0.12617,0.260015904903,0.04893,T,0.098826,0.40015,T,0.0938011,0.63355,D,0.0772584,0.75211,D,0.106747360008648,0.12918,T,0.852615,0.53662,D,0.096304744,0.22477,0.09333296,0.22003,0.09800102,0.22901,0.07730816,0.17192,-3.059,0.10842,T,.,0.04993,.,0.00105470856972761,0.09785,0.99718000,0.98290,0.042,0.10339,.,.,.,.,.,.,1.918289,0.24404,16.37,0.9181781247871236,0.21378,0.169829,0.29455,N,-0.929974890242364,0.10024,0.4834715,-0.879878298600479,0.12355,0.6474283,4.92,2.88,0.32534,3.03,0.55386,2.465,0.44835,6.225000,0.55234,-0.114,0.14662,0.492,0.26984,1.0,0.68239,0.007,0.07843,543,0.72771,.,.,.,.,.,.,.,.,.,.,.,.,6,264690,2.2668026E-5,.,3,109406,2.742080e-05,0,5,208130,2.402340e-05,0,7,236868,2.955230e-05,0,0,7164,0.000000e+00,0,0,17112,0.000000e+00,0,0,2320,0.000000e+00,0,0,9046,0.000000e+00,0,0,13392,0.000000e+00,0,3,42768,7.014590e-05,0,0,15690,0.000000e+00,0,3,42768,7.014590e-05,0,0,16218,0.000000e+00,0,0,30524,0.000000e+00,0,0,6212,0.000000e+00,0,0,13416,0.000000e+00,0,0,16732,0.000000e+00,0,5,89554,5.583220e-05,0,0,30608,0.000000e+00,0,5,89554,5.583220e-05,0,0,14902,0.000000e+00,0,0,34260,0.000000e+00,0,0,9572,0.000000e+00,0,0,17692,0.000000e+00,0,0,21630,0.000000e+00,0,7,102672,6.817830e-05,0,0,30526,0.000000e+00,0,7,102672,6.817830e-05,0,.,50,1613986,3.097920e-05,0,45,1180018,3.813500e-05,0,1,74914,1.334860e-05,0,0,912,0.000000e+00,0,0,59958,0.000000e+00,0,0,29606,0.000000e+00,0,0,44898,0.000000e+00,0,0,64032,0.000000e+00,0,0,6084,0.000000e+00,0,45,1180018,3.813500e-05,0,0,91082,0.000000e+00,0,1,19780,5.0556117290192114E-5,0,298,0,0,86,0,1,7864,1.271617497456765E-4,0,146,0,0,610,0,0,26,0,0,98,0,0,1982,0,1,8162,1.2251899044351874E-4,0,112,0,2,30890,6.474587245063128E-5,Benign,"BRCA1-related_disorder|not_specified|Hereditary_breast_ovarian_cancer_syndrome|Breast_and/or_ovarian_cancer|Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1",reviewed_by_expert_panel,NC_000017.11:g.43071098T>C,ClinGen:CA003037|UniProtKB:P38398#VAR_007790,CN169374|C0677776|CN221562|C0027672|C3661900|C2676676,604370,145|140162|145,.,Lys,Glu,46168.0,single nucleotide variant,NM_007294.4(BRCA1):c.4816A>G (p.Lys1606Glu),672.0,BRCA1,HGNC:1100,Benign,0.0,"Jun 18, 2019",80356943.0,-,RCV000048668|RCV000436368|RCV000735492|RCV000130005|RCV004554630|RCV000031193|RCV001281714,"MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374|MedGen:CN221562|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162||MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900","Hereditary breast ovarian cancer syndrome|not specified|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|BRCA1-related disorder|Breast-ovarian cancer, familial, susceptibility to, 1|not provided",germline;unknown,germline,GRCh38,NC_000017.11,17,43071098.0,43071098.0,17q21.31,reviewed by expert panel,16.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA003037,UniProtKB:P38398#VAR_007790",2.0,37612.0,43071098.0,T,C,-,-,-,-,-,-,SCV001161595,-,-,4816A>G ,Lys1606Glu,NM_007294.4,3.0,2_Benign,29.69,0.975609756097561,['604370'],multiple,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Adamovich_2022_HDR_var4184,BRCA1_Adamovich_2022_HDR,BRCA1,1100,-1.0,,43071098.0,43071098.0,,4816,A,G,1606.0,K,E,c.4816A>G,p.Lys1606Glu,missense_variant,missense_variant,-0.60284298225,-1.495297087;-0.143238327;-1.102137018;0.329300504,,No,0.0000309792030414,Benign,reviewed by expert panel,"Jun 18, 2019",aa,urn:mavedb:00001222-b-1,ENST00000357654.9,NM_007294.4,immortalized human cells,,fluorescence intensity (BAO_0000363),"DNA repair (GO:0006281), double-strand break repair via homologous recombination (GO:0000724)",No,Functional,"(-0.233, Inf)",Normal,LOF,"(-Inf, -0.562)",Abnormal,Intermediate,"[-0.562,-0.233]",Not specified,,,,,,,,,,updated,0.464,0.0708,likely_benign,0.08190000799,,1.3848098419,0.11480923316,,0.01302119676814161,0.02,Multifac new calc,Benign,0.1,0.0014447094358116797,Likely Benign,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Lys1606Glu,Lys1606Glu,false
BRCA1,BRCA1_Met1Thr,2.6505609192138624,0.03291488248938516,-5.415058354854697,0.000992346045870956,2025_01_Batch_13-14,0.9188140326650334,0.9527153734968281,0.9840460552581236,0.984750990435898,0.793637090171406,0.8536066331104628,0.8623721456022353,0.9654591126834374,0.9354789732760659,0.8121469904325598,0.8862103328877481,0.9075437595495317,0.9747525839707805,0.960114981855982,0.8028920403019829,false,false,true,true,false,0.0,0.0,0.0,0.0,0.0,true,BRCA1,ENSG00000012048,14613,218377.0,CCSBVarC003294,ALE00003294,NC_000017.11:43124095:A:G,2T>C,Met1Thr,CEGS2,CegsMutGDEh1015,F12,GDEhDisVCh_40059,F04,1.0,,,,,,,,,1.0,1.0,0.0,,0.0,,,0.0,,,0.0,,,BRCA1_Met1Thr,17.0,43124095.0,A,G,17,Y,N,N,N,N,17-43124095-A-G,69412.0,single nucleotide variant,NM_007294.4(BRCA1):c.2T>C (p.Met1Thr),672.0,BRCA1,HGNC:1100,Pathogenic/Likely pathogenic,1.0,"May 05, 2024",80357111.0,-,RCV000111545|RCV001017950|RCV001387017,"MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145","Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43124095.0,43124095.0,17q21.31,"criteria provided, multiple submitters, no conflicts",6.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,ClinGen:CA001954,2.0,54745.0,43124095.0,A,G,-,-,-,-,-,-,SCV000325520|SCV000785479|SCV001179120|SCV001587504,-,-,2T>C ,Met1Thr,NM_007294.4,2.0,1_Pathogenic,,54745.0,17,43124095.0,A,G,M,T,rs80357111,17,41276112.0,17,38529638.0,1.0,BRCA1,ENSG00000012048,ENST00000618469,ENSP00000478114,P38398,BRCA1_HUMAN,c.2T>C,p.Met1?,c.2T>C,p.Met1?,principal2,Y,1,.,.,-,ATG,2.0,0.0,A,./.,./.,./.,./.,.,0.91343,.,.,0.92967,.,0.967,0.56423,D,0.916,0.65195,D,.,0.99291,.,.,.,.,.,.,.,.,0.71435,.,.,0.96886,0.4652,0.90013,D,0.7036,0.89769,D,9,0.98665875,0.98978,D,0.950787,0.99662,D,.,0.89789,0.987,0.99867,E9PFC7,M1T,Loss of stability (P = 2e-04)| Gain of catalytic residue at M1 (P = 0.0208)| Gain of glycosylation at M1 (P = 0.121)| Gain of disorder (P = 0.1374)| Gain of helix (P = 0.2684),0.883389812914,0.88134,.,0.29790,.,.,.,.,.,0.298644,0.66936,T,0.3844,0.88912,D,0.314388,0.88772,D,0.991858303546906,0.82073,D,0.9,0.64967,D,0.9435044,0.95537,0.71842754,0.83181,0.9426614,0.95450,0.7257,0.83606,-9.871,0.82067,D,.,.,.,0.999999935724936,0.99831,0.99948680,0.99428,.,.,.,.,.,.,.,.,3.997208,0.58947,24.0,0.9771474788796806,0.35682,0.056815,0.10376,N,0.358832926107613,0.58998,4.098281,0.311400030491244,0.55978,3.783919,3.83,3.83,0.43219,2.37,0.44186,4.168,0.58094,11.022000,0.84990,0.634,0.51995,1.0,0.71675,1.0,0.68239,0.255,0.23438,469,0.78193,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Pathogenic/Likely_pathogenic,"Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1","criteria_provided,_multiple_submitters,_no_conflicts",NC_000017.11:g.43124095A>G,ClinGen:CA001954,C0677776|C0027672|C2676676,604370,145|140162|145,.,Met,Thr,69412.0,single nucleotide variant,NM_007294.4(BRCA1):c.2T>C (p.Met1Thr),672.0,BRCA1,HGNC:1100,Pathogenic/Likely pathogenic,1.0,"May 05, 2024",80357111.0,-,RCV000111545|RCV001017950|RCV001387017,"MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145","Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43124095.0,43124095.0,17q21.31,"criteria provided, multiple submitters, no conflicts",6.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,ClinGen:CA001954,2.0,54745.0,43124095.0,A,G,-,-,-,-,-,-,SCV000325520|SCV000785479|SCV001179120|SCV001587504,-,-,2T>C ,Met1Thr,NM_007294.4,2.0,1_Pathogenic,41.59,1.0,['604370'],multiple,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Findlay_2018_var70,BRCA1_Findlay_2018,BRCA1,1100,-1.0,41276112.0,43124095.0,43124095.0,NM_007294.3,2,T,C,1.0,M,T,c.2T>C,p.Met1Thr,Missense,missense_variant,-1.65656907663554,-1.63928030061456;-1.67385785265652,LOF,Yes,,Pathogenic/Likely pathogenic,"criteria provided, multiple submitters, no conflicts","Feb 09, 2022",nucleotide,urn:mavedb:00000097-0-2,ENST00000357654.9,NM_007294.3,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,Functional ,"[-0.748, Inf)",Normal,Intermediate,"(-1.328, -0.748)",Not specified,Non-functional,"(-Inf,-1.328]",Abnormal,,,,,,,,,,,0.714,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Met1Thr,Met1Thr,true
BRCA1,BRCA1_Met671Lys,2.267013845164269,0.05773114204962296,0.8349415031917329,0.43132063358320427,2025_01_Batch_13-14,0.9704484609385355,0.9116781681071608,0.9469280859184088,0.9403527782700145,0.9102883342188165,0.9505938449333811,0.8635539212999332,0.8959331127479064,0.9408515549566256,0.7977029247017272,0.9605211529359583,0.887616044703547,0.9214305993331576,0.9406021666133201,0.8539956294602719,true,false,false,false,false,0.0,0.0,0.0,0.0,0.0,true,BRCA1,,14613,,CCSBVarC011871,,NC_000017.11:43051071:A:T,2012T>A,Met671Lys,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Met671Lys,17.0,43051071.0,A,T,17,,,,,,17-43051071-A-T,32734.0,single nucleotide variant,NM_007294.4(BRCA1):c.5324T>A (p.Met1775Lys),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Aug 10, 2015",41293463.0,-,RCV000019265|RCV000496817|RCV001526335,"MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162","Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome",germline;not applicable,germline,GRCh38,NC_000017.11,17,43051071.0,43051071.0,17q21.31,reviewed by expert panel,10.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00110,ClinGen:CA003476,UniProtKB:P38398#VAR_063212,OMIM:113705.0036",3.0,17695.0,43051071.0,A,T,-,-,-,-,-,-,SCV000244397,-,-,5324T>A ,Met1775Lys,NM_007294.4,3.0,1_Pathogenic,,17695.0,17,43051071.0,A,T,M,K,rs41293463,17,41203088,17,38456614,1775.0,BRCA1,ENSG00000012048,ENST00000357654,ENSP00000350283,P38398,BRCA1_HUMAN,c.5324T>A,p.Met1775Lys,c.5324T>A,p.Met1775Lys,principal2,Y,1,YES,Select,-,ATG,2.0,0.0,A,A/A,A/A,A/A,A/A,0.0,0.91343,D,0.0,0.92967,D,0.99,0.90580,D,0.798,0.86259,P,0.95,0.99291,A,simple_aae,5.0,95.0,2.33,0.66629,M,-1.1,0.77340,N,0.878,0.98669,0.6922,0.93053,D,0.7837,0.92637,D,10,0.8988125,0.89121,D,0.804846,0.98472,D,0.734,0.90683,.,.,.,.,.,0.963482532597,0.96276,.,0.86847,.,0.52277,0.562978863716,0.47621,T,0.234774,0.59973,T,0.436191,0.91778,D,0.388781,0.91677,D,0.990923941135406,0.81018,D,.,0.83947,.,0.9531011,0.96527,0.80974793,0.88742,0.9654434,0.97787,0.735878,0.84203,-12.423,0.89812,D,0.8787,0.86232,P,0.996656271029341,0.92339,0.99989700,0.99879,0.957,0.98136,.,.,.,.,.,.,3.769401,0.54208,23.4,0.98558459070339721,0.43068,0.719653,0.66927,D,0.693440170392724,0.79088,7.028289,0.666244745644706,0.79713,7.165023,5.21,5.21,0.71966,.,.,5.026,0.63961,11.142000,0.87118,0.756,0.943,1.0,0.71675,1.0,0.68239,0.997,0.79771,449,0.79449,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Pathogenic,"Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome|Hereditary_breast_ovarian_cancer_syndrome",reviewed_by_expert_panel,NC_000017.11:g.43051071A>T,BRCA1-HCI:BRCA1_00110|ClinGen:CA003476|OMIM:113705.0036|UniProtKB:P38398#VAR_063212,C2676676|C0027672|C0677776,604370,145|140162|145,.,Met,Lys,32734.0,single nucleotide variant,NM_007294.4(BRCA1):c.5324T>A (p.Met1775Lys),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Aug 10, 2015",41293463.0,-,RCV000019265|RCV000496817|RCV001526335,"MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162","Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome",germline;not applicable,germline,GRCh38,NC_000017.11,17,43051071.0,43051071.0,17q21.31,reviewed by expert panel,10.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00110,ClinGen:CA003476,UniProtKB:P38398#VAR_063212,OMIM:113705.0036",3.0,17695.0,43051071.0,A,T,-,-,-,-,-,-,SCV000244397,-,-,5324T>A ,Met1775Lys,NM_007294.4,3.0,1_Pathogenic,90.88,0.0797872340425532,['604370'],,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Findlay_2018_var2896,BRCA1_Findlay_2018,BRCA1,1100,-1.0,41203088.0,43051071.0,43051071.0,NM_007294.3,5324,T,A,1775.0,M,K,c.5324T>A,p.Met1775Lys,Missense,missense_variant,-1.83186236584358,-2.2524146079474;-1.41131012373976,LOF,Yes,,Pathogenic,reviewed by expert panel,"Aug 10, 2015",nucleotide,urn:mavedb:00000097-0-2,ENST00000357654.9,NM_007294.3,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,Functional ,"[-0.748, Inf)",Normal,Intermediate,"(-1.328, -0.748)",Not specified,Non-functional,"(-Inf,-1.328]",Abnormal,,,,,,,,,,,0.734,0.8787,likely_pathogenic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Met1775Lys,Met1775Lys,false
BRCA1,BRCA1_His41Arg,-0.7905479031010616,0.45515193572773704,2.625988804254552,0.03411090005792832,2025_01_Batch_13-14,0.7635952103109365,0.9180190411090324,0.6955686537564537,0.6385853229034477,0.5758214868863146,0.9836352860827905,0.9407984783796364,0.9415830691802393,0.9804317122724854,0.9444769747268804,0.8736152481968635,0.9294087597443343,0.8185758614683465,0.8095085175879666,0.7601492308065976,false,false,false,false,false,0.0,0.0,0.0,0.0,0.0,true,BRCA1,,14613,,CCSBVarC011865,,NC_000017.11:43115738:T:C,122A>G,His41Arg,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_His41Arg,17.0,43115738.0,T,C,17,,,,,,17-43115738-T-C,68833.0,single nucleotide variant,NM_007294.4(BRCA1):c.122A>G (p.His41Arg),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Aug 10, 2015",80357276.0,-,RCV000047383|RCV000111820|RCV000484980|RCV000569789,"MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162","Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43115738.0,43115738.0,17q21.31,reviewed by expert panel,11.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00130,ClinGen:CA000805",2.0,54166.0,43115738.0,T,C,-,-,-,-,-,-,SCV000244297,-,-,122A>G ,His41Arg,NM_007294.4,3.0,1_Pathogenic,,54166.0,17,43115738.0,T,C,H,R,rs80357276,17,41267755,17,38521281,41.0,BRCA1,ENSG00000012048,ENST00000618469,ENSP00000478114,P38398,BRCA1_HUMAN,.,.,c.122A>G,p.His41Arg,principal2,Y,1,.,.,-,CAC,2.0,0.0,T,T/T,T/T,T/T,T/T,.,0.91343,.,.,0.92967,.,0.959,0.90580,D,0.542,0.92348,P,.,0.99291,.,.,.,.,3.995,0.96666,H,.,0.95148,.,.,0.88119,0.9682,0.96663,D,0.9917,0.99792,D,10,.,0.99449,.,0.885446,0.99127,D,.,0.99491,0.966,0.99665,E9PFC7,H41R,Gain of MoRF binding (P = 0.0172)| Loss of catalytic residue at D40 (P = 0.0761)| Gain of disorder (P = 0.0885)| Gain of helix (P = 0.132)| Gain of phosphorylation at T37 (P = 0.2265),.,0.99628,.,0.94303,.,0.46401,0.697537183762,0.66732,T,0.460215,0.93020,T,0.562828,0.96258,D,0.570687,0.96198,D,0.998141407966614,0.93292,D,0.955504,0.83052,D,0.9505324,0.96261,0.6308536,0.78232,0.9015565,0.91402,0.6761325,0.80766,-13.38,0.93979,D,.,0.95417,.,0.999422575166627,0.96550,0.99957854,0.99505,0.964,0.98523,.,.,.,.,.,.,4.490848,0.70206,25.5,0.99650553719529922,0.77280,0.750685,0.69060,D,0.939969350591933,0.93540,12.13134,0.850731219321243,0.93019,11.79838,5.97,5.97,0.96929,.,.,3.518,0.533,7.815000,0.69605,0.665,0.62996,1.0,0.71675,1.0,0.68239,0.999,0.91597,464,0.78507,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Pathogenic,"Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1",reviewed_by_expert_panel,NC_000017.11:g.43115738T>C,BRCA1-HCI:BRCA1_00130|ClinGen:CA000805,C0677776|C0027672|C3661900|C2676676,604370,145|140162|145,"Zinc finger, C3HC4 RING-type|Zinc finger, RING-type, conserved site|Zinc finger, RING-type|Zinc finger, RING-type",His,Arg,68833.0,single nucleotide variant,NM_007294.4(BRCA1):c.122A>G (p.His41Arg),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Aug 10, 2015",80357276.0,-,RCV000047383|RCV000111820|RCV000484980|RCV000569789,"MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162","Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43115738.0,43115738.0,17q21.31,reviewed by expert panel,11.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00130,ClinGen:CA000805",2.0,54166.0,43115738.0,T,C,-,-,-,-,-,-,SCV000244297,-,-,122A>G ,His41Arg,NM_007294.4,3.0,1_Pathogenic,90.04,0.3369565217391304,['604370'],,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Findlay_2018_var499,BRCA1_Findlay_2018,BRCA1,1100,-1.0,41267755.0,43115738.0,43115738.0,NM_007294.3,122,A,G,41.0,H,R,c.122A>G,p.His41Arg,Missense,missense_variant,-2.07795707321754,-2.42242241093943;-1.73349173549566,LOF,Yes,,Pathogenic,reviewed by expert panel,"Aug 10, 2015",nucleotide,urn:mavedb:00000097-0-2,ENST00000357654.9,NM_007294.3,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,Functional ,"[-0.748, Inf)",Normal,Intermediate,"(-1.328, -0.748)",Not specified,Non-functional,"(-Inf,-1.328]",Abnormal,,,,,,,,,,,0.964,0.9824,likely_pathogenic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_His41Arg,His41Arg,true
BRCA1,BRCA1_Arg71Lys,0.07187573777971566,0.9447113095236084,2.3731690749830956,0.049375562988145376,2025_01_Batch_13-14,0.933072995991214,0.9452772116535713,0.8545819894997295,0.9024167501696188,0.7431486177108632,0.9796857254805389,0.9318387526566191,0.937694960222789,0.9745554138250025,0.9081625358729246,0.9563793607358764,0.9385579821550951,0.8961384748612593,0.9384860819973107,0.8256555767918938,true,true,false,false,false,1.0,0.0,0.0,0.0,0.0,true,BRCA1,ENSG00000012048,14613,218389.0,CCSBVarC003297,ALE00003297,NC_000017.11:43106456:C:T,212G>A,Arg71Lys,CEGS2,CegsMutGDEh1010,A12,GDEhDisVCh_40059,E03,1.0,,,,,,,,,1.0,7.0,0.0,,0.0,,,0.0,,,0.0,,,BRCA1_Arg71Lys,17.0,43106456.0,C,T,17,N,N,N,N,N,17-43106456-C-T,69138.0,single nucleotide variant,NM_007294.4(BRCA1):c.212G>A (p.Arg71Lys),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Jul 30, 2024",80356913.0,-,RCV000112023|RCV000503702|RCV001180531|RCV001384425|RCV004795985,"MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333","Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43106456.0,43106456.0,17q21.31,"criteria provided, multiple submitters, no conflicts",11.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA001420,UniProtKB:P38398#VAR_020681",2.0,54471.0,43106456.0,C,T,-,-,-,-,-,-,SCV000325249|SCV001345474|SCV001583916|SCV002046151|SCV002600545|SCV002726126|SCV003809169|SCV005416672,-,-,212G>A ,Arg71Lys,NM_007294.4,2.0,1_Pathogenic,0.0,54471.0,17,43106456.0,C,T,R,K,rs80356913,17,41258473.0,17,38511999.0,71.0,BRCA1,ENSG00000012048,ENST00000494123,ENSP00000419103,P38398,BRCA1_HUMAN,c.212G>A,p.Arg71Lys,c.212G>A,p.Arg71Lys,principal2,Y,1,.,.,-,AGG,2.0,0.0,C,C/C,C/C,C/C,C/C,0.0,0.91343,D,0.016,0.68204,D,0.9,0.59057,P,0.275,0.68273,B,.,0.99291,.,.,.,.,2.455,0.71058,M,-0.66,0.59576,N,.,0.78462,0.7801,0.94146,D,0.8430,0.94745,D,9,0.82008123,0.81025,D,0.514985,0.95351,D,0.737,0.90816,0.727,0.86044,E9PFC7,R71K,Gain of methylation at R71 (P = 0.0062)| Gain of relative solvent accessibility (P = 0.0522)| Gain of ubiquitination at R71 (P = 0.068)| Gain of disorder (P = 0.0771)| Gain of solvent accessibility (P = 0.1456),0.968767862813,0.96814,.,0.47432,.,0.17790,0.610298812389,0.54292,T,0.29865,0.66937,T,0.411382,0.90492,D,0.353145,0.90373,D,0.960748553276062,0.65672,D,.,0.27626,.,0.80958927,0.84328,0.4717919,0.69118,0.759881,0.81221,0.3838624,0.63093,-8.907,0.67174,D,0.7791,0.80812,LP,0.996372846491178,0.92086,0.99942493,0.99371,0.917,0.95747,.,.,.,.,.,.,5.467383,0.91245,32.0,0.9950540223175232,0.68305,0.849361,0.76532,D,0.589132871463434,0.72350,5.814887,0.56907193894025,0.72585,5.856808,4.64,4.64,0.57348,.,.,4.108,0.57643,7.641000,0.63257,0.531,0.24877,1.0,0.71675,1.0,0.68239,0.995,0.73271,459,0.78836,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0,0,0,0,0,0,0,0,0,0,424,0,0,0,0,0,0,0,0,0,0,0,0,0,0,52,0,0,424,0,0,0,0,0,476,0,Pathogenic,"Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1","criteria_provided,_multiple_submitters,_no_conflicts",NC_000017.11:g.43106456C>T,ClinGen:CA001420|UniProtKB:P38398#VAR_020681,C0677776|C0027672|C3661900|C2676676,604370,145|140162|145,.,Arg,Lys,69138.0,single nucleotide variant,NM_007294.4(BRCA1):c.212G>A (p.Arg71Lys),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Jul 30, 2024",80356913.0,-,RCV000112023|RCV000503702|RCV001180531|RCV001384425|RCV004795985,"MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333","Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43106456.0,43106456.0,17q21.31,"criteria provided, multiple submitters, no conflicts",11.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA001420,UniProtKB:P38398#VAR_020681",2.0,54471.0,43106456.0,C,T,-,-,-,-,-,-,SCV000325249|SCV001345474|SCV001583916|SCV002046151|SCV002600545|SCV002726126|SCV003809169|SCV005416672,-,-,212G>A ,Arg71Lys,NM_007294.4,2.0,1_Pathogenic,82.37,0.9758064516129032,"['604370', '617883', '604370', '614320']",multiple,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; FANCONI ANEMIA, COMPLEMENTATION GROUP S; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Findlay_2018_var865,BRCA1_Findlay_2018,BRCA1,1100,-1.0,41258473.0,43106456.0,43106456.0,NM_007294.3,212,G,A,71.0,R,K,c.212G>A,p.Arg71Lys,Missense,missense_variant,-2.14933911864244,-2.15581674233152;-2.14286149495336,LOF,Yes,,Pathogenic,"criteria provided, multiple submitters, no conflicts","Aug 28, 2023",nucleotide,urn:mavedb:00000097-0-2,ENST00000357654.9,NM_007294.3,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,Functional ,"[-0.748, Inf)",Normal,Intermediate,"(-1.328, -0.748)",Not specified,Non-functional,"(-Inf,-1.328]",Abnormal,,,,,,,,,,,0.737,0.6817,likely_pathogenic,1.9779,,,,,1.9779,0.97,Combined LR is not <0.5 or >2,,0.1,0.18017107096985763,VUS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Arg71Lys,Arg71Lys,true
BRCA1,BRCA1_Pro510Ser,1.2763374668476026,0.24254813146313225,4.261917325727006,0.003737738849101049,2025_01_Batch_13-14,0.9640036687223583,0.9118111337128814,0.9045387301347584,0.9339901222773391,0.9422400489874985,0.9842508167638084,0.9279514829560971,0.9366244489548248,0.9797877565913151,0.94228323593355,0.9741272427430834,0.9198813083344892,0.9205815895447915,0.9568889394343272,0.9422616424605242,true,false,false,false,true,1.0,0.0,0.0,0.0,1.0,true,BRCA1,,14613,,CCSBVarC013098,,NC_000017.11:43071074:G:A,1528C>T,Pro510Ser,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Pro510Ser,17.0,43071074.0,G,A,17,,,,,,17-43071074-G-A,69968.0,single nucleotide variant,NM_007294.4(BRCA1):c.4840C>T (p.Pro1614Ser),672.0,BRCA1,HGNC:1100,Benign,0.0,"Aug 10, 2015",70953660.0,-,RCV000048676|RCV000112411|RCV000162988|RCV000167771|RCV001811342|RCV003492390,"MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900|MedGen:CN221562","not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast and/or ovarian cancer",germline,germline,GRCh38,NC_000017.11,17,43071074.0,43071074.0,17q21.31,reviewed by expert panel,13.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00089,ClinGen:CA003048",2.0,55301.0,43071074.0,G,A,-,-,-,-,-,-,SCV000244370,-,-,4840C>T ,Pro1614Ser,NM_007294.4,3.0,2_Benign,,55301.0,17,43071074.0,G,A,P,S,rs70953660,17,41223091,17,38476617,1614.0,BRCA1,ENSG00000012048,ENST00000357654,ENSP00000350283,P38398,BRCA1_HUMAN,c.4840C>T,p.Pro1614Ser,c.4840C>T,p.Pro1614Ser,principal2,Y,1,YES,Select,-,CCA,1.0,0.0,G,G/G,G/G,G/G,G/G,0.074,0.34767,T,0.331,0.42259,T,0.001,0.11208,B,0.001,0.11213,B,0.2,0.44282,N,simple_aae,80.0,20.0,1.245,0.31258,L,-1.13,0.49862,N,0.197,0.28185,-0.7260,0.58992,T,0.3747,0.73191,T,10,0.013456136,0.00282,T,0.081866,0.73689,D,0.544,0.80920,.,.,.,.,.,0.445007932271,0.43742,.,0.22008,.,0.10213,0.220991373062,0.01370,T,0.118253,0.43590,T,-0.292457,0.09169,T,-0.197798,0.54546,T,0.00209908424908425,0.00022,T,.,0.52390,.,0.01818675,0.00340,0.03539876,0.02796,0.012395442,0.00033,0.035112027,0.02713,-2.617,0.09611,T,0.0853,0.14859,B,0.209477282755653,0.50387,0.99514270,0.97711,0.086,0.24271,.,.,.,.,.,.,0.15678,0.05499,1.947,0.41163095527126975,0.02973,0.128273,0.24383,N,-1.18046810113445,0.05234,0.241072,-1.24446342853677,0.05132,0.2478793,4.36,-1.9,0.07233,0.973,0.28966,-0.1,0.10995,0.294000,0.16973,-0.106,0.15547,0.0,0.06393,0.0,0.08389,0.008,0.08289,543,0.72771,2,3.9936102236421724E-4,1,7.564296520423601E-4,0,0.0,1,0.001440922190201729,0,0.0,0,0.0,187,264690,7.064868E-4,.,25,109408,2.285020e-04,0,44,208130,2.114060e-04,0,43,236858,1.815430e-04,0,24,7164,3.350080e-03,0,1,17112,5.843850e-05,0,0,2320,0.000000e+00,0,0,9046,0.000000e+00,0,0,13394,0.000000e+00,0,0,42768,0.000000e+00,0,0,15690,0.000000e+00,0,24,7164,3.350080e-03,0,41,16218,2.528060e-03,0,1,30524,3.276110e-05,0,0,6212,0.000000e+00,0,0,13416,0.000000e+00,0,0,16734,0.000000e+00,0,1,89552,1.116670e-05,0,0,30608,0.000000e+00,0,41,16218,2.528060e-03,0,38,14902,2.549990e-03,0,4,34260,1.167540e-04,0,0,9572,0.000000e+00,0,0,17692,0.000000e+00,0,0,21632,0.000000e+00,0,1,102658,9.741080e-06,0,0,30526,0.000000e+00,0,38,14902,2.549990e-03,0,.,178,1614124,1.102770e-04,0,156,75024,2.079330e-03,0,156,75024,2.079330e-03,0,0,910,0.000000e+00,0,7,60006,1.166550e-04,0,0,29602,0.000000e+00,0,0,44892,0.000000e+00,0,0,64026,0.000000e+00,0,0,6062,0.000000e+00,0,4,1180006,3.389810e-06,0,0,91088,0.000000e+00,0,0,163048,0,0,360,0,0,4502,0,13,9362,0.0013885921811578722,0,442,0,0,950,0,0,1848,0,0,280,0,1,13148,7.6057195010648E-5,13,9722,0.0013371734211067683,0,6350,0,14,193940,7.218727441476746E-5,Benign,"not_provided|not_specified|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Breast_and/or_ovarian_cancer",reviewed_by_expert_panel,NC_000017.11:g.43071074G>A,BRCA1-HCI:BRCA1_00089|ClinGen:CA003048,C3661900|CN169374|C0677776|C0027672|C2676676|CN221562,604370,145|140162|145,.,Pro,Ser,69968.0,single nucleotide variant,NM_007294.4(BRCA1):c.4840C>T (p.Pro1614Ser),672.0,BRCA1,HGNC:1100,Benign,0.0,"Aug 10, 2015",70953660.0,-,RCV000048676|RCV000112411|RCV000162988|RCV000167771|RCV001811342|RCV003492390,"MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900|MedGen:CN221562","not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast and/or ovarian cancer",germline,germline,GRCh38,NC_000017.11,17,43071074.0,43071074.0,17q21.31,reviewed by expert panel,13.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00089,ClinGen:CA003048",2.0,55301.0,43071074.0,G,A,-,-,-,-,-,-,SCV000244370,-,-,4840C>T ,Pro1614Ser,NM_007294.4,3.0,2_Benign,39.92,0.8823529411764706,['604370'],,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Adamovich_2022_HDR_var4266,BRCA1_Adamovich_2022_HDR,BRCA1,1100,-1.0,,43071074.0,43071074.0,,4840,C,T,1614.0,P,S,c.4840C>T,p.Pro1614Ser,missense_variant,missense_variant,-0.1959409615,-0.346431859;-0.249604404;-0.593236602;0.40550902,,No,0.000110276533897,Benign,reviewed by expert panel,"Aug 10, 2015",aa,urn:mavedb:00001222-b-1,ENST00000357654.9,NM_007294.4,immortalized human cells,,fluorescence intensity (BAO_0000363),"DNA repair (GO:0006281), double-strand break repair via homologous recombination (GO:0000724)",No,Functional,"(-0.233, Inf)",Normal,LOF,"(-Inf, -0.562)",Abnormal,Intermediate,"[-0.562,-0.233]",Not specified,,,,,,,,,,updated,0.544,0.0853,likely_benign,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Pro1614Ser,Pro1614Ser,false
BRCA1,BRCA1_Cys44Tyr,-0.8137193508629426,0.4426010528135844,5.676268140463764,0.0007536407364486894,2025_01_Batch_13-14,0.831148627985987,0.9066524143661844,0.8216178034576009,0.8244578506765782,0.7124769240548263,0.9441987717219412,0.8729902762931168,0.9135044475399889,0.9649343906044164,0.860136022816206,0.887673699853964,0.8898213453296506,0.8675611254987949,0.8946961206404973,0.7863064734355162,false,false,false,false,false,0.0,0.0,0.0,0.0,0.0,true,BRCA1,ENSG00000012048,14613,218386.0,CCSBVarC003296,ALE00003296,NC_000017.11:43115729:C:T,131G>A,Cys44Tyr,CEGS2,CegsMutGDEh1010,C05,GDEhDisVCh_40059,D03,1.0,,,,,,,,,1.0,7.0,0.0,,0.0,,,0.0,,,0.0,,,BRCA1_Cys44Tyr,17.0,43115729.0,C,T,17,N,N,N,N,N,17-43115729-C-T,68866.0,single nucleotide variant,NM_007294.4(BRCA1):c.131G>A (p.Cys44Tyr),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Aug 10, 2015",80357446.0,-,RCV000077486|RCV000235119|RCV000509871|RCV001386839,"MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145","Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43115729.0,43115729.0,17q21.31,reviewed by expert panel,12.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00114,ClinGen:CA000861",2.0,54199.0,43115729.0,C,T,-,-,-,-,-,-,SCV000244299,-,-,131G>A ,Cys44Tyr,NM_007294.4,3.0,1_Pathogenic,,54199.0,17,43115729.0,C,T,C,Y,rs80357446,17,41267746.0,17,38521272.0,44.0,BRCA1,ENSG00000012048,ENST00000494123,ENSP00000419103,P38398,BRCA1_HUMAN,c.131G>A,p.Cys44Tyr,c.131G>A,p.Cys44Tyr,principal2,Y,1,.,.,-,TGC,2.0,0.0,C,C/C,C/C,C/C,C/C,0.016,0.91343,D,0.0,0.92967,D,0.994,0.66535,D,0.84,0.60164,P,.,0.99291,.,.,.,.,4.005,0.96727,H,-2.52,0.98949,D,.,0.95504,1.0538,0.98195,D,0.9802,0.99389,D,10,0.99267334,0.99802,D,0.72305,0.97758,D,0.853,0.95458,0.99,0.99894,E9PFC7,C44Y,Loss of disorder (P = 0.0407)| Loss of helix (P = 0.1299)| Loss of catalytic residue at I42 (P = 0.1404)| Loss of stability (P = 0.2362)| Loss of ubiquitination at K45 (P = 0.2592),0.998941922364,0.99891,.,0.91966,.,0.18552,0.729841411114,0.71433,T,0.47499,0.93038,T,0.562886,0.96259,D,0.57077,0.96199,D,0.987259089946747,0.77622,D,.,0.90786,.,0.92106634,0.93252,0.6351263,0.78468,0.91385037,0.92549,0.69650024,0.81922,-13.581,0.94506,D,0.9966,0.97393,LP,0.999496437666765,0.96769,0.99973255,0.99655,0.94,0.97139,.,.,.,.,.,.,5.096311,0.85159,28.5,0.9922808718824678,0.56189,0.829447,0.74743,D,0.895383086000917,0.91485,10.93124,0.837834818254792,0.92242,11.33957,5.97,5.97,0.96929,.,.,3.475,0.52993,7.600000,0.61593,0.599,0.40292,1.0,0.71675,1.0,0.68239,0.996,0.76032,464,0.78507,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Pathogenic,"not_provided|Hereditary_cancer-predisposing_syndrome|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1",reviewed_by_expert_panel,NC_000017.11:g.43115729C>T,BRCA1-HCI:BRCA1_00114|ClinGen:CA000861,C3661900|C0027672|C0677776|C2676676,604370,140162|145|145,"Zinc finger, C3HC4 RING-type|Zinc finger, RING-type, conserved site|Zinc finger, RING-type|Zinc finger, RING-type",Cys,Tyr,68866.0,single nucleotide variant,NM_007294.4(BRCA1):c.131G>A (p.Cys44Tyr),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Aug 10, 2015",80357446.0,-,RCV000077486|RCV000235119|RCV000509871|RCV001386839,"MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145","Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43115729.0,43115729.0,17q21.31,reviewed by expert panel,12.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00114,ClinGen:CA000861",2.0,54199.0,43115729.0,C,T,-,-,-,-,-,-,SCV000244299,-,-,131G>A ,Cys44Tyr,NM_007294.4,3.0,1_Pathogenic,92.79,0.0296296296296296,['604370'],multiple,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Findlay_2018_var525,BRCA1_Findlay_2018,BRCA1,1100,-1.0,41267746.0,43115729.0,43115729.0,NM_007294.3,131,G,A,44.0,C,Y,c.131G>A,p.Cys44Tyr,Missense,missense_variant,-2.39797407768976,-2.5519950082978;-2.24395314708172,LOF,Yes,,Pathogenic,reviewed by expert panel,"Aug 10, 2015",nucleotide,urn:mavedb:00000097-0-2,ENST00000357654.9,NM_007294.3,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,Functional ,"[-0.748, Inf)",Normal,Intermediate,"(-1.328, -0.748)",Not specified,Non-functional,"(-Inf,-1.328]",Abnormal,,,,,,,,,,,0.853,0.9965,likely_pathogenic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Cys44Tyr,Cys44Tyr,true
BRCA1,BRCA1_Phe591Leu,1.6193629120142436,0.14940127798338723,2.277705449148239,0.056828180249927085,2025_01_Batch_13-14,0.937408693262149,0.9212174631292718,0.8452376868441218,0.8871382643932934,0.920129200991745,0.9166854857442854,0.8859929476156592,0.8991794953942224,0.9508716312140828,0.8529090893143416,0.9270470895032172,0.9036052053724655,0.8722085911191721,0.9190049478036881,0.8865191451530433,true,false,false,false,true,0.0,0.0,0.0,0.0,0.0,true,BRCA1,ENSG00000012048,14613,218428.0,CCSBVarC003305,ALE00003305,NC_000017.11:43063941:A:T,1773T>A,Phe591Leu,CEGS2,CegsMutGDEh1019,H03,GDEhDisVCh_40059,F06,1.0,,,,,,,,,1.0,1.0,0.0,,0.0,,,0.0,,,0.0,,,BRCA1_Phe591Leu,17.0,43063941.0,A,T,17,Y,N,N,N,N,17-43063941-A-T,70056.0,single nucleotide variant,NM_007294.4(BRCA1):c.5085T>A (p.Phe1695Leu),672.0,BRCA1,HGNC:1100,Conflicting classifications of pathogenicity,0.0,"Apr 26, 2023",80357387.0,-,RCV000112493|RCV000562837|RCV001853018,"MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145","Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome",germline;not applicable,germline,GRCh38,NC_000017.11,17,43063941.0,43063941.0,17q21.31,"criteria provided, conflicting classifications",4.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,ClinGen:CA003223,2.0,55389.0,43063941.0,A,T,-,-,-,-,-,-,SCV000660974|SCV002187048,-,-,5085T>A ,Phe1695Leu,NM_007294.4,1.0,3_Conflicting,,55389.0,17,43063941.0,A,T,F,L,rs80357387,17,41215958.0,17,38469484.0,1695.0,BRCA1,ENSG00000012048,ENST00000470026,ENSP00000419274,P38398,BRCA1_HUMAN,.,.,c.5085T>A,p.Phe1695Leu,principal2,Y,1,.,.,-,TTT,3.0,2.0,A,A/A,A/A,A/A,A/A,.,0.25997,.,.,0.09167,.,0.237,0.30812,B,0.107,0.31213,B,.,.,.,.,.,.,0.135,0.08601,N,.,0.42578,.,.,0.55139,0.4353,0.89578,D,0.6291,0.86934,D,10,.,0.54565,.,0.768432,0.98164,D,.,0.77150,.,.,.,.,.,.,0.82922,.,0.46484,.,0.27990,0.637575030327,0.58154,T,0.133578,0.46135,T,0.169896,0.709,D,0.00626705,0.70525,D,0.324614346916885,0.25715,T,.,0.56037,.,0.2819536,0.50902,0.15177552,0.35630,0.2757978,0.50311,0.17792259,0.40291,-3.59,0.38578,T,.,0.80507,.,0.151693788840998,0.47210,0.99911267,0.99153,0.531,0.73422,.,.,.,.,.,.,1.972208,0.25095,16.62,0.918993205517774,0.21471,0.371736,0.45580,N,-0.338194724745546,0.27430,1.522421,-0.156317829821601,0.32854,1.89438,5.83,4.74,0.59667,1.84,0.37836,1.51,0.35504,2.150000,0.30988,0.665,0.62996,1.0,0.71675,1.0,0.68239,0.996,0.76032,549,0.72286,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0,109358,0.000000e+00,0,0,207972,0.000000e+00,0,1,236754,4.223790e-06,0,0,7154,0.000000e+00,0,0,17104,0.000000e+00,0,0,2314,0.000000e+00,0,0,9038,0.000000e+00,0,0,13394,0.000000e+00,0,0,42754,0.000000e+00,0,0,15686,0.000000e+00,0,.,.,.,.,0,16194,0.000000e+00,0,0,30508,0.000000e+00,0,0,6206,0.000000e+00,0,0,13402,0.000000e+00,0,0,16734,0.000000e+00,0,0,89470,0.000000e+00,0,0,30600,0.000000e+00,0,.,.,.,.,0,14886,0.000000e+00,0,0,34246,0.000000e+00,0,0,9556,0.000000e+00,0,0,17682,0.000000e+00,0,0,21628,0.000000e+00,0,1,102632,9.743550e-06,0,0,30518,0.000000e+00,0,1,102632,9.743550e-06,0,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Conflicting_classifications_of_pathogenicity,"Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1","criteria_provided,_conflicting_classifications",NC_000017.11:g.43063941A>T,ClinGen:CA003223,C0677776|C0027672|C2676676,604370,145|140162|145,BRCT domain|BRCT domain|BRCT domain,Phe,Leu,70056.0,single nucleotide variant,NM_007294.4(BRCA1):c.5085T>A (p.Phe1695Leu),672.0,BRCA1,HGNC:1100,Conflicting classifications of pathogenicity,0.0,"Apr 26, 2023",80357387.0,-,RCV000112493|RCV000562837|RCV001853018,"MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145","Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome",germline;not applicable,germline,GRCh38,NC_000017.11,17,43063941.0,43063941.0,17q21.31,"criteria provided, conflicting classifications",4.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,ClinGen:CA003223,2.0,55389.0,43063941.0,A,T,-,-,-,-,-,-,SCV000660974|SCV002187048,-,-,5085T>A ,Phe1695Leu,NM_007294.4,1.0,3_Conflicting,94.82,0.1421319796954314,['604370'],multiple,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Findlay_2018_var1878,BRCA1_Findlay_2018,BRCA1,1100,-1.0,41215958.0,43063941.0,43063941.0,NM_007294.3,5085,T,A,1695.0,F,L,c.5085T>A,p.Phe1695Leu,Missense,missense_variant,0.227802226615599,0.280153004238848;0.17545144899235,FUNC,Yes,,Conflicting classifications of pathogenicity,"criteria provided, conflicting classifications","Apr 26, 2023",nucleotide,urn:mavedb:00000097-0-2,ENST00000357654.9,NM_007294.3,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,Functional ,"[-0.748, Inf)",Normal,Intermediate,"(-1.328, -0.748)",Not specified,Non-functional,"(-Inf,-1.328]",Abnormal,,,,,,,,,,,0.483,0.6047,likely_pathogenic,,,1.0330920372,0.77971092599,,0.8055131489792701,0.03,Combined LR is not <0.5 or >2,,0.1,0.08214900502816846,Likely Benign,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Phe1695Leu,Phe1695Leu,false
BRCA1,BRCA1_Asp67Tyr,2.5125896208651195,0.04024421782312692,-0.9756740391325569,0.3617299832806894,2025_01_Batch_13-14,0.9909520492431141,0.9587707827180625,0.975413541128114,0.9870750278331963,0.9642158549481505,0.9162230980428752,0.8907745672989336,0.9196469894768488,0.9442195653598557,0.7599903085066182,0.9535875736429946,0.924772675008498,0.9475302653024813,0.965647296596526,0.8621030817273844,true,true,false,true,false,0.0,0.0,0.0,0.0,0.0,true,BRCA1,,14613,,CCSBVarC013083,,NC_000017.11:43106469:C:A,199G>T,Asp67Tyr,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Asp67Tyr,17.0,43106469.0,C,A,17,,,,,,17-43106469-C-A,69098.0,single nucleotide variant,NM_007294.4(BRCA1):c.199G>T (p.Asp67Tyr),672.0,BRCA1,HGNC:1100,Benign,0.0,"Aug 10, 2015",80357102.0,-,RCV000047675|RCV000083176|RCV000148404|RCV000162582|RCV000195312|RCV000589035|RCV001353503|RCV002490619,"MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:CN221562|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333","not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Malignant tumor of breast|Familial cancer of breast;Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43106469.0,43106469.0,17q21.31,reviewed by expert panel,24.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00052,ClinGen:CA001328,UniProtKB:P38398#VAR_070460",2.0,54431.0,43106469.0,C,A,-,-,-,-,-,-,SCV000244311,-,-,199G>T ,Asp67Tyr,NM_007294.4,3.0,2_Benign,,54431.0,17,43106469.0,C,A,D,Y,rs80357102,17,41258486,17,38512012,67.0,BRCA1,ENSG00000012048,ENST00000713676,ENSP00000518978,P38398,BRCA1_HUMAN,.,.,c.199G>T,p.Asp67Tyr,principal2,Y,.,.,.,-,GAT,1.0,0.0,C,C/C,C/C,C/C,C/C,.,0.72322,.,.,0.79703,.,0.868,0.47756,P,0.24,0.38861,B,.,0.51279,.,.,.,.,1.25,0.31597,L,.,0.75325,.,.,0.67836,-0.0620,0.80864,T,0.6621,0.88225,D,10,.,0.34335,.,0.282437,0.90256,D,.,0.87125,.,.,.,.,.,.,0.86240,.,0.43573,.,0.11448,0.42940607667,0.29092,T,0.14757,0.48293,T,0.108459,0.64942,D,0.173063,0.81457,D,0.0394584648311138,0.03564,T,.,0.83345,.,0.28895706,0.51563,0.10798522,0.25949,0.378384,0.58872,0.13106883,0.31396,-6.164,0.51688,T,.,0.56478,.,0.956250935363193,0.81217,0.99734180,0.98344,0.64,0.79945,.,.,.,.,.,.,2.280806,0.29216,18.03,0.99318147251181976,0.59339,0.233566,0.35440,N,-0.260466381601807,0.30407,1.713454,-0.295009425429782,0.27944,1.574398,4.64,-1.4,0.08479,1.19,0.30954,0.033,0.13684,-0.025000,0.12924,0.531,0.24877,0.943,0.32853,0.0,0.08389,0.993,0.69292,459,0.78836,1,1.9968051118210862E-4,0,0.0,1,9.940357852882703E-4,0,0.0,0,0.0,0,0.0,10,264690,3.7780046E-5,.,8,109008,7.338910e-05,0,14,207104,6.759890e-05,0,17,235908,7.206200e-05,0,0,7140,0.000000e+00,0,1,16978,5.889980e-05,0,0,2308,0.000000e+00,0,0,9042,0.000000e+00,0,0,13390,0.000000e+00,0,7,42690,1.639730e-04,0,0,15548,0.000000e+00,0,7,42690,1.639730e-04,0,0,16118,0.000000e+00,0,2,30338,6.592390e-05,0,0,6186,0.000000e+00,0,0,13394,0.000000e+00,0,0,16710,0.000000e+00,0,12,89212,1.345110e-04,0,0,30298,0.000000e+00,0,12,89212,1.345110e-04,0,0,14808,0.000000e+00,0,2,34062,5.871650e-05,0,0,9548,0.000000e+00,0,0,17668,0.000000e+00,0,0,21604,0.000000e+00,0,15,102410,1.464700e-04,0,0,30216,0.000000e+00,0,15,102410,1.464700e-04,0,.,132,1596780,8.266640e-05,0,126,1165696,1.080900e-04,0,1,74666,1.339300e-05,0,0,912,0.000000e+00,0,2,59860,3.341130e-05,0,0,29466,0.000000e+00,0,0,44696,0.000000e+00,0,0,63924,0.000000e+00,0,0,5778,0.000000e+00,0,126,1165696,1.080900e-04,0,0,89912,0.000000e+00,0,12,129722,9.250551178674396E-5,0,352,0,0,2726,0,0,8264,0,0,790,0,0,946,0,0,626,0,0,280,0,0,7514,0,0,8616,0,0,3352,0,12,151220,7.935458272715249E-5,Benign,"Malignant_tumor_of_breast|not_provided|not_specified|Breast_and/or_ovarian_cancer|Hereditary_breast_ovarian_cancer_syndrome|Familial_cancer_of_breast|Fanconi_anemia,_complementation_group_S|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Pancreatic_cancer,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome",reviewed_by_expert_panel,NC_000017.11:g.43106469C>A,BRCA1-HCI:BRCA1_00052|ClinGen:CA001328|UniProtKB:P38398#VAR_070460,C0006142|C3661900|CN169374|CN221562|C0677776|C0346153|C4554406|C2676676|C3280442|C0027672,114480|617883|604370|614320,145|227535|145|1333|140162,.,Asp,Tyr,69098.0,single nucleotide variant,NM_007294.4(BRCA1):c.199G>T (p.Asp67Tyr),672.0,BRCA1,HGNC:1100,Benign,0.0,"Aug 10, 2015",80357102.0,-,RCV000047675|RCV000083176|RCV000148404|RCV000162582|RCV000195312|RCV000589035|RCV001353503|RCV002490619,"MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:CN221562|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333","not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Malignant tumor of breast|Familial cancer of breast;Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43106469.0,43106469.0,17q21.31,reviewed by expert panel,24.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00052,ClinGen:CA001328,UniProtKB:P38398#VAR_070460",2.0,54431.0,43106469.0,C,A,-,-,-,-,-,-,SCV000244311,-,-,199G>T ,Asp67Tyr,NM_007294.4,3.0,2_Benign,82.51,0.6073619631901841,"['604370', '114480', '617883', '604370', '614320']",,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST CANCER; FANCONI ANEMIA, COMPLEMENTATION GROUP S; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Findlay_2018_var828,BRCA1_Findlay_2018,BRCA1,1100,-1.0,41258486.0,43106469.0,43106469.0,NM_007294.3,199,G,T,67.0,D,Y,c.199G>T,p.Asp67Tyr,Missense,missense_variant,-0.0809950046543564,-0.269270142048911;0.107280132740199,FUNC,Yes,0.0000826663660616,Benign,reviewed by expert panel,"Aug 10, 2015",nucleotide,urn:mavedb:00000097-0-2,ENST00000357654.9,NM_007294.3,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,Functional ,"[-0.748, Inf)",Normal,Intermediate,"(-1.328, -0.748)",Not specified,Non-functional,"(-Inf,-1.328]",Abnormal,,,,,,,,,,,0.658,0.2168,likely_benign,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Asp67Tyr,Asp67Tyr,true
BRCA1,BRCA1_Leu660Pro,0.7722291595565172,0.4652467741162628,-0.4813800816904408,0.6449300602568304,2025_01_Batch_13-14,0.6971719961665781,0.7869883368284541,0.8313592527357382,0.834891704386117,0.49776189252515146,0.5429659929631443,0.5390418791814273,0.5403372846854197,0.5283318857429251,0.49704311042399857,0.6200689945648612,0.6630151080049407,0.6858482687105789,0.6816117950645211,0.497402501474575,false,false,false,false,false,0.0,0.0,0.0,0.0,0.0,true,BRCA1,ENSG00000012048,14613,218449.0,CCSBVarC003309,ALE00003309,NC_000017.11:43051104:A:G,1979T>C,Leu660Pro,CEGS2,CegsMutGDEh1027,B03,GDEhDisVCh_40059,B09,1.0,,,,,,,,,1.0,1.0,0.0,,0.0,,,0.0,,,0.0,,,BRCA1_Leu660Pro,17.0,43051104.0,A,G,17,Y,N,N,N,N,17-43051104-A-G,70177.0,single nucleotide variant,NM_007294.4(BRCA1):c.5291T>C (p.Leu1764Pro),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Aug 10, 2015",80357281.0,-,RCV000112604|RCV000509995|RCV000588744|RCV001528204,"MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900","Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43051104.0,43051104.0,17q21.31,reviewed by expert panel,12.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00049,ClinGen:CA003449,UniProtKB:P38398#VAR_063908",2.0,55510.0,43051104.0,A,G,-,-,-,-,-,-,SCV000244395,-,-,5291T>C ,Leu1764Pro,NM_007294.4,3.0,1_Pathogenic,,55510.0,17,43051104.0,A,G,L,P,rs80357281,17,41203121.0,17,38456647.0,1764.0,BRCA1,ENSG00000012048,ENST00000618469,ENSP00000478114,P38398,BRCA1_HUMAN,.,.,c.5291T>C,p.Leu1764Pro,principal2,Y,1,.,.,-,CTA,2.0,0.0,A,A/A,A/A,A/A,A/A,.,0.91343,.,.,0.79703,.,0.999,0.90580,D,0.937,0.77493,D,.,0.99291,.,.,.,.,2.255,0.63995,M,.,0.80457,.,.,0.93732,0.6256,0.92204,D,0.7595,0.91786,D,10,.,0.90949,.,0.852334,0.98860,D,.,0.88008,.,.,.,.,.,.,0.98778,.,0.82492,.,0.52805,0.554721057415,0.46456,T,0.394982,0.75228,T,0.436743,0.91807,D,0.389575,0.91707,D,0.994264304637909,0.85335,D,0.89611,0.63951,D,0.8910151,0.90460,0.6202942,0.77645,0.89131314,0.90488,0.55023813,0.73742,-11.462,0.82186,D,.,0.84401,.,0.997750985165462,0.93509,0.99987125,0.99835,0.96,0.98304,.,.,.,.,.,.,4.871541,0.79856,27.2,0.9989876250763176,0.97125,0.796452,0.72256,D,0.591172089691292,0.72477,5.834971,0.566318150584601,0.72388,5.826055,5.06,5.06,0.67796,5.33,0.93090,5.026,0.63961,11.097000,0.86063,0.756,0.943,1.0,0.71675,1.0,0.68239,0.96,0.51684,449,0.79449,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Pathogenic,"not_provided|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1",reviewed_by_expert_panel,NC_000017.11:g.43051104A>G,BRCA1-HCI:BRCA1_00049|ClinGen:CA003449|UniProtKB:P38398#VAR_063908,C3661900|C0677776|C0027672|C2676676,604370,145|140162|145,.,Leu,Pro,70177.0,single nucleotide variant,NM_007294.4(BRCA1):c.5291T>C (p.Leu1764Pro),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Aug 10, 2015",80357281.0,-,RCV000112604|RCV000509995|RCV000588744|RCV001528204,"MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900","Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided",germline;not applicable;unknown,germline,GRCh38,NC_000017.11,17,43051104.0,43051104.0,17q21.31,reviewed by expert panel,12.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00049,ClinGen:CA003449,UniProtKB:P38398#VAR_063908",2.0,55510.0,43051104.0,A,G,-,-,-,-,-,-,SCV000244395,-,-,5291T>C ,Leu1764Pro,NM_007294.4,3.0,1_Pathogenic,93.27,0.1646341463414634,['604370'],multiple,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Findlay_2018_var2801,BRCA1_Findlay_2018,BRCA1,1100,-1.0,41203121.0,43051104.0,43051104.0,NM_007294.3,5291,T,C,1764.0,L,P,c.5291T>C,p.Leu1764Pro,Missense,missense_variant,-1.98674456258502,-2.40978849951526;-1.56370062565477,LOF,Yes,,Pathogenic,reviewed by expert panel,"Aug 10, 2015",nucleotide,urn:mavedb:00000097-0-2,ENST00000357654.9,NM_007294.3,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,Functional ,"[-0.748, Inf)",Normal,Intermediate,"(-1.328, -0.748)",Not specified,Non-functional,"(-Inf,-1.328]",Abnormal,,,,,,,,,,,0.676,0.9211,likely_pathogenic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Leu1764Pro,Leu1764Pro,false
BRCA1,BRCA1_Thr581Ala,0.0497091547769512,0.9617428060924307,4.326359069964326,0.003453197422548223,2025_01_Batch_13-14,0.9167490291041218,0.9030116271717452,0.903340193991352,0.9247672489714605,0.8009118765693297,0.8837938926005537,0.8520433324779236,0.8593154762600081,0.9488159897593582,0.7574468749360753,0.9002714608523378,0.8775274798248345,0.8813278351256801,0.9367916193654093,0.7791793757527026,true,false,false,false,false,0.0,0.0,0.0,0.0,0.0,true,BRCA1,,14613,,CCSBVarC011843,,NC_000017.11:43067629:T:C,1741A>G,Thr581Ala,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Thr581Ala,17.0,43067629.0,T,C,17,,,,,,17-43067629-T-C,70031.0,single nucleotide variant,NM_007294.4(BRCA1):c.5053A>G (p.Thr1685Ala),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Aug 10, 2015",80356890.0,-,RCV000048749|RCV000112475|RCV000163024|RCV000212192,"MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900","Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided",germline;not applicable,germline,GRCh38,NC_000017.11,17,43067629.0,43067629.0,17q21.31,reviewed by expert panel,10.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00042,ClinGen:CA003174,UniProtKB:P38398#VAR_063902",2.0,55364.0,43067629.0,T,C,-,-,-,-,-,-,SCV000244379,-,-,5053A>G ,Thr1685Ala,NM_007294.4,3.0,1_Pathogenic,,55364.0,17,43067629.0,T,C,T,A,rs80356890,17,41219646,17,38473172,1685.0,BRCA1,ENSG00000012048,ENST00000357654,ENSP00000350283,P38398,BRCA1_HUMAN,c.5053A>G,p.Thr1685Ala,c.5053A>G,p.Thr1685Ala,principal2,Y,1,YES,Select,-,ACT,1.0,0.0,T,T/T,T/T,T/T,T/T,0.0,0.91343,D,0.0,0.92967,D,0.53,0.77914,P,0.183,0.88579,B,0.91,0.99291,A,simple_aae,9.0,91.0,3.31,0.90471,M,-0.82,0.74769,N,0.875,0.91505,0.7304,0.93530,D,0.7785,0.92454,D,10,0.8680128,0.85903,D,0.754689,0.98044,D,0.882,0.96531,.,.,.,.,.,0.952919659821,0.95202,.,0.86482,.,0.09116,0.670587182045,0.62862,T,0.403358,0.81781,T,0.418536,0.90878,D,0.363421,0.90764,D,0.970580279827118,0.68797,D,.,0.76208,.,0.96085334,0.97324,0.6886691,0.81474,0.9444927,0.95639,0.6872717,0.81396,-14.503,0.94593,D,0.523,0.76577,A,0.979632873704045,0.85227,0.99986613,0.99835,0.966,0.98629,.,.,.,.,.,.,3.78294,0.54478,23.5,0.99777731049735807,0.86531,0.717269,0.66764,D,0.641941303045784,0.75718,6.379083,0.607013709110586,0.75311,6.31232,5.24,5.24,0.72825,3.42,0.61925,4.786,0.62201,7.873000,0.72109,0.56,0.28431,1.0,0.71675,1.0,0.68239,0.983,0.59808,545,0.72635,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Pathogenic,"not_provided|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome",reviewed_by_expert_panel,NC_000017.11:g.43067629T>C,BRCA1-HCI:BRCA1_00042|ClinGen:CA003174|UniProtKB:P38398#VAR_063902,C3661900|C0677776|C2676676|C0027672,604370,145|145|140162,BRCT domain|BRCT domain|BRCT domain,Thr,Ala,70031.0,single nucleotide variant,NM_007294.4(BRCA1):c.5053A>G (p.Thr1685Ala),672.0,BRCA1,HGNC:1100,Pathogenic,1.0,"Aug 10, 2015",80356890.0,-,RCV000048749|RCV000112475|RCV000163024|RCV000212192,"MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900","Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided",germline;not applicable,germline,GRCh38,NC_000017.11,17,43067629.0,43067629.0,17q21.31,reviewed by expert panel,10.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"BRCA1-HCI:BRCA1_00042,ClinGen:CA003174,UniProtKB:P38398#VAR_063902",2.0,55364.0,43067629.0,T,C,-,-,-,-,-,-,SCV000244379,-,-,5053A>G ,Thr1685Ala,NM_007294.4,3.0,1_Pathogenic,94.85,0.352112676056338,['604370'],,Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Findlay_2018_var1723,BRCA1_Findlay_2018,BRCA1,1100,-1.0,41219646.0,43067629.0,43067629.0,NM_007294.3,5053,A,G,1685.0,T,A,c.5053A>G,p.Thr1685Ala,Missense,missense_variant,-1.84066821677464,-1.71745181073762;-1.96388462281166,LOF,Yes,,Pathogenic,reviewed by expert panel,"Aug 10, 2015",nucleotide,urn:mavedb:00000097-0-2,ENST00000357654.9,NM_007294.3,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,Functional ,"[-0.748, Inf)",Normal,Intermediate,"(-1.328, -0.748)",Not specified,Non-functional,"(-Inf,-1.328]",Abnormal,,,,,,,,,,,0.882,0.523,ambiguous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BRCA1_Thr1685Ala,Thr1685Ala,false
